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ABSTRACT OF DISSERTATION 
DIFFERENTIAL ACTIVITY AND CONTENT OF HIGH-AFFINITY 
GLUTAMATE TRANSPORTERS, CONTENT OF THEIR REGULATORY 
PROTEINS, AND CAPACITY FOR GLUTAMINE AND GLUTATHIONE 
SYNTHESIS IN TISSUES OF FINISHED VERSUS GROWING STEERS 
Improvement of feeding regimens for production animals has been hindered 
by a lack of fundamental knowledge about how the capacity to regulate nutrient 
absorption across cell membranes affects the function of nutrient metabolizing 
enzymes. The objective is to determine if the activities and protein content of system 
X-AG glutamate transporter, its regulatory protein (GTRAP3-18 and ARL6IP1), 
glutamine synthetase (GS) and glutathione (GSH) content, changes in liver 
(Experiment 1), longissimus dorsi (LM) and subcutaneous adipose tissue (SF) 
(Experiment 2) as beef steers transitioned from predominantly-lean (growing) to -
lipid (finished) tissue accretion phases. In liver (Experiment 1), system X-AG activity 
in canalicular membranes was abolished as steers developed from growing to 
finished stages but did not change in basolateral membranes. EAAC1 protein content 
in liver homogenates decreased in finished vs. growing steers, whereas GTRAP3-18 
and ARL6IP1 content increased and GLT-1 content did not change. Concomitantly, 
hepatic GS activity decreased in finished steers whereas GS protein content did not 
differ. Hepatic GSH content did not differ in finished vs. growing steers. These 
results demonstrate a negative functional relationship between GTRAP3-18 and 
system X-AG activity with glutamine synthesis capacity in livers of fattened cattle. In 
addition to liver, skeletal muscle and adipose tissues play important roles in 
maintaining whole-body glutamate and nitrogen homeostasis. In Experiment 2, 
Western blot analysis of LM homogenates showed decreased EAAC1 and GS 
content, whereas GTRAP3-18 and ARL6IP1 did not differ in finished vs. growing 
steers. GSH content in LM was increased in finished vs. growing steers in 
concomitance with increased mRNA expression of GSH-synthesizing enzymes. In 
SF, GTRAP3-18 and ARL6IP1 content was increased, whereas EAAC1 and GS 
content did not differ. Concomitantly, GSH content in SF was decreased in finished 
vs. growing steers in parallel with decreased mRNA expression of GSH-
metabolizing enzymes. These results demonstrate that the negative regulatory 
relationship between GTRAP3-18 and ARL6IP1 with EAAC1 and GS expression, 
which exists in liver, does not exist in LM and SF of fattened cattle; and antioxidant 
capacity in LM and SF changes and differs as steer compositional gain shifts from 
lean to lipid phenotype. To further explore the upstream regulatory machinery of 
EAAC1, transcriptome analysis (Experiment 3) was conducted to gain a greater 
understanding of hepatic metabolic shifts associated with the change in whole-body 
compositional gain of growing vs. finished beef steers. The expression of upstream 
regulators of EAAC1 was decreased in a manner consistent with the decreased 
EAAC1 activity in Experiment 1. Bioinformatic analysis found that, for amino acid 
metabolism, finished steers had increased capacities for ammonia, arginine, and urea 
production, and shunting of amino acid carbons into pyruvate. For carbohydrate 
metabolism, capacity for glycolysis was inhibited, whereas glycogen synthesis was 
stimulated in finished steers. For lipid metabolism, finished steers showed decreased 
capacity for fatty acid activation and desaturation, but increased capacity for fatty 
acid β-oxidation and lipid storage. In addition, redox capacity and inflammatory 
responses were decreased in finished steers. Collectively, these data describe novel 
regulatory relationships of system X-AG in liver and peripheral tissues, and the 
metabolic mechanisms that control nutrient use efficiency, as beef steers develop 
from lean to lipid phenotypes. 
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Chapter 1. Introduction 
 
L-glutamate (Glu) transport and metabolism are critical to support whole-animal 
energy and N homeostasis (Heitmann and Bergman, 1981a; Wu, 1998; Burrin and Stoll, 
2009). Glu can serve as a source of oxidizable fuel, precursor for amino acid synthesis, 
carbon receptor for alpha-amino- and ammonia-nitrogen derived from the catabolism of 
other amino acids, or substrate for de novo protein synthesis. The predominant metabolic 
fate of Glu is tissue specific. For example, in the intestinal epithelia, dietary and enteric 
Glu serve as important sources of carbons for oxidation-derived metabolic energy and 
endogenous synthesis of alanine and other amino acids (Wu, 1998). In the liver, Glu is a 
central substrate for ureagenesis, gluconeogenesis, glutathione (GSH) production, de 
novo protein synthesis, and nitrogen shuttling via glutamine (Gln) (Meijer et al., 1990; 
Brosnan, 2000; Watford, 2000). In skeletal muscle (Biolo et al., 1995; Vesali et al., 2002) 
and subcutaneous fat (Kowalski and Watford, 1994), the production of Gln from plasma 
Glu is thought to constitute an important route for whole-body ammonia recovery and 
detoxification.  
The principal source of circulating Glu is the liver where the Glu/Gln cycle 
occurs. Under normal physiological conditions, Glu produced from the deamination of 
Gln by liver-type glutaminase, and subsequently exported into sinusoidal blood by 
periportal vein hepatocytes, is thought to be the principal source of Glu for peripheral 
tissue use. In contrast to this net export of Glu by the liver, tissues that are net users of 
Glu (including the subcutaneous adipose and skeletal muscle) also are net exporters of 
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Gln (Hediger and Welbourne, 1999a; Patterson et al., 2002). Given the central role of Glu 
to support tissue and whole-body growth and maintenance, plus that plasma membrane 
transport capacity is thought to limit Glu metabolism (Low et al., 1994; Nissim, 1999; 
Gegelashvili et al., 2003), knowledge of how Glu transport capacity is regulated to 
support peripheral tissue metabolism, including Gln synthesis and GSH metabolism, is 
critical (Brosnan, 2000; Vandenberg and Ryan, 2013).  
Growing and finishing phases are two important animal production stages, which 
differ fundamentally in compositional growth. The growing stage reflects the acceleration 
growth phase of greatest lean (protein) to fat deposition. In contrast, the finishing phase 
reflects a time of greatest fat to lean deposition ratio with maximized meat yield and fat 
cover (U.S market weight). Understanding the physiological mechanisms altered 
concomitantly with the shift in whole-body compositional gain as cattle fatten (growing 
vs. finished steers), should provide mechanistic knowledge that can be applied to 
optimize tissue protein accretion. Accordingly, the goals of this dissertation were:  
1. To determine whether the hepatic activities and protein content of system X-AG 
transporters (EAAC1, GLT-1), system X-AG regulatory proteins (GTRAP3-18, 
ARL6IP1), and glutamine synthetase (GS) change as beef steers developed from 
predominantly lean to predominantly lipid deposition growth phases (Chapter 4). 
2.   To determine whether the content of system X-AG transporters, their regulatory 
proteins, glutamine synthetase (GS), glutathione (GSH), and mRNA expression of GSH-
synthesizing and metabolizing enzymes change in longissimus dorsi (LM) and 
subcutaneous adipose (SA) tissues of the same steers developing from predominantly 
lean into predominantly lipid growth phases (Chapter 5). 
 
3 
3. To identify shifts in hepatic transcriptome profiling and the upstream regulatory 
mechanisms of EAAC1 as beef steers develop from lean to lipid phenotype (Chapter 6). 
For convenience, the L-isomer form of amino acids is implied unless indicated 
otherwise.
 
4 
Chapter 2. Literature Review 
 
Molecular and Functional Characterization of Proteins Capable of Glu Transport  
In mammals, mediated absorption of Glu occurs by Na+-dependent and Na+-
independent biochemical activities. System X-AG is a high affinity Glu transport system 
(K = 4-40 μM) that mediates Na+-dependent uptake of L-Glu, D-, L-aspartate and L-
cysteine with an obligatory counter-exchange of K+ across cell membranes (Guidotti and 
Gazzola, 1992; Ganapathy et al., 1994; Danbolt, 2001). In addition to system X-AG, 
systems ASC and B0 also mediate Na+-dependent transport of L-Glu and L-aspartate, but 
only in acidic (pH < 5.5) environments. In contrast to Na+-dependent biochemical 
activities, Na+-independent uptake of Glu is mediated by system x-c. System x-c transport 
is an obligate exchange activity that typically mediates the exchange of intracellular L-
Glu for extracellular L-cystine (Sato et al., 1999; Matthews, 2005). The molecular 
identification and functional properties of these transporters have been characterized in 
mammals (see below) (Matthews, 2005). 
System X-AG Transporters.  Five mammalian proteins capable of system X-AG 
have been cloned, with the nonhuman system X-AG orthologs known as excitatory amino 
acid carrier 1 (EAAC1) (Kanai and Hediger, 1992), Glu transporter 1 (GLT1) (Pines et 
al., 1992), Glu-aspartate transporter 1 (GLAST1) (Storck et al., 1992) and excitatory 
amino acid transporter 4 (EAAT4) (Fairman et al., 1995b) and excitatory amino acid 
transporter 5 (EAAT5) (Kanai and Hediger, 2003; Beart and O'shea, 2007). The 
expression and function of these high- affinity Glu transporters has been extensively 
studied in the brain to understand how their presence facilitates the use of Glu as a 
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neurotransmitter (Danbolt, 2001). Except for EAAT5, all the system X-AG transporters are 
highly expressed by brain tissue, but with distinct distribution patterns. GLAST1 and 
GLT-1 represent glial-specific Glu transporters that are involved in the neurotransmission 
(Torp et al., 1994; Berger and Hediger, 1998), whereas EAAC1 and EAAT4 are the 
predominant transporters in neurons to support metabolic functions of brain tissues (Torp 
et al., 1997; Berger and Hediger, 1998).  
In addition to being the predominant transporter in the brain tissues, EAAC1 is 
the most widely distributed of the Glu transporters in peripheral tissues. For example, in 
the rabbit, EAACl mRNA is expressed by the duodenum, jejunum, ileum, heart, liver, 
and placenta, but not the colon, lung, or spleen (Kanai and Hediger, 1992). In ruminants, 
EAAC1 and GLT-1 are expressed by the intestinal epithelia, liver, kidney, and skeletal 
muscle tissues, whereas only EAAC1 protein is consistently detectable in adipose tissues 
(Howell et al., 2001; Howell et al., 2003; Xue et al., 2010; Miles et al., 2015; Matthews et 
al., 2016). In humans, GLAST1 mRNA is expressed in heart, lung, skeletal muscle and 
placenta tissues (Nakayama et al., 1996). However, in cattle and sheep, GLAST1 protein 
is not detectable by immunoblot analysis in non-neuronal tissues that express EAAC1 
and GLT-1, except for the pancreas (Howell et al., 2001). In contrast to the wide 
distribution of EAAC1 and GLT-1, the expression of EAAT4 and EAAT5 is restricted in 
the brain (Fairman et al., 1995a; Nagao et al., 1997) and in the retina (Arriza et al., 1997), 
respectively.  
System ASC/B0 Transporters. Na+-dependent system ASC transports alanine, 
serine, cysteine, and other neutral α-amino acids. ASCTl cDNA, originally cloned from 
human brain tissue, encodes for system ASC-like activity and shares nearly 40% amino 
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acid sequence identity with the anionic EAAT transporters (Arriza et al., 1993; 
Utsunomiya Tate et al., 1996). Although ASCT1 also transports Glu and Asp at pH of 5.5 
or lower, system ASC accounts for the majority uptake of neutral amino acids above pH 
6 (Palacín et al., 1998). ASCTl mRNA is highly expressed in the brain, skeletal muscle, 
and pancreas, and also detectable in liver, heart, lung, placenta, and kidney human tissues 
(Arriza et al., 1993; Hofmann et al., 1994; Weiss et al., 2001).  
Similar to system ASC transporter, system B0 mediates Na+-coupled uptake of 
neutral amino acids, including alanine, serine and cysteine (Stevens et al., 1982). In 
acidic (pH < 5.5) environments, system B0 also transports L-Glu and L-aspartate. The 
cDNAs of ATB0 and ASCT2 that encode for the system B0 activity have been isolated in 
mammals (Kekuda et al., 1996; Kekuda et al., 1997; Pollard et al., 2002). ATB0 is 
localized to the brush border membrane in proximal tubule cells and enterocytes (Avissar 
et al., 2001; Bröer et al., 2004), which is consistent with previously characterized pattern 
of biochemically defined system B0 activity (Stevens et al., 1982; Lynch and McGivan, 
1987). In mice, expression of ASCT2 mRNA has been identified in various tissues, such 
as adipose, skeletal muscle, placenta, kidney, large intestine, lung, pancreas, and testes 
(Liao and Lane, 1995; Utsunomiya Tate et al., 1996).  
System x-C Transporters. System x-C is the most widely expressed Na+-
independent transport activity for anionic amino acids. Although system x-C activity is 
typically low, this activity mediates the highly specific counter-exchange of intracellular 
L-Glu for extracellular L-cystine (Bannai and Kitamura, 1980), which finally yields two 
cysteine molecules as cystine is rapidly reduced in the cytosol. Because cysteine is 
thought to be the limiting substrate for glutathione synthesis (Sato et al., 1999; Matthews, 
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2005), it follows that system x-C is important in regulating GSH synthesis and cellular 
redox balance. Indeed, system x-C activity is upregulated in response to oxidative stress 
(Sato et al., 2005). 
The protein capable of system x-C activity has been identified in human and 
mouse, is designated as xCT (Sato et al., 1999). Human xCT (Bassi et al., 2001) displays 
Km values of 43 and 93 µM for L-cystine and L-Glu, respectively. Knockout of xCT 
leads to alterations of redox balance (Sato et al., 2005), further suggesting system x-C 
activity influences the redox potential of a cell by transporting cystine for glutathione 
synthesis (Kilberg, 1982; Takada and Bannai, 1984; Bannai and Tateishi, 1986). 
Glu transport in support of tissue-specific metabolism 
Liver. A primary function of the mammalian liver is to coordinate whole-body 
energy and N metabolism. Hepatic transport and intermediary metabolism of Glu are 
critical to these processes as Glu is a central substrate for hepatic ureagenesis, 
gluconeogenesis, glutathione production, de novo protein synthesis, and nitrogen 
shuttling via Gln (Meijer et al., 1990; Nissim, 1999; Watford, 2000) (Figure 2.1; Figure 
2.2). Hepatocytes are highly polarized cells containing three functionally distinct surface 
domains: sinusoidal, lateral and canalicular (Boyer, 1980; Evans, 1980). Because the 
sinusoidal and lateral membranes are in physical continuity and highly specialized for the 
exchange of metabolites with the blood, these two plasma membrane surface areas are 
designated as the basolateral domain. In contrast, the bile canalicular domain participates 
in the primary secretion of bile constituents, including bile acids, and other detoxified 
substances (Boyer, 1980). 
Glu/Gln Metabolism in the liver. An important aspect of Glu metabolism in the 
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liver is the heterogeneity of Gln/Glu metabolism. Specifically, Gln, arriving from the 
peripheral tissues via the portal vein, is efficiently absorbed by periportal hepatocytes and 
deaminated by glutaminase (liver-type) to release ammonia and Glu. Alanine 
transaminase (glutamic-pyruvic transaminase, GPT), also primarily expressed by 
periportal vs. pericentral hepatocytes, supports ammonia production by transaminating 
Ala to pyruvate (Welsh, 1972), producing Glu from α-KG. Glu, in turn, can be 
deaminated by Glu dehydrogenase to produce ammonia and α-KG. Ammonia from 
peripheral Gln and Ala now can be incorporated into carbamoyl phosphate for 
ureagenesis. Moreover, aspartate transaminase (GOT) expressed in the periportal 
hepatocytes (Boon et al., 1999; Braeuning et al., 2006) converts oxaloacetate and Glu 
into aspartate and oxoglutarate, that also feeds into urea cycle, whereas the remaining Glu 
is available for conversion to α-KG (as an anapleurotic reaction to replenish the citric 
acid cycle), used for gluconeogenesis, used for protein synthesis, or transported into the 
sinusoids.  
In contrast to the periportal zone, when released into the sinusoidal blood, Glu is 
available for absorption by “down-acinus” pericentral hepatocytes, which express the 
high-affinity system X-AG activity (Häussinger and Gerok, 1983; Braeuning et al., 2006; 
Brosnan and Brosnan, 2009) (Figure 2.3). If absorbed by pericentral hepatocytes, Glu and 
the “scavenged” sinusoidal ammonia that escapes incorporation into urea by periportal 
hepatocytes are incorporated into Gln by pericentral hepatocyte-specific GS activity, thus 
completing the hepatic Gln-Glu cycle (Moorman et al., 1989; Moorman et al., 1990; 
Wagenaar et al., 1994). Besides supporting Gln synthesis by GS, pericentral hepatocyte-
localized system X-AG uptake of Glu complements pericentral hepatocyte-specific 
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synthesis of glutathione by glutamylcysteine ligase and glutathione synthetase 
(Braeuning et al., 2006), as well as supplying Glu as source of gluconeogenic carbons 
and for de novo protein synthesis (Watford, 2000).  
To gain an insight into the molecular mechanisms of the metabolic function of 
bovine hepatocytes, it is essential to determine if Glu transport capacities are localized in 
basolateral (sinusoidal) and canalicular (apical) membranes of hepatocytes. Using 
isolated membrane vesicles from rat liver, system X-AG activity has been detected in 
canalicular-enriched fractions and a Na+-independent activity in the sinusoidal membrane 
domain (Ballatori et al., 1986; Cariappa and Kilberg, 2006). In contrast, other studies 
have shown both system X-AG activity and Na+-independent (exchanger) Glu transport 
activities exist in sinusoidal membranes of rat hepatocytes (Low et al., 1992). 
Furthermore, the system X-AG activity was upregulated in response to catabolic hormones 
(corticosteroid, glucagon), whereas the Na+-independent, Glu exchanger activity (system 
x-c-like) was insensitive to alteration of whole-body catabolic status. These results 
suggest that system X-AG activity on the sinusoidal membrane facilitates adaptation of 
hepatocytes to handle the increase in sinusoidal ammonia loads that accompany catabolic 
stress. That is, possession of an increased concentrative Glu transport capacity would 
supply more Glu to serve as an acceptor of ammonia through the activities of glutamine 
synthetase.  
However, it has been argued that Na+-dependent Glu uptake does not limit 
pericentral hepatocyte GS activity and that GS activity is relatively insensitive to change 
in various metabolic states for nonruminants (Watford, 2000). For example, during 
acidosis and long-term starvation in nonruminants, the liver switches from a net 
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consumer to net producer of Gln (Heitmann and Bergman, 1980) by decreasing 
glutaminase activity and the rate of urea synthesis to conserve nitrogen, with the absolute 
rate of Gln synthesis unchanged. In contrast, in ruminants, hepatic GS activity and 
protein content do not change during metabolic acidosis (Lobley et al., 2001; Xue et al., 
2010). Thus, these findings may represent differences in hepatic Glu/Gln metabolism 
between ruminants and nonruminats. 
Glutathione synthesis and metabolism. In addition to supporting Gln synthesis, 
Glu is also the substrate for glutathione synthesis. The tripeptide glutathione (γ-L-
glutamyl-L-cysteinylglycine) is present in mammalian tissues at 1-10 mM concentrations 
with highest concentrations in liver (Lu, 2013) (Table 2.1). GSH functions as the major 
antioxidant and serves as a transport reservoir of cysteine to maintain the celluar thiol 
reduction potential (Aoyama et al., 2008; Forman et al., 2009; Schmidt and Dringen, 
2012). Of the total cellular glutathione pool, 80-85% of GSH is found in the cytosol 
versus 10-15% in the mitochondria, and a small amount in the endoplasmic reticulum 
(Meredith and Reed, 1982; Hwang et al., 1992; Yuan and Kaplowitz, 2009; Lu, 2013). 
Glutathione modulates diverse cellular processes. For example, GSH is involved in redox 
signaling, detoxification of xenobiotics and regulates cell proliferation, apoptosis and 
immunity (Meister and Anderson, 1983; Suthanthiran et al., 1990; Ballatori et al., 2009; 
Lu, 2009; Pallardó et al., 2009; Liu and Pravia, 2010). 
Biosynthesis and whole-body utilization of GSH occurs in a tightly regulated 
manner. Cellular GSH synthesis strongly depends on the availability of Cys and Glu 
(Sato et al., 1999; Flaring et al., 2003; Matthews, 2005). Cys can be derived from the 
diet, protein breakdown by liver, and other sulfur amino acid GSH precursor such as 
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methionine via the transsulfuration pathway (Lu, 2013). Cys is oxidized to disulfide 
cystine extracellularly, but cystine can be rapidly reduced to Cys once taken up by cells 
(Bannai and Tateishi, 1986). In hepatocytes, the uptake of Cys is mediated by Na+ 
dependent system X-AG transporters and the ASC system, whereas cystine (the oxidized 
form of cysteine) is absorbed by the Na+ -independent x-C system (Kilberg, 1982; Takada 
and Bannai, 1984; Matthews, 2005). In addition to cysteine uptake mediated by 
transporters, Glu plays an important role in GSH synthesis. GSH synthesis is enhanced 
with high intracellular Glu concentration in canine erythrocytes (Griffith, 1999). 
However, in patients with cancer or brain injury with high extracellular Glu 
concentration, Cys uptake is competitively inhibited by Glu, resulting in reduced GSH 
synthesis (Tapiero et al., 2002). Glu also prevents the feedback inhibitory effect of GSH 
on GSH-synthesizing enzymes (e.g., glutamate-cysteine ligase) by competing with GSH 
for binding to the enzyme (Griffith, 1999).  
The main site for GSH production is the liver with system X-AG transporters, with 
GSH and bile acid synthesizing enzymes being co-localized to pericentral hepatocytes 
(Häussinger and Gerok, 1983; Boon et al., 1999; Braeuning et al., 2006). Because GSH 
exported from the liver to the blood is utilized by organs such as muscle and kidney, 
depletion of liver GSH under oxidative stress may also deplete GSH in these tissues. 
Thus, factors that regulate hepatic GSH production and secretion play a critical role in 
whole animal GSH homeostasis (Lauterburg et al., 1984; Deneke and Fanburg, 1989; 
Ookhtens and Kaplowitz, 1998). 
Antioxidant function of GSH 
Glutathione is the most abundant cellular thiol present in mammalian tissues. 
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Several GSH related enzymes guard cells against oxidative injury by scavenging reactive 
oxygen species and nitrogen radicals. In the cytosol and mitochondria, superoxide 
dismutase (SOD) catalyzes the dismutation of superoxide radical (O2-) into H2O2, which 
is subsequently reduced into water and oxygen by catalase in the peroxisome (Salvi et al., 
2007). However, in mitochondria and cytosol, GSH is especially important in defending 
against oxidative stress (Fernandez Checa et al., 1997; Garcia Ruiz and Fernandez Checa, 
2006; Lu, 2013). The antioxidant function of GSH is catalyzed by GSH peroxidase, 
which reduces lipid peroxide and hydrogen peroxide into corresponding alcohols and 
water to prevent the organism from the oxidative damage. Glutathione can also conjugate 
with xenobiotics via glutathione-S-transferases (GST) for the purpose of detoxification 
(Schmidt and Dringen, 2012). At the same time, GSH (reduced form of glutathione) is 
oxidized to GSSG (disulfide-oxidized form) that can be subsequently reduced back into 2 
GSH by GSSG reductase, forming a redox cycle.  In the cell, the ratio of GSH to GSSG 
mainly determines the intracellular redox potential (Forman et al., 2009). However, 
severe oxidative injury may compromise the ability of the cell to reduce GSSG into 2 
GSH molecules, leading to GSSG accumulation (Lu, 2009). To maintain the redox 
equilibrium, GSSG is either exported out of the cell or reacts with a protein sulfhydryl 
group to form a mixed disulfide (Figure 2.4) (Schmidt and Dringen, 2012; Lu, 2013). 
Glutathione synthesis 
Glutathione synthesis involves two consecutive ATP-requiring enzymatic 
reactions: formation of γ-glutamylcysteine from Glu and Cys by γ-glutamylcysteine 
ligase (GCL) and formation of glutathione from γ-glutamylcysteine and glycine by 
glutathione synthase. The rate-limiting enzyme GCL is composed of a catalytic subunit 
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(GCLC) and a modifier subunit (GCLM) (Yang et al., 2002; Franklin et al., 2009). GCLC 
catalyzes γ-glutamylcysteine synthesis, whereas GCLM modulates GCLC by lowering 
the Km for Glu and increasing the Ki for the feedback inhibition of GCL by glutathione 
(Richman and Meister, 1975; Huang et al., 1993a; Huang et al., 1993b; Chen et al., 
2005). Consequently, the holoenzyme GCL more efficiently catalyzes γ-glutamylcysteine 
synthesis and is subject to less GSH feedback inhibition compared to GCLC. The second 
step of GSH synthesis from γ-glutamylcysteine and glycine is catalyzed by glutathione 
synthase (GSS). Although glutathione synthase is usually not considered to be rate 
limiting, increased glutathione synthase expression can further promote GSH production 
in rat hepatocytes (Huang et al., 2000; Dalton et al., 2004). 
Extracellular metabolism of glutathione 
Glutathione is transported out of the cell by GSH transporters such as the 
multidrug resistance protein Mrp family (Schmidt and Dringen, 2012; Bachhawat et al., 
2013). The unique structure of GSH is that Cys is linked with γ-carboxyl group of Glu 
instead of α-carboxyl group, which makes glutathione resistant to intracellular 
degradation (Lu, 2013). The only enzyme to hydrolyze the γ-carboxyl-amine bound of 
glutathione is γ-glutamyltranspeptidase (GGT), expressed on the surface of certain cell 
types (Meister and Anderson, 1983). GGT is highly expressed in epithelium of lung, 
kidney and intestine (Deneke and Fanburg, 1989). However, importantly, GGT is lowly 
expressed in hepatocytes, which is consistent with the role of liver as a net exporter of 
GSH (see below) (Lauterburg et al., 1984). GGT transfers the γ-glutamyl motif to an 
acceptor amino acid, forming γ-glutamyl amino acid and cysteinylglycine. The γ-
glutamyl amino acid can be transported back into the cell to release 5-oxoproline, which 
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is finally converted to Glu as the substrate for GSH synthesis. On the other hand, 
cysteinylglycine is broken down by dipeptidase to yield cysteine and glycine, which are 
also transported back into the cell to be reincorporated into GSH. Once inside the cell, 
most of the cysteine is used for GSH synthesis while the rest is broken down into sulfate 
and taurine or is incorporated into new protein.  Therefore, the γ-glutamyl cycle is 
important to maintain GSH homeostasis by breaking down extracelluar glutathione 
through GGT and recycling back into the rate-limiting cysteine for intracellular GSH 
synthesis (Figure 2.5) (Lu, 2013). 
Inter-organ flux of GSH  
The main site for the GSH production is the liver with system X-AG transporters 
and glutathione and bile acid synthesizing enzymes localized to pericentral hepatocytes 
(Häussinger and Gerok, 1983; Boon et al., 1999; Braeuning et al., 2006). After GSH 
synthesized by the liver is exported into blood and bile, the kidney can either directly take 
up GSH from the plasma into cells or salvage plasma GSH through the GGT reaction.  
Plasma GSH can also be utilized by other organs such as lung and intestinal epithelium 
with high levels of GGT activity (Deneke and Fanburg, 1989). The portal vein brings 
blood from the intestine to the liver where xenobiotics are neutralized by hepatocytes if 
not detoxified in the intestine (Fernandez Checa and Kaplowitz, 2005; Lushchak, 2012). 
Because the liver has low GGT activity and is a net exporter of GSH, depletion of liver 
GSH under oxidative stress or xenobiotics metabolism may also deplete GSH in other 
tissues. Therefore, hepatic GSH production and secretion play a critical role in the whole 
animal glutathione homeostasis (Figure 2.6) (Lauterburg et al., 1984; Deneke and 
Fanburg, 1989; Ookhtens and Kaplowitz, 1998). 
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GSH mediated oxidative capacity in the liver in response to physiological challenges in 
animal models 
The oxidative capacity in liver changes in response to physiological challenges. 
Selenoproteins, such as glutathione peroxidase and selenoprotein W (SEPW1), bind to 
GSH and target reactive oxygen species such as hydrogen peroxide and lipid peroxide 
(Jeong et al., 2002). Administration of selenium protects rats from the arsenic-induced 
oxidative damage in liver (Messarah et al., 2012). In maturing beef heifers, 
supplementation of different forms of selenium (inorganic, organic and mixed form) 
changes the hepatic transcriptome profiles (Matthews et al., 2014). The seleneoprotein W 
(SEPW1) mRNA was upregulated in all forms of selenium supplementation, suggesting a 
greater antioxidant capacity (Matthews et al., 2014). Moreover, GSH content and 
expression of enzymes responsible for GSH synthesis change under disease conditions. In 
chronic liver disease, the cellular glutathione content and GPx expression are increased 
upon activation of rat hepatic stellate cells to protect against the ROS induced toxicity 
(Dunning et al., 2013). Similarly, the increased transcription rate of GCLC and 
glutathione synthase results in elevated GSH levels for liver regeneration in human 
hepatocellular carcinoma (Huang et al., 2001). 
In summary, much still remains to be determined about how the submembrane 
localization of Glu transport activities supports Gln and GSH synthesis and metabolism. 
Moreover, improvement of feeding regimens for production animals has been hindered 
by a lack of fundamental knowledge about how the capacity to regulate nutrient 
absorption across cell membranes affects the function of nutrient metabolizing enzymes. 
Although plasma membrane transport capacity is thought to limit Glu metabolism (Low 
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et al., 1994; Nissim, 1999; Gegelashvili et al., 2003), knowledge of how hepatic Glu 
transport capacity may be regulated to support changes in metabolic capacity associated 
with different phases of growth (e.g., predominately-lean to predominately-lipid tissue 
accretion) is limited. 
Skeletal Muscle Tissues. The uptake of plasma Glu, its intracellular conversion to 
Gln, and subsequent export of Gln to the plasma by skeletal muscle is critical to the 
proper functioning of intestinal epithelia and immune system (Newsholme and Parry-
Billings, 1990; Hack et al., 1996). In addition to having important roles in other tissues of 
the body, Glu is central to many metabolic processes in skeletal muscle. For example, 
Glu is required for transamination of branch-chain amino acids, pivotal to the formation 
of ammonia, Asp, Ala, and Gln, and is the primary AA taken up by resting and active 
muscles (Mourtzakis and Graham, 2002). A reduction in the capacity for plasma Glu 
uptake by skeletal muscle is thought to cause intracellular deficiencies of Glu, Gln, 
glutathione, and citric acid cycle intermediates (Hack et al., 1996; Ushmorov et al., 
1999).  
In skeletal muscle (Biolo et al., 1995; Vesali et al., 2002), the production of Gln 
from plasma Glu is thought to constitute an important route for whole-body ammonia 
recovery and detoxification. However, information on the molecular identity of Glu 
transporters expressed in muscle tissue is limited. System X-AG activity has been reported 
in skeletal myocytes (Low et al., 1994), as has EAAC1 mRNA and protein expression by 
rat and human skeletal muscle (Kanai and Hediger, 1992). Recently, we have identified 
the presence of both mRNA and protein for two system X-AG transporters (EAAC1 and 
GLT-1) in the Longissimus dorsi (LM) of fattening cattle (Matthews et al., 2016), 
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whereas GLT-1, GLAST-1 or EAAT4 protein was not detected. These results suggest 
EAAC1 and GLT-1 play an important role in supporting carbon and N metabolism in this 
skeletal muscle. Moreover, although GS mRNA was identified in LM, GS protein was 
not detected in LM, indicating a relatively low GS content in LM. This low GS content in 
steer LM is consistent with the general understanding that although GS activity is low in 
mammalian skeletal muscle, the total amount of skeletal muscle- expressed GS activity is 
very high, as a consequence of the large total skeletal muscle mass (Kuhn et al., 1999). 
From a developmental perspective, an important observation was that the protein 
expression of both EAAC1 and GLT-1 was inversely proportional to developmental age. 
That is, the content of both EAAC1 and GLT-1 in the Longissimus dorsi of suckling 
animals (30 days old) was greater than in weanling age (184 days old), which was greater 
than that by backgrounding (284 days) or finishing (423 days old) cattle. These results 
suggest longissimus dorsi of steers developing through typical production stages have 
different capacities for Glu uptake. Whether this reduction in Glu transport capacity in 
skeletal muscle reflects a shift in nitrogen and glutathione metabolism remains to be 
determined.  
GSH mediated oxidative capacity in the skeletal muscle in response to physiological 
challenges in animal models 
In addition to supporting nitrogen metabolism, Glu transporters contribute to the 
cellular redox potential by delivering substrates to support intracellular GSH synthesis in 
LM. However, under oxidative stress conditions, Glu transporter proteins and enzymes 
supporting the sodium and Glu gradients (e.g., Na, K-ATPase, Gln synthetase) can be 
oxidized in presence of higher concentrations of reactive oxygen radicals, leading to 
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inhibition of metabolic functions (Volterra et al., 1994; Gegelashvili and Schousboe, 
1997). In a human trauma model, glutathione concentration decreases in skeletal muscle, 
indicating oxidative stress caused by tissue injury (Flaring et al., 2003). However, 
glutathione depletion in muscle can be attenuated by Gln supplementation via a supply of 
Glu for glutathione synthesis (Flaring et al., 2003). Thus, dietary amino acid 
supplementation seems to be a good therapeutic strategy to modulate GSH synthesis. On 
the contrary, a deficient sulfur amino acids diet decreases growth and glycolysis of 
longissimus muscle in piglets (Conde-Aguilera et al., 2015), suggesting the inadequate 
nutrition supply impairs GSH homeostasis.  
Adipose tissues. Adipose tissues play a significant role in whole body amino acid 
metabolism (Frayn et al., 1991; Kowalski et al., 1997; Patterson et al., 2002). 
Subcutaneous adipose has been proven to be a net user of Glu and net producer of Gln 
(Frayn et al., 1991) with the metabolic capacity to be an important site for Gln synthesis 
in the body (Ritchie et al., 2001). The inguinal adipose pad/adipocyte tissue of fed rats 
also appears to be a net user of Glu and ammonia, and a producer of Gln (Kowalski and 
Watford, 1994). Accordingly, these studies gave rise to the concept that the adipose 
tissues of normally-nourished mammals absorb Glu to synthesize Gln and, therefore, 
contribute to whole-body nitrogen metabolism through the production of Gln and 
removal of ammonia from the blood. Thus, it seems reasonable to suggest that the 
relative contribution of adipose-synthesized Gln to whole-body N metabolism is strongly 
influenced by the relative activity of Glu transporters and GS (Ritchie et al., 2001).  
However, information characterizing amino acid uptake in adipose tissue in vivo 
is very limited. EAAC1 was the only system X-AG transporter expressed in subcutaneous 
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and kidney adipose tissues (Matthews et al., 2016), suggesting EAAC1 function may be 
critical for Glu-based adipose metabolism, including the synthesis of Gln from plasma 
Glu. Another important finding of Matthews et al. (2016) was that expression of GS 
paralleled the increase in EAAC1 content from the weanling to backgrounding stage, but 
not during the finished stage, when GS content, but not EAAC1, was decreased 
(Matthews et al., 2016). Thus, Gln formation in the younger steer is important to steer 
development, but by the finishing stage, assuming that increased EAAC1 content is 
equivalent to increased Glu uptake, the increased Glu is used for some function other 
than Gln formation. For example, Glu carbons could enter the TCA cycle as α-
ketoglutarate to be used for fatty acid synthesis. Although speculative, the metabolic 
significance of this finding may be that glucose molecules are spared from oxidation to 
be available for glycerol synthesis to support triglyceride synthesis by oxidizing Glu 
instead of glucose or lactate (Smith and Prior, 1982; Smith, 1995). When combined with 
the higher GS content in subcutaneous and kidney adipose tissues at backgrounding vs. 
finishing, although speculative, the aggregate findings demonstrate the capacity to handle 
increase ammonia production as steers develop is concomitant with an increased capacity 
of the disproportionately accreting adipose tissue – up to the finishing phase.  
In addition to subcutaneous and kidney adipose tissues, EAAC1 protein was 
expressed by subcutaneous, kidney, omental, mesenchymal, and intramuscular adipose 
tissues in finishing steers. These depots displayed differential expression of EAAC1, 
suggesting that EAAC1 function may be linked to the metabolic differences known to 
exist among bovine adipose depots (Eguinoa et al., 2003; Baldwin et al., 2007). Among 
these adipose depots, intramuscular adipose tissues had higher EAAC1 content than 
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kidney and subcutaneous adipose tissues, suggesting a greater ability to absorb Glu to 
support ammonia capture and/or glucose-sparing in these tissues (Matthews et al., 2016). 
 In addition to maintaining whole-body Glu and nitrogen homeostasis, adipose 
tissues also contribute to the redox potential and energy homeostasis in the whole animal 
body. Increased oxidative stress in obesity has been shown in human, mice, and pig 
models: increased reactive species production and oxidative damage were observed in 
subcutaneous adipose tissue in obese and type 2 diabetes (Chattopadhyay et al., 2015); 
dysregulation of adipose glutathione peroxidase 3 results in systemic oxidative stress in 
obese mice (Lee et al., 2008); moreover, selenoprotein gene profiles change in different 
tissues such as liver and subcutaneous fat in pigs fed on a high fat diet (Zhao et al., 2015), 
suggesting a potential change of redox potential. In addition to obesity, adipogenesis can 
be inhibited by oxidative stress accumulation in adipose tissue in aging mice (Findeisen 
et al., 2011).  
Regulation of Glu transport capacity 
Posttranscriptional Regulation of Glu Transporter Content and Capacity. An 
important question of gene and protein expression is at what level the regulation occurs. 
The mRNA expression of system X-AG transporters by liver, skeletal muscle, adipose 
tissues, kidney, small intestine epithelia and placenta, does not always correlate with the 
protein expression levels (Matthews et al., 1998; Howell et al., 2001; Howell et al., 2003; 
Matthews et al., 2016). Other studies also reported that increased content of EAAC1 by 
AA-deprived NBL-1 cells is accompanied by a decrease in EAAC1 mRNA levels 
(Plakidou-Dymock and McGivan, 1993). These findings indicate that posttranscriptional 
regulation is an important form of regulating the expression of system X-AG transporters 
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(Vogel and Marcotte, 2012). 
MicroRNAs (miRNAs) are small, non-coding RNAs (approximately 22 
nucleotides) that regulate gene expression primarily through mRNA degradation or 
inhibition of protein translation in a sequence-specific manner, although some miRNAs 
are reported to enhance translation (Bartel, 2004). In mouse dopaminergic neurons, miR-
96-5p has been identified to target EAAC1, resulting in degradation of EAAC1 mRNA 
(Kinoshita et al., 2014). Intracerebroventricular administration of miR-96-5p inhibitor 
increases the mRNA and protein level of EAAC1 as well as that of GSH and 
consequently, exhibits a neuroprotective effect in the mouse brain (Kinoshita et al., 
2014).  
Posttranslational Regulation of Glu Transporter Content and Capacity. At the 
post-translational level, platelet-derived growth factor (PDGF) stimulates EAAC1 
expression and transport activities through the phosphatidylinositol 3-kinase (PI3K) 
pathway in mouse neuronal cells (Sims et al., 2000). PI3K activates serum- and 
glucocorticoid- inducible kinase 1 (SGK1) and protein kinase B (Akt/PKB) through 
phosphoinositide-dependent kinase 1(PDK1) activation (Aoyama and Nakaki, 2013). 
Consequently, the constitutively active SGK1 and Akt/PKB stimulate Glu uptake by 
EAAC1(Schniepp et al., 2004) (Figure 2.7). Another upstream regulator of EAAC1 is 
protein kinase C (PKC). PKCa activation increases the transport activity and the cell 
surface expression of EAAC1, whereas PKCe activation stimulates Glu transport activity 
of EAAC1 without changing the protein abundance on the plasma membrane (González 
et al., 2002; Huang et al., 2006). EAAC1 is also up-regulated by the serine/threonine 
kinase mammalian target of rapamycin (mTOR) (Almilaji et al., 2012), which plays a 
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critical role in protein synthesis, cell growth and proliferation (Hay and Sonenberg, 
2004). Conversely, EAAC1 activity and expression were decreased by expression of the 
constitutively active AMP-activated protein kinase (AMPK) in Xenopus oocytes (Sopjani 
et al., 2010).  
In addition to various signal transduction pathways in which EAAC1 is involved, 
EAAC1 is also regulated by protein-protein interactions (Figure 2.8). The activity of 
EAAC1 is regulated by two endoplasmic reticulum (ER)-localized proteins, GTRAP3-18 
(Glu transporter-associated protein 3-18, a.k.a. addicsin and ADP-ribosylation factor-like 
6 interacting protein 5/ARL6IP5, or PRAF3) and ARL6IP1 (ADP-ribosylation factor-like 
6 interacting protein 1). GTRAP3-18 forms homodimers to bind to EAAC1, thus 
decreasing EAAC1 trafficking from ER to the Golgi and, subsequently, cell surface 
localization of EAAC1 (Ruggiero et al., 2008). Once the [GTRAP3-18]2-EAAC1 
complex reaches the cell surface, GTRAP3-18 negatively regulates EAAC1 transport 
activity by decreasing its substrate affinity (Lin et al., 2001). Accordingly, inhibition of 
GTRAP3-18 leads to an increase in EAAC1 activity and GSH production, at least in mice 
neurons (Watabe et al., 2007, 2008; Aoyama et al., 2012). However, an ER-localized 
protein ARL6IP1 serves as a positive regulator of EAAC1 by interacting with GTRAP3-
18 to decrease the GTRAP3-18/EAAC1 interaction. If ARL6IP1 abundance is relative 
high to GTRAP3-18, ARL6IP1 interacts with GTRAP3-18 to prevent formation of 
[GTRAP3-18]2-EAAC1 complexes and therefore, indirectly promotes EAAC1 transport 
activity and GSH synthesis in neurons (Figure 2.8) (Akiduki and Ikemoto, 2008). 
Collectively, above findings indicate that regulation of system X-AG proteins is 
complex and likely involves transcriptional, posttranscriptional, and posttranslational 
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regulation, depending on the particular effects. Much research has been performed 
regarding the regulation of system X-AG transporters in neuronal tissues. However, 
despite the central role of system X-AG in supporting carbon and nitrogen metabolism, 
little is known about the regulatory mechanisms of system X-AG transporters in peripheral 
tissues of production animal species. Moreover, even less is known regarding the 
relationship between system X-AG activities and expression of system X-AG proteins, and 
their possible role in GS activity and GSH content. 
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Table 2. 1 Glutathione levels in liver, muscle and adipose tissues in animal models 
Tissues Species Glutathione levels Assay method Reference 
Liver Rat GSH: 
96.5nmol/mg 
protein 
DTNB (Ellman’s 
method) 
(Moron et al., 
1979) 
Liver Rat GSH: 59 
nmol/mg protein 
Ellman’s method 
(Ellman, 1959) 
(Sadi et al., 
2014) 
Liver Rat GSH/GSSG ratio: 
44 
Oxis GSH/GSSG-412 
assay kit  
(Zhang et al., 
2003) 
Liver Rat Total glutathione: 
3.2 µmol/g liver; 
GSH/GSSG ratio: 
8.6 
Enzymatic method 
(Tietze, 1969) 
(Perez et al., 
2005) 
Liver Rat 120 nmol/mg 
protein 
DTNB (Ellman’s 
method) 
(Messarah et 
al., 2012) 
Liver Rat GSH: 117.8 
nmol/mg protein; 
GSSG: 1.0 
nmol/mg protein; 
GSH/GSSG ratio: 
122.3 
DTNB method (Picklo et al., 
2013) 
Liver Rat GSH: 9.8 µmol/g 
liver 
Bioxytech GSH 400 kit (Bagchi et al., 
1996) 
Liver Rat Cytosolic 
fraction: 32 
nmol/mg protein 
HPLC (Vendemiale et 
al., 1998) 
Liver Rat GSH: 45 
nmol/mg protein; 
GSSG: 1.23 
nmol/mg protein 
HPLC (Ercal et al., 
2001) 
Liver Rat 16.3 µg/mg 
protein 
Enzymatic method 
(Anderson, 1985) 
(Lacroix et al., 
2004) 
Liver Rat GSH: 6 mM; 
GSSG:0.1mM 
M4VP+DTNB (Shaik and 
Mehvar, 2006) 
Liver Rat Total glutathione: 
3.27 µmol/g wet 
wt 
(Tietze, 1969) (Sen et al., 
1992) 
Liver  Rat Total glutathione: 
6.4 µmol/g fresh 
tissue 
Enzymatic method (Mosoni et al., 
2004) 
Soleus muscle Rat GSH: 2.64 
µmol/g wet 
tissue; GSSG: 
0.10 µmol/g wet 
tissue;  
HPLC (Leeuwenburgh 
et al., 1994) 
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Table 2.1 (continued) 
Gastrocnemius 
muscle  
 
Rat Total glutathione: 
0.8 µmol/g fresh 
tissue 
Enzymatic method (Mosoni et al., 
2004) 
Longissimus 
dorsi 
Rat Total glutathione: 
0.29 µmol/g wet 
wt 
(Tietze, 1969) (Sen et al., 
1992) 
Skeletal 
muscle 
Rat GSH: 1.4 
nmol/mg wet 
weight; GSSG: 
0.08 nmol/mg wet 
weight; 
GSH/GSSG ratio: 
17.15 
HPLC (Dam et al., 
2012) 
Visceral 
adipose 
Rat GSH: 26.6 
nmol/mg protein; 
GSSG: 2.6 
nmol/mg protein; 
GSH/GSSG ratio: 
11.4 
DTNB method (Picklo et al., 
2013) 
Inguinal white 
adipose  
 
Rat Total glutathione: 
4nmol/mg protein 
HPLC (Galinier et al., 
2006) 
Liver Mouse Total glutathione: 
2.5 nmol/mg 
liver; GSSG: 0.17 
nmol/mg liver 
M2VP+DTNB (Eriksson et al., 
2015) 
Liver Mouse GSH: 53 
nmol/mg protein; 
GSSG: 3.7 
nmol/mg protein 
HPLC-MS/MS (Bouligand et 
al., 2006) 
Liver Mouse GSH: 37 
nmol/mg protein 
Fluorogenic assay (Riehle et al., 
2013) 
Skeletal 
muscle 
Mouse GSH: 4.0 µmol/g 
protein; GSSG: 
0.42 µmol/g 
protein; GSSG: 
GSH ratio: 0.1 
BIOXYTECH 
GSH/GSSG-412 kit, 
OxisResearch  
 
(Ham et al., 
2014) 
Skeletal 
muscle 
Mouse Total glutathione 
in mitochondria: 
19 nmol/mg 
protein 
HPLC (Adjeitey et al., 
2013) 
Gastrocnemius 
muscle  
Mouse GSH: 38.75 
nmol/mg protein; 
GSSG/GSH ratio: 
0.13 
Spectrophotometric 
recycling assay 
(Cruzat et al., 
2014) 
 
26 
Table 2.1 (continued) 
epididymal 
adipose tissue  
Mouse GSH/GSSG ratio: 
52 
Bioxytech GSH/GSSG-
412 kit (Oxis Research)  
(Findeisen et 
al., 2011) 
White adipose  Mice GSH: 42 
nmol/mg protein; 
GSH/GSSG ratio: 
50 
Bioxytech GSH/GSSG- 
412 kit (Oxis Research, 
Portland, OR)  
(Kobayashi et 
al., 2009) 
Liver Human GSH: 22.4 
nmol/mg protein  
Enzymatic assay (Huang et al., 
2001) 
Skeletal 
muscle 
Human Total glutathione: 
1.47 mmol/kg 
w.w. 
HPLC (Hellsten et al., 
2001) 
Skeletal 
muscle 
Human Total glutathione: 
1.74-1.90 
mmol/kg w.w. ; 
GSH: 1.45-1.65 
mmol/kg w.w. 
HPLC (Flaring et al., 
2003) 
Liver Pig GSH: 4.9 µmol/g 
liver 
Enzymatic assay (Kannan et al., 
1997) 
Liver Pig GSH: 40 
nmol/mg protein 
Spectrophotometric 
recycling assay (Tietze, 
1969) 
(Cadenas et al., 
1995) 
Liver Pig GSH/GSSG ratio: 
49 
HPLC (Podszun et al., 
2014) 
Liver Pig GSH: 11.12 mg/g 
protein 
GSH kit (Nanjing 
Jiancheng 
Bioengineering 
Institute)  
 
(Li et al., 2015) 
Longissimus 
Dorsi 
Pig GSH: 3.23 mg/g 
protein 
GSH kit (Nanjing 
Jiancheng 
Bioengineering 
Institute)  
(Li et al., 2015) 
longissimus  
 
Pig   Total 
glutathione: 117 
pmol/g fresh 
tissue; GSH: 94.6 
pmol/g fresh 
tissue; GSSG: 
43.9 pmol/g fresh 
tissue;  
HT Glutathione Assay 
Kit (7511-100-K; 
Trevigen)  
(Conde-
Aguilera et al., 
2015) 
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Table 2.1 (continued) 
Liver Cow Total glutathione: 
12.64 µmol/g 
protein 
Bioxytech® GSH-420 
assay  
(Abd et al., 
2008) 
Liver Cow Total glutathione: 
42-78 µmol/g 
protein; GSH: 40-
75 µmol/g protein 
(cat. no. NWK-GSH01; 
Northwest Life Science 
Specialties LLC, 
Vancouver, WA)  
(Osorio et al., 
2014) 
Liver Bull GSSG: 0.09 
µmol/g liver; 
GSH: 2.5 µmol/g 
liver; GSH/GSSG 
ratio: 27 
Spectrophotometric 
recycling assay 
(Netto et al., 
2014) 
Muscle psoas 
major  
Steers GSH: 0.278-
0.514 mM; 
GSSG: 0.0338-
0.0629 mM; 
GSH/GSSG: 8.5 
(Tietze, 1969) (Descalzo et 
al., 2007) 
Longissimus 
Lumborum 
 
Beef 
steers 
GSH: 14.5 
mg/100g raw 
muscle 
SIGMA Glutathione 
Assay Kit, Catalog 
Number CS0260  
 
(Rakowska et 
al., 2017) 
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Figure 2. 1 Illustration of glutamate metabolism and its link to the TCA cycle, urea cycle, 
and glutamine and glutathione synthesis (Nissim, 1999).  
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Figure 2. 2 Diagrammatic representation of the net utilization (-, +) of plasma glutamate 
(Glu) by gut and peripheral tissues in relationship to glutamine (Gln) and alanine (Ala) 
use and/or production (Matthews, 2005).  
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Figure 2. 3 Diagrammatic representation of hepatic acinus. See text for justification for 
the distribution of X-AG (X) and x-C (xc) transport activities in periportal and/or pericentral 
hepatocytes, and within a hepatocyte population, assignment to canalicular (bile-facing) 
or basal (sinusoidal blood-facing) membrane subdomains (Matthews, 2005).  
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Figure 2. 4 Antioxidant function of glutathione (GSH) (Lu, 2013). Hydrogen peroxide is 
metabolized by GSH peroxidase in the cytosol and mitochondria. The oxidized form of 
GSH (GSSG) is reduced back to GSH by GSSG reductase forming a redox cycle. During 
oxidative stress, protein thiols are protected by glutathionylation forming Prot-SSG, 
which can be subsequently reduced back to Prot-SH. To maintain cellular redox 
equilibrium, GSSG can be transported out of the cell via glutathione transporters.  
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Figure 2. 5 Extracelluar metabolism of glutathione (GSH) via γ-glutamyl cycle and 
intracellular synthesis (Lu, 2013). γ-glutamyltranspeptidase (GGT) cleaves extracellular 
GSH into γ-glutamyl amino acid and cysteinylglycine. The γ-glutamyl amino acid can be 
transported back into the cell and finally converted into Glu to incorporate into GSH. The 
cysteinylglycine is broken down into cysteine and glycine, which can also be utilized as 
the substrate for intracellular GSH synthesis. 
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Figure 2. 6 Inter-organ flux of glutathione (GSH) (Deneke and Fanburg, 1989). Liver 
exports GSH into blood and bile and the plasma GSH can be utilized by kidney, lung and 
intestine. 
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Figure 2. 7 Signaling pathways with stimulatory (right arrow) and inhibitory (-|) 
modifications for EAAC1 activity (Aoyama and Nakaki, 2013). The abbreviations are as 
follows: platelet-derived growth factor (PDGF), phosphatidyl-inositol 3-kinase (PI3K), 
Janus-activated tyrosine kinase-2 (JAK-2), phosphoinositide-dependent kinase 1 (PDK1), 
serum- and glucocorticoid-inducible kinase 1 (SGK1), Akt/protein kinase B (Akt/PKB), 
protein kinase C (PKC), mammalian target of rapamycin (mTOR), AMP-activated 
protein kinase (AMPK), excitatory amino acid carrier 1 (EAAC1).  
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Figure 2. 8 ADP-ribosylation factor-like 6 interacting protein 1 (ARL6IP1) positively 
regulates the metabolic function of EAAC1 (excitatory amino acid carrier 1) by 
decreasing EAAC1/GTRAP3-18 (Glu transporter-associated protein 3-18, a.k.a. addicsin 
and ADP-ribosylation factor-like 6 interacting protein 5/ARL6IP5, or PRAF3) interaction 
in the ER. After exiting from the ER to the trans-Golgi, EAAC1 is subject to the 
internalization in endosome and then recycled back to the plasma membrane. After 
trafficking to the plasma membrane, EAAC1 transports Glu and cysteine for GSH 
synthesis (Aoyama and Nakaki, 2012). 
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Chapter 3. Dissertation Objectives 
 
Growing and finishing phases are two important animal production stages, which 
differ fundamentally in compositional growth. The growing stage reflects the acceleration 
growth phase of greatest lean (protein) to fat deposition. In contrast, the finishing phase 
reflects a time of greatest fat to lean deposition ratio with maximized meat yield and fat 
cover (U.S market weight). Understanding the physiological mechanisms altered 
concomitantly with the shift in whole-body compositional gain as cattle fatten (growing 
vs. finished steers), should provide mechanistic knowledge that can be applied to 
optimize tissue protein accretion. Accordingly, the overall goal of the dissertation was to 
answer the following questions: 
1) Where is system X-AG activity localized in hepatocytes, canalicular or 
basolateral membrane? Do the activities and protein content of system X-AG and GS 
change in the liver of finished vs. growing steers? Are the regulatory proteins of system 
X-AG expressed in the cattle liver, and how does the hepatic content of regulatory proteins 
change in finished vs. growing steers? (Experiment 1; Chapter 4) 
2) Does the content of GSH, system X-AG and GS change in Longissimus dorsi 
and subcutaneous adipose tissues of finished vs. growing steers? Are the regulatory 
proteins of system X-AG expressed in LM and SF, and how does the content of regulatory 
proteins change in LM and SF of finished vs. growing steers? How is the GSH-mediated 
antioxidant capacity achieved in LM and SF when beef steers develop from growing to 
finished stage? (Experiment 3; Chapter 5) 
3) What are the upstream regulatory mechanisms of EAAC1 and the metabolic 
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pathways altered in the liver, as beef steers develop from lean to lipid phenotype 
(Experiment 2; Chapter 6)? 
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Chapter 4. Hepatic glutamate transport and glutamine synthesis capacities are 
decreased in finished vs. growing beef steers, concomitant with increased GTRAP3-
18 content 
 
ABSTRACT 
The liver plays important roles in maintaining whole-body glutamate and nitrogen 
homeostasis via glutamate transporters and the glutamine-glutamate cycle. The objective 
of this study was to determine if hepatic activities and protein content of system X-AG 
transporter (EAAC1, GLT-1) and system X-AG regulatory proteins (GTRAP3-18, 
ARL6IP1), and glutamine synthetase (GS) activity and content, differed as beef steers 
transitioned from predominantly-lean (growing) to –lipid (finished) tissue accretion 
phases. Sixteen weaned Angus steers were randomly assigned (n = 8) to growing or 
finished treatment and fed a cotton seed hull-based diet to achieve a final body weight of 
301 ± 7.36 or 576 ± 36.9 kg, respectively, at a constant rate of growth. Liver tissues were 
collected at slaughter and glutamate uptake assays determined that X-AG activity in 
canalicular membranes was abolished (P = 0.07) as steers developed from growing (n = 
6) to finished stages (n = 4) but did not change in basolateral membranes. EAAC1 protein 
content in liver homogenates (n = 8, Western blot analysis) decreased (P = 0.02) in 
finished vs. growing steers, whereas GTRAP3-18 and ARL6IP1 content increased (P ≤ 
0.05) and GLT-1 content did not change. Concomitantly, hepatic GS activity decreased 
(P = 0.01) whereas GS protein content did not differ as steers fattened. We conclude that 
hepatic Glu transport and GS synthesis capacities are reduced in livers of fattened cattle. 
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These are the first data to describe a negative functional relationship between GTRAP3-
18 and system X-AG activity outside of neuronal tissue. 
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INTRODUCTION 
 
Improvement of feeding regimens for production animals has been hindered by a 
lack of fundamental knowledge about how the capacity to regulate nutrient absorption 
across cell membranes affects the function of nutrient metabolizing enzymes. Hepatic L-
glutamate (Glu) transport and metabolism are critical to support whole-animal energy and 
N homeostasis (Heitmann and Bergman, 1981b; Wu, 1998; Burrin and Stoll, 2009). In 
the liver, Glu is a central substrate for ureagenesis, gluconeogenesis, glutathione 
production, de novo protein synthesis, and nitrogen shuttling via glutamine (Meijer et al., 
1990; Brosnan, 2000; Watford, 2000). Although plasma membrane transport capacity is 
thought to limit Glu metabolism (Low et al., 1994; Nissim, 1999; Gegelashvili et al., 
2003), knowledge of how hepatic Glu transport capacity may be regulated to support 
changes in metabolic capacity associated with different phases of growth (e.g., 
predominately-lean to predominately-lipid tissue accretion) is limited. 
Two high-affinity (µM), concentrative, Glu transporters (GLT-1 and EAAC1) that 
demonstrate system X-AG activity (Na+-dependent L-Glu and L-Asp uptake that is 
inhibited by D-Asp) are expressed by the intestinal epithelia, liver, and kidney of sheep 
(Howell et al., 2001; Howell et al., 2003; Xue et al., 2010) and cattle (Howell et al., 2001; 
Miles et al., 2015). In mouse neuronal cells, the function of EAAC1 (solute carrier 
1A1/SLC1A1) and GLT-1 (SLC1A2) is inhibited by endoplasmic reticulum-localized 
GTRAP3-18 (glutamate transporter-associated protein 3-18; a.k.a. addicsin, ADP-
ribosylation factor-like 6 interacting protein 5/ARL6IP5, PRAF3) (Ruggiero et al., 2008; 
Watabe et al., 2008) and that the effect of GTRAP3-18 on EAAC1 activity is 
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proportional to GTRAP3-18 content (Lin et al., 2001). However, ADP-ribosylation 
factor-like 6 interacting protein 1 (ARL6IP1) binds and inhibits GTRAP3-18, and 
indirectly promotes EAAC1 activity (Akiduki and Ikemoto, 2008; Aoyama and Nakaki, 
2012). The ARL6IP1/GTRAP3-18/EAAC1 triad is highly expressed in rat liver (Akiduki 
and Ikemoto, 2008), whereas cow liver expresses at least EAAC1 and GTRAP3-18 
(Miles et al., 2015). The objective of this study was to determine whether the hepatic 
activities and protein content of system X-AG transporters (EAAC1, GLT-1), system X-AG 
regulatory proteins (GTRAP3-18, ARL6IP1), and GS changed as beef steers developed 
from predominantly lean to predominantly lipid deposition growth phases. 
 
MATERIALS AND METHODS 
 
Animal Model 
All procedures involving animals were approved by the University of Kentucky 
Institutional Animal Care and Use Committee. The steers were raised, and trial 
conducted, at the University of Kentucky Research and Education Center in Princeton, 
KY.  
Sixteen weaned, predominately Angus, steers of similar shrunk (denied feed and 
water for 14 h) BW were randomly assigned (n = 8) to either growing (BW = 215 ± 28.6 
kg) or finished (BW = 202 ± 30.2 kg) treatment groups. Steers then were randomly 
assigned to one of 4 feedlot pens that contained Calan gates in a dry-lot barn. Four steers 
were assigned per pen. Steers were individually fed enough of a diet that contained (% 
as-fed) cracked corn (60), cottonseed hulls (20), soybean meal (7), soybean hulls (5), 
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dried distiller’s grain (2), alfalfa meal (2), glycerin (2), limestone (1.5), and urea (0.5) to 
support 1.51 kg gain/d (NRC, 1996) throughout the trial. Steers had ad libitum access to 
fresh water and a vitamin-mineral mix (UK IRM Beef Cattle Vitamin-mineral Mix, 
Burkmann Mill, Inc., Danville, KY). Full BW were determined every 14 d and amount of 
diet adjusted to achieve target rate of gain. Steer ADG was calculated as the difference 
between shrunk BW at trial initiation and 1 d before slaughter.  
 
Slaughter, Tissue Collection, and Carcass Evaluation 
One steer per day was slaughtered. Steers were stunned by captive bolt pistol and 
then exsanguinated to allow recovery of carcasses for consumption. Fresh liver tissue was 
collected from the middle of the right lobe and used for (a) preparation of plasma 
membrane vesicles and determination of glutamine synthesis activity and (b) placed in 
foil packs, snap-frozen in liquid nitrogen, and stored at -80°C until assayed for RNA and 
protein expression. 
After 24 h postmortem, carcass evaluations were conducted on the right side of 
the carcass according to USDA standards (USDA, 1997).  
 
Isolation of Enriched Canalicular (cLPM) and Basolateral (bLPM) Liver Plasma 
Membrane (LPM) Vesicles 
Isolation of cLPM- and bLPM-enriched vesicles from liver homogenates was 
performed as described by Meier and Boyer (1990) with minor modifications. Ten grams 
of fresh liver tissue was cut into small pieces, washed three times in 80 mL ice-cold 1 
mM NaHCO3, and homogenized in 80 mL 1 mM NaHCO3 with a Dounce homogenizer 
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(nine to eleven up-and-down strokes). The homogenate was centrifuged (SA-600 rotor, 
Sorvall Instruments Inc.) at 1,500 x g for 15 min. The pellet was resuspended in 2.2 
volumes of 70% (w/w) sucrose. After stirring for 15 min to disrupt membrane aggregates, 
12 mL of suspension was filled into SW32 rotor (Beckman Instruments) tubes and 
overlayed with 10 mL of 44% and then 10 mL 36.5% (w/w) of sucrose. The tubes were 
filled to the top with 8.1% sucrose and the gradient system centrifuged at 89,300 x g for 
90 min. After slow deceleration to a complete stop, a mixed liver plasma membrane 
fraction was carefully collected from the 44/36.5% sucrose interface with a plastic 
Pasteur pipet and diluted with 8.1% sucrose to a total volume of 9.1 mL. The mixed liver 
membrane fraction was then homogenized in a glass-glass Dounce homogenizer using 50 
strokes (1 stroke equals up and down) and loaded on top of a three-step sucrose gradient 
consisting of 10.5 mL 38%, 6.5 mL 34%, and 6.5 mL 31% sucrose. The tubes were 
centrifuged at 195,700 x g for 3 h in a Beckman SW41 rotor (Beckman Coulter Inc., 
Brea, CA). This resulted in three distinct bands and a pellet. The fractions at the 31/34% 
(cLPM-enriched) and the 34/38% (bLPM-enriched) interfaces were recovered, diluted in 
8.1% sucrose and sedimented at 105,000 x g (Ti 70 rotor, Beckman Coulter Inc., Brea, 
CA) for 60 min. The resulting cLPM and bLPM pellets were resuspended in the preload 
buffer (250 mM sucrose, 100 mM KCl, 0.2 mM CaCl2, 50 mM Hepes/Tris, pH 7.5) by 
repeated (20 times in and out) aspiration through a 25-gauge needle. The protein content 
of cLPM and bLPM was quantified at 280 nm using a NANODROP ND-1000 
spectophotometer (NanoDrop Technologies Inc., Wilmington, DE). The vesiculated 
membranes were stored in liquid nitrogen for Glu uptake assays, and at -80°C for enzyme 
activity and immunoblot analyses.  
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Na+K+-ATPase and γ-Glutamyltransferase Activity Assays 
The Na+K+-ATPase activity in liver homogenate and cLPM and bLPM vesicles 
was determined using an ATPase assay kit (Sigma, St. Louis, MO) in 96-well plates, as 
per manufacturer instructions. The reaction was initiated by combining 30 µL of pre-
incubated (37°C for 30 min) sample solution (40 mM Tris, 80 mM NaCl, 8 mM MgAc2, 
1 mM EDTA, pH 7.5) containing 0.35 µg of homogenate or vesicle protein (in the 
absence or presence of 1 mM ouabain) with 10 µL of 4 mM ATP. After a 30 min 
incubation period at room temperature, the reaction was terminated by the addition of 200 
µL malachite green reagent. The plate was further incubated at room temperature in the 
dark for 30 min. The amount of inorganic phosphate (Pi) released from ATP was 
quantified colorimetrically at 620 nm (SpectraMax 250, Molecular Devices, Sunnyvale, 
CA). Samples were assayed in triplicate and Na+K+-ATPase-specific activity (μmol Pi ∙ 
min-1 ∙ μg-1 protein) was calculated by subtracting the ouabain-insensitive activity from 
the overall activity (in the absence of ouabain). The inter- and intra-assay CV were 8.5 
and 1.8%, respectively. 
γ-Glutamyltransferase activity in liver homogenate and cLPM and bLPM vesicles 
was determined using a high-sensitivity colorimetric assay kit (Sigma, St. Louis, MO) 
following the manufacturer’s instructions. Ten microliters of sample solution (40 mM 
Tris, 80 mM NaCl, 8 mM MgAc2, 1 mM EDTA, pH 7.5) that contained 35 µg of 
homogenate or vesicle protein was incubated with 90 µL substrate L-γ-glutamyl-p-
nitroanilide solution at 37°C in the dark for 18 min. The amount of chromogen p-
nitroanilide released was quantified colorimetrically at 418 nm (SpectraMax 250), as 
described (Meister, 1981). Samples were assayed in triplicate, and the activity of γ-
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glutamyltransferase is reported as μmol p-nitroanilide liberated from L-γ-Glutamyl-p-
nitroanilide per min by 1 μg of protein (μmol p-nitroanilide ∙ min-1 ∙ μg-1 protein). The 
inter- and intra-assay CV were 13.3 and 3.8%, respectively. 
 
LPM Vesicle Transport Assays 
Uptake of Glu by isolated cLPM and bLPM vesicles was conducted using a rapid 
filtration technique (Ballatori et al., 1986). The previously frozen and preloaded 
membrane vesicles (see above) were quickly thawed, diluted in preload buffer to the 
desired protein concentration (50-100 μg of protein in 20 μL), and aspirated 10 times 
through a 25-gauge needle. Membrane vesicles and appropriate Glu uptake buffers (22.5 
µM unlabeled Glu, 195 mM sucrose, 0.2mM CaCl2, 50 mM HEPES, 5 mM MgCl2, and 
100 mM of either NaCl or choline chloride, at pH 7.5) were separately pre-incubated at 
25°C for 10 min. Uptake assays were initiated by addition of 20 µL of membrane vesicles 
and 10 µCi of L- [3,4-3H]Glu ([3H]Glu, PerkinElmer, Waltham, MA; specific activity: 
47.5 Ci/mmol) to 80 µL of the appropriate Glu uptake buffer. Uptake reactions were 
performed at 25°C for 10 min. Preliminary experiments determined that Glu uptake was 
linear and optimal under these conditions (data not shown). 
Uptake reactions were terminated by addition of 2 mL of ice-cold stop solution 
(175 mM sucrose, 0.2 mM CaCl2, 5 mM MgCl2, 150 mM NaCl, 10mM HEPES/Tris, pH 
7.5), followed by immediate filtration of the uptake reaction/stop solution mix through 
Millipore HAWP filters (25 mm, 0.45 µm; Millipore Corp., Bedford, MA), using a 1225 
sampling vacuum manifold (Millipore Corp.). The uptake tubes were rinsed 2 times with 
2 mL of stop solution, filtering the resulting uptake reaction/stop solution mix through the 
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filter after each rinse. Filters were then washed 3 times more with 2 mL stop 
solution/wash, and dissolved in 6 mL of liquid scintillation cocktail (SX 25, Fisher 
Scientific). The radioactivity per filter was measured by liquid scintillation counting 
(TRI-CARB 2900TR spectrometer, PerkinElmer, Downers Grove, IL). Nonspecific 
binding of [3H]Glu to filters or vesicles was determined by adding 1 mL 4°C stop 
solution to the [3H]Glu uptake mixture before addition to LPM vesicles. The resulting 
“background” values were subtracted from each experimental Glu uptake observation. 
Sodium-dependent Glu uptake activity was calculated as the difference between Glu 
uptake in the presence of NaCl vs. choline chloride. System X-AG activity was calculated 
as the difference between Na+-dependent Glu uptake and Na+-dependent Glu uptake in 
the presence of 500 µM of D-aspartate. Samples were assayed in triplicate and all uptake 
activities are reported as pmol Glu ∙ 10 min-1 ∙ μg-1 protein per steer liver preparation. 
 
Hepatic Glutamine Synthetase Activity Analysis 
About 400 mg of liver tissue was homogenized (30,000 rpm for 15 s, twice) in 5 
volumes of ice-cold extraction buffer (pH 7.9) containing 50 mM Tris and 2mM EDTA, 
using a PowerGen 125 homogenizer (Thermo Fisher Scientific, Waltham, MA). The 
homogenate was centrifuged at 2000 x g and 4ºC for 10 min. The derived supernatant 
was assayed for glutamine synthetase activity (EC 6.3.1.2) using a radiochemical method 
modified from that of (James et al., 1998). A 50 µL aliquot of the supernatant was mixed 
with 200 µL of reaction medium which consisted of 0.25 µCi L-[1-14C]Glu (ARC, Saint 
Louis, MO; specific activity: 50-60 mCi/mmol), 25 mM unlabeled glutamate, 25 mM 
MgCl2, 25 mM NH4Cl, 18.75 mM ATP, 12.5 mM phosphocreatine, 4 units creatine 
 
47 
kinase, and 62.5 mM imidazole-HCl buffer, at pH 7.6. The mixture was incubated at 
37ºC for 20 min, and the reaction was then terminated by adding 1 mL of ice-cold 20 mM 
imidazole-HCl buffer, at pH 7.5. An aliquot of the incubate (1 mL) was loaded into a 4 
mL prefilled (formate resin) ion-exchange column (Bio-Rad, Hercules, CA) previously 
rinsed by distilled water. The column was washed with 4 mL of distilled water, and the 
effluent was collected. An aliquot of the effluent (1 mL) was mixed with 4 mL of 
ScintiSafe Plus 50% cocktail (Thermo Fisher Scientific, Waltham, MA), and the 
radioactivity was determined by liquid scintillation counting using a TRI-CARB 2900TR 
spectrometer (PerkinElmer). Assays were conducted in triplicate. Positive control 
contained 2.5 units of glutamine synthetase from Escherichia coli (Sigma, Saint Louis, 
MO) instead of supernatant from liver tissue. Negative control contained neither 
supernatant nor glutamine synthetase. Samples were assayed in triplicate and glutamine 
synthetase activity is expressed as nmol ∙ min-1 ∙mg-1 wet mass. The intra- and inter assay 
CV were 8.5% and 8.8%, respectively. 
 
Western Blot Analysis 
In general, Western blot analyses of liver tissue and LPM vesicles was performed 
as previously described by this research group (Howell et al., 2001; Miles et al., 2015). 
For liver homogenates, 1 g of liver tissue was homogenized on ice for 30 s (setting 11, 
POLYTRON, Model PT10/35; Kinematic, Inc., Neuchâtel) in 7.5 mL of 4°C sample 
extraction buffer solution (0.25 mM sucrose, 10 mM HEPES-KOH pH 7.5, 1 mM EDTA, 
and 50 µL of protease inhibitor (Sigma, St. Louis, MO). Protein was quantified by a 
modified Lowry assay, using bovine serum albumin as a standard (Kilberg, 1989). For 
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liver homogenates (30 μg/lane) and LPM (15 μg/lane, protein quantified during 
preparation), proteins were separated by 12% SDS-PAGE, followed by electrotransfer to 
a 0.45 µm nitrocellulose membrane (Bio-Rad, Hercules, CA). Blots were stained with 
Fast-Green (Fisher, Pittsburgh, PA) and the relative amount of stained protein per 
lane/sample determined by densitometric analyses and recorded as arbitrary units 
(Howell et al., 2001; Miles et al., 2015). 
The relative protein content of EAAC1, GLT-1, GTRAP3-18, GS, and β-catenin 
in liver homogenates was detected using antibodies as described previously (Brown et al., 
2009; Miles et al., 2015; Miles et al., 2016). For ARL6IP1, an antibody raised against the 
human ortholog (see below) was validated for detection of cattle ARL6IP1 using a 
standard pre-hybridization regimen (Xue et al., 2011; data not shown). More specifically, 
blots were hybridized with 1 μg of IgG antihuman EAAC1 polyclonal anti-body (Santa 
Cruz Biotechnology, Inc., Santa Cruz, CA), 1 μg of IgG anti-rabbit GLT-1 polyclonal 
antibody (Abcam Inc., Cambridge, MA), 4 μg of IgG anti-human GTRAP3-18 (Abcam 
Inc., Cambridge, MA), and 5 μg of IgG antihuman ARL6IP1 (Abgent Inc., San Diego, 
CA), respectively, per mL of blocking solution (1% nonfat dry milk (w, v) in 30 mM 
Tris-Cl, 200 mM NaCl, 0.1% Tween 20 (v, v), pH 7.5) for 1.5 h at room temperature with 
gentle rocking. For β-catenin detection, blots were hybridized with 14.5 μg of IgG anti-
chicken beta-catenin (Abcam Inc., Cambridge, MA) per mL of blocking solution (1.5% 
nonfat dry milk [wt/vol] in 30 mM Tris-Cl [pH 7.5], 200 mM NaCl, 0.1% Tween-20) for 
1.5 h at room temperature with gentle rocking, whereas GS was detected using 1.25 μg of 
IgG anti-sheep polyclonal antibody (BD Biosciences, San Jose, CA) per mL of blocking 
solution (5% nonfat dry milk [wt/vol], 10 mM Tris-Cl [pH 7.5], 100 mM NaCl, 0.1% 
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Tween 20 [vol/vol]) for 1 h at 37°C with gentle rocking.  
All protein-primary antibody binding reactions were visualized with a 
chemiluminescence kit (Pierce, Rockford, IL) after hybridization of primary antibodies 
with horseradish peroxidase-conjugated donkey anti-rabbit IgG (Amersham, Arlington 
Heights, IL; GLT-1, EAAC1 and ARL6IP1, 1:5,000); horseradish peroxidase-conjugated 
goat anti-mouse IgG (BD Biosciences, San Jose, CA; GS, 1:5,000, and beta-catenin, 
1:10,000); and horseradish peroxidase-conjugated donkey anti-goat IgG (Santa Cruz 
Biotechnology; GTRAP3–18, 1:5,000).  
Densitometric analysis of immunoreactive products was performed as described 
previously (Howell et al., 2003; Fan et al., 2004; Xue et al., 2011). Briefly, after exposure 
to autoradiographic film (Amersham, Arlington Heights, IL), a digital image of the 
radiographic bands was recorded and quantified as described (Swanson et al., 2000). 
Apparent migration weights (Mr) were calculated by regression of the distance migrated 
against the Mr of a 16 to 185 kDa standard (Gibco BRL, Grand Island, NY) using the 
Versadoc imaging system (BioRad) and Quantity One software (BioRad). Band 
intensities of all observed immunoreactive species (one for GTRAP3-18, ARL6IP1, GS, 
and β-catenin; two for EAAC1 and GLT-1) within a sample were quantified by 
densitometry (as described above for Fast-Green stained proteins) and reported as 
arbitrary units. Densitometric data then were corrected for unequal (≤ 12%) loading, 
transfer, or both, and amount of detected protein normalized to relative amounts of Fast-
Green-stained proteins common to all immunoblot lanes/samples (Miles et al., 2015). 
Digital images were prepared using PowerPoint software (Microsoft, PowerPoint 2003, 
Bellvue, MA).  
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Statistical Analysis 
Individual steers were the observational units. Data were analyzed as a completely 
randomized design by ANOVA using the GLM procedures of SAS (SAS Inst. Inc., Cary, 
NC). Except for the enzymatic and immunological characterization of bovine cLPM and 
bLPM vesicles, all data were analyzed in a 1-way ANOVA model to test for finished vs. 
growing treatment effects. For Glu transport data, significance was declared when P < 
0.10, and for all other data, treatment differences were considered significant at the α = 
0.05 level. For the enzymatic characterization of cLPM and bLPM fractionation data, 
enzyme activities among homogenates, cLPM, and bLPM were compared by ANOVA, 
followed by Fisher’s protected LSD test. For the immunological characterization of 
cLPM and bLPM fractionation, the relative amount of beta-catenin in cLPM and bLPM 
vesicles was compared by ANOVA, both within and between growing and finished 
steers. Unequal experimental treatment observations resulted from loss of sample 
integrity during collection or storage. 
 
RESULTS 
 
Animal Model 
The growth and carcass characteristics of growing and finished steers are 
presented in Table 4.1. The growing treatment steers required 57 ± 7 d to reach target 
weights and 261 ± 12 d were required for finished treatment steers to reach their target 
weight. As planned, ADG (1.51 vs. 1.46 kg/d), initial BW (215 vs. 202 kg) and frame 
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scores (4.73 vs. 4.61) did not differ (P ≥ 0.42) between growing and finished steers. As 
expected, finished steers had greater (P < 0.01) final BW (91%), HCW (107%), ribeye 
area (44%), 12th rib adipose (220%), marbling score (126%), yield grade (71%) and 
whole liver wet weight (44%), while KPH tended (P = 0.06) to be greater. In contrast, 
whole liver wet weight/100 kg of final BW was 25% less (P < 0.01) in finished vs. 
growing steers. 
 
Enzymatic and Immunological Characterization of cLPM and bLPM Vesicles 
The enrichment of cLPM and bLPM from liver tissue homogenate was evaluated 
by comparing the enzyme activity (μmol ∙ min-1 ∙ μg-1 protein) of marker proteins in 
growing steers (Table 4.2). The bLPM vesicles had 24 times more (P < 0.01) Na+K+ 
ATPase activity than liver homogenates (1.655 vs. 0.070) and 60% more (P < 0.01) than 
cLPM vesicles, whereas cLPM had 15 times more (P < 0.01) Na+K+ ATPase activity than 
liver homogenates (1.039 vs. 0.070). In contrast, the cLPM vesicles had 27 times more (P 
< 0.01) GGT activity than liver homogenates (0.054 vs. 0.002) and 93% more (P < 0.01) 
than bLPM, whereas bLPM had 14 times more (P < 0.01) GGT activity than liver 
homogenates.  
To further characterize the membrane composition of cLPM and bLPM vesicles, 
the relative content of the basolateral marker protein β-catenin (Lutz and Burk, 2006; 
Decaens et al., 2008) was determined by Western blot analysis (Fig. 4.1) in both growing 
and finished steers. For growing steers, the β-catenin content of bLPM-enriched vesicles 
was 158% greater (P = 0.003) than for cLPM. Similarly, the β-catenin content of bLPM-
enriched vesicles from finished steers was 78.0% greater (P = 0.009) than for cLPM. 
 
52 
Between growing and finished steers, the amount of β-catenin in cLPM (P = 0.75) or 
bLPM (P = 0.88) vesicles did not differ. Consistently, the bLPM:cLPM ratio of β-catenin 
did not differ (P = 0.60) between growing and finished steers.  
 
Decreased Glu Transport Activity in Hepatic Vesicles Isolated from Finished vs. 
Growing Steers 
Glu uptake (pmols ∙ 10 min-1 uptake ∙ µg protein-1) assays were conducted using 
canalicular- and basolateral-enriched liver plasma membrane vesicles isolated from livers 
of growing (n = 6) and finished (n = 4) steers. In hepatic canalicular plasma membrane 
vesicles (Table 4.3), total L-Glu uptake and Na+-dependent Glu uptake decreased (P ≤ 
0.03) 75% and 90%, respectively, whereas Na+-independent Glu uptake did not change 
(P = 0.80). Concomitantly, X-AG activity (0 ± 0 vs. 2.78 ± 2.57) in canalicular membranes 
was abolished (P = 0.07) and non- X-AG activity tended to decrease (P = 0.10) in finished 
vs. growing steers. 
In hepatic bLPM vesicles (Table 4.4), total L-Glu uptake (56%), Na+-dependent 
Glu uptake (60%) and Na+-independent Glu uptake (56%) also decreased (P ≤ 0.08) in 
finished vs. growing steers. However, in contrast to decreased X-AG activity in cLPM, X-
AG activity in bLPM did not change (P = 0.55) whereas non- X-AG activity decreased 
(73%, P = 0.08) in finished vs. growing steers. 
 
Decreased EAAC1 Protein Content Concomitant with Increased GTRAP3-18 and 
ARL6IP1 Content in Liver Tissue of Finished vs. Growing Steers 
Canalicular LPM- and bLPM-enriched vesicles were subjected to Western blot 
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analysis to determine the relative content of system X-AG activity transporter proteins 
(Fig. 4.2). Both EAAC1 and GLT-1 were detected in both membrane fractions and 
development phases. Densitometric analyses (Table 4.5) found that the amount of 
EAAC1 decreased (P ≤ 0.09) 47% and 19%, respectively, in both canalicular and 
basolateral liver plasma membrane fractions of finished vs. growing steers, whereas 
GLT-1 content did not change (P = 0.58). 
Liver tissue homogenates were subjected to Western blot analysis to determine 
the relationship among the relative contents of system X-AG activity transporters and their 
regulatory proteins (Fig. 4.3). All proteins were detected in liver tissue from both 
development phases. Densitometric analysis found that the relative abundance in liver 
homogenates of EAAC1 was 24% less (P = 0.02) in finished vs. growing steers, whereas 
GLT-1 content did not differ (P = 0.66) (Table 4.6). Concomitantly, hepatic GTRAP3-18 
and ARL6IP1 content increased (P ≤ 0.05) 63% and 23%, respectively, in finished vs. 
growing steers.  
 
Decreased GS activity but not GS protein Content in Liver Homogenate of Finished vs. 
Growing Steers 
Glutamine synthetase activity was determined in liver homogenates. Paralleling 
the decreased system X-AG-specific and total Glu uptake in cLPM vesicles, GS activity 
decreased (P = 0.01) 32% (Table 4.7) as steers developed from growing to finished 
production states. In contrast, GS protein content did not differ (P = 0.72) between 
growing and finished steers (Table 4.7). 
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DISCUSSION 
 
A primary function of the mammalian liver is to coordinate whole-body energy 
and N metabolism. Hepatic transport and intermediary metabolism of glutamate is critical 
to these processes as glutamate is a central substrate for hepatic ureagenesis, 
gluconeogenesis, glutathione production, de novo protein synthesis, and nitrogen 
shuttling via glutamine (Meijer et al., 1990; Watford, 2000). An important aspect of 
glutamate metabolism in the liver is the heterogeneity of Gln/Glu metabolism. 
Specifically, Gln arriving from the peripheral tissues via the portal vein, is efficiently 
absorbed by periportal hepatocytes and deaminated by glutaminase (liver-type) to release 
ammonia and Glu. The released ammonia can be incorporated into carbamoyl phosphate 
for ureagenesis, whereas the remaining Glu is available for conversion to α-KG (as an 
anapleurotic reaction to replenish the citric acid cycle), used for gluconeogenesis, used 
for protein synthesis, or transported into the sinusoids.  
Sinusoidal blood Glu is available for absorption by “down-acinus” pericentral 
hepatocytes, which express the high-affinity system X−AG Glu transporters, as well as 
Glu-using enzymes for the synthesis of Gln and glutathione (Häussinger and Gerok, 
1983; Braeuning et al., 2006; Brosnan and Brosnan, 2009). If absorbed by pericentral 
hepatocytes, Glu and the “scavenged” sinusoidal ammonia that escapes incorporation into 
urea by periportal hepatocytes are incorporated into Gln by pericentral hepatocyte-
specific GS activity, thus completing the hepatic Gln-Glu cycle (Moorman et al., 1989; 
Moorman et al., 1990; Wagenaar et al., 1994). Besides supporting Gln synthesis by GS, 
pericentral hepatocyte-localized system X−AG uptake of Glu complements pericentral 
 
55 
hepatocyte-specific synthesis of glutathione by glutamylcysteine ligase and glutathione 
synthetase (Braeuning et al., 2006), as well as supplying Glu as source of gluconeogenic 
carbons and for de novo protein synthesis (Watford, 2000).  
Na+-dependent, high-affinity glutamate transporters are members of the solute 
carrier family 1A (SLC1A) and function to mediate the Na+-dependent, concentrative 
uptake of glutamate, aspartate, and cysteine across cell membranes. The functional 
capacities of these system X-AG transporters are critical to support cell- and tissue-level 
nitrogen and carbon metabolism (Heitmann and Bergman, 1981b; Häussinger et al., 
1989; Hediger and Welbourne, 1999b; Nissim, 1999; Hundal and Taylor, 2009). In 
bovine liver, EAAC1 and GLT-1 are the only known system X−AG transporters (Howell et 
al., 2001). In rodents, it has been shown that endoplasmic reticulum-localized GTRAP3-
18 binds and inhibits the function of EAAC1 and GLT-1 (Ruggiero et al., 2008; Watabe 
et al., 2008) and that the effect of GTRAP3-18 on EAAC1 activity is proportional to 
GTRAP3-18 content (Lin et al., 2001). GTRAP3-18 also is expressed by bovine liver 
tissue, and the content of GTRAP3-18 is greater in liver tissue of aged vs. mature cattle, 
concomitant with decreased GS content (Miles et al., 2015). 
Understanding how the expression and function of system X-AG transporters, its 
regulatory proteins, and GS are coordinated could yield important insight into the 
importance of Glu use and metabolism as production animals grow, especially as they 
transition from predominantly low to high lipid accretion phases. Accordingly, the 
objective of this study was to determine if hepatic activities and protein content of 
EAAC1, GLT-1, GTRAP3-18, and ARL6IP1, and GS activity and protein content in liver 
changes as steers developed from growing through finished stages, using a commercially-
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relevant development regimen. To obviate potential metabolic changes as a result of 
ruminants growing at different rates (Howell et al., 2003), diets for the growing and 
finished treatment groups were formulated to support the same average rate of growth. As 
planned, ADG did not differ in finished vs. growing steers and lipid accretion clearly 
differed among development stages (Table 4.1). That is, the transition from 
predominantly lean phenotypes of growing steers, to predominantly lipid phenotype of 
finished steers was demonstrated by higher final BW, HCW, ribeye area, adjusted 12th 
rib adipose, marbling scores, and yield grade in finished vs. growing steers. Thus, the 
steers of each treatment group in this study were typical of growing and finished beef 
cattle phenotypes. 
 
Characterization of Enriched cLPM and bLPM 
Hepatocytes are highly polarized cells containing three functionally distinct 
surface domains: sinusoidal, lateral and canalicular (Boyer, 1980; Evans, 1980). Because 
the sinusoidal and lateral membranes are in physical continuity and highly specialized for 
the exchange of metabolites with the blood, these two plasma membrane surface areas are 
designated as the basolateral domain. In contrast, the bile canalicular domain participates 
in the primary secretion of bile constituents, including bile acids, and other detoxified 
substances (Boyer, 1980). To gain an insight into the molecular mechanisms of the 
metabolic function of bovine hepatocytes, it is essential to isolate liver plasma 
membranes enriched in canalicular and basolateral fractions in sufficient yield to permit 
functional studies of membrane solute transport processes. Thus, we used a well-
established hepatic membrane isolation regimen (Meier and Boyer, 1990) to 
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simultaneously isolate canalicular (cLPM)- and basolateral (bLPM)-enriched plasma 
membranes from bovine liver.  
The enrichment of hepatic canalicular- and basolateral-enriched liver plasma 
membrane separation was evaluated by determining the relative amount of marker 
enzyme activities in cLPM and bLPM vesicles vs. the homogenates of liver tissue from 
which they were isolated (Table 4.2). Na+K+-ATPase activity was enriched 22-fold in 
bLPM and 15-fold in cLPM over homogenates, consistent with the known enrichment of 
Na+K+-ATPase activity in both bLPM and cLPM isolated from human and rat 
hepatocytes (Wannagat et al., 1978; Boyer et al., 1983; Schenk and Leffert, 1983; Leffert 
et al., 1985; Sutherland et al., 1988; Benkoël et al., 1995), and the higher enrichment of 
Na+K+-ATPase activity in bLPM than cLPM vesicles (Poupon and Evans, 1979; Boyer et 
al., 1983; Sutherland et al., 1988; Ali et al., 1990). The determination of Na+K+-ATPase 
activity in our cLPM vesicles is incompatible with that of Meier et al. (1984), in which 
the cLPM sub-fraction isolated from rat hepatocytes was reported as lacking Na+K+-
ATPase activity, but is consistent with many other rat studies (Toda et al., 1975; 
Wannagat et al., 1978; Boyer et al., 1983; Inoue et al., 1983; Sutherland et al., 1988). 
These data suggest that, in addition to the highly enriched Na+K+ -ATPase activities in 
basolateral membrane, Na+K+ -ATPase also localizes to the canalicular membrane of the 
bovine hepatocytes, perhaps to support the secretion of bile constituents and other 
functions (Wheeler, 1972; Reichen and Paumgartner, 1977; Simon et al., 1977). 
The degree of enrichment of isolated cLPM and bLPM vesicles from bovine liver 
tissue was further demonstrated by the 29-fold greater GGT activity in cLPM vesicles vs. 
homogenates (Table 4.2), consistent with previous findings that GGT is highly enriched 
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in canalicular membranes isolated from rat and human liver (Poupon and Evans, 1979; 
Inoue et al., 1983; Meier et al., 1984). γ-Glutamyltransferase activity also was enriched 
(16-fold) in bovine bLPM vesicles, consistent with previous studies showing a 4- to 19-
fold enrichment of the canalicular markers in bLPM isolated from rat liver (Meier et al., 
1984). The demonstration of GGT activity in both cLPM and bLPM vesicles isolated 
from bovine liver is consistent with histochemical studies showing that GGT is 
distributed in both canalicular and basolateral membrane of rat and pig liver (Lanca and 
Israel, 1991; Carrion et al., 1993; Videla and Fernández, 1995).  
In summary, we successfully isolated enriched cLPM and bLPM vesicles from 
bovine liver homogenates. This conclusion is demonstrated by the 22-fold enrichment 
over homogenate in Na+K+ -ATPase activity in bLPM and the 29-fold enrichment in 
GGT activity in cLPM. The additional finding that the ratio of β-catenin in bLPM:cLPM 
did not differ between growing and finished steers (Figure 4.1) indicates that the 
preparation of vesicles was not affected by steer phenotype.   
 
Glu Uptake and Gln Synthesis Capacity of Finished Beef Steers 
To test whether hepatic Glu transport capacity changed as steers develop from 
growing to finished stages, Glu uptake assays by cLPM- and bLPM-enriched vesicles 
from growing and finished steers were performed. Total Glu uptake decreased in 
canalicular and basolateral plasma membranes as steers developed from growing to 
finished production stages. This finding may be indicative of a decreased requirement for 
sinusoidal blood/bile-derived Glu as the steers developed from a predominately-lean to 
predominately-lipid tissue accretion phases, due to either (a) an increased supply of intra-
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cellular Glu from increased glutamate dehydrogenase or ornithine transaminase activity, 
or (b) a reduced need to capture sinusoidal Glu and ammonia.  
Although the activities of glutamate dehydrogenase or ornithine transaminase 
were not determined, we did measure GS activity in liver homogenates and found that GS 
activity was decreased 33% in finished vs. growing steers (Table 4.7), paralleling the 
reduced total Glu uptake by both cLPM and bLPM, and system X-AG-mediated Glu 
uptake by cLPM. This finding suggests that the ability of liver tissue to use sinusoidal 
ammonia decreased from growing to finished steers or that the load of sinusoidal 
ammonia decreased. With regard to the possibility of decreased use of sinusoidal 
ammonia, detoxification of ammonia by GS may have been limited due to a shortage of 
intracellular glutamate (Boon et al., 1999). If so, the above findings suggest that the 
observed decreased Glu uptake capacity and concomitant decreased GS activity, was 
paralleled by a decreased ability to produce intracellular Glu. With regard to the second 
possibility of decreased sinusoidal levels of ammonia, ammonia concentrations may have 
been decreased due to an elevated capacity to synthesize urea by periportal hepatocytes.  
Regardless of the cause, our findings indicate that the hepatic capacity for plasma 
membrane glutamate uptake and glutamine synthesis was less in liver tissue of finished 
vs. growing steers. Both of these findings appear incongruent with accepted 
understandings for nonruminants. That is, for nonruminants, it has been argued that Na+-
dependent Glu uptake does not limit pericentral hepatocyte GS activity and that GS 
activity is relatively insensitive to change in various metabolic states (Watford, 2000). 
Thus, our findings may represent another difference in hepatic Gln metabolism between 
ruminants and nonruminats. For example, during acidosis in nonruminants, the liver 
 
60 
switches from a net consumer to net producer of Gln (Heitmann and Bergman, 1980), 
whereas hepatic GS activity and protein content do not change in ruminants (Lobley et 
al., 2001; Xue et al., 2010). 
 
Regulation of EAAC1 Transporter in Livers of Growing and Finished Steers 
As mentioned earlier, EAAC1 is a high-affinity glutamate transporter that 
mediates “system X-AG” transporter activity. In mouse neuronal cells, the activity of 
EAAC1 is regulated by two endoplasmic reticulum (ER)-localized proteins, GTRAP3-18 
and ARL6IP1. GTRAP3-18, the negative regulator of EAAC1, decreases EAAC1-
mediated Glu uptake by interacting and retaining EAAC1 in the ER, thus delaying 
EAAC1 trafficking to the trans-Golgi and plasma membrane, increasing its rate of 
degradation, or both (Lin et al., 2001; Ruggiero et al., 2008). However, an ER localized 
protein ARL6IP1 serves as a positive regulator of EAAC1 by interacting with GTRAP3-
18 to decrease GTRAP3-18/EAAC1 binding. Consequently, high ARL6IP1 expression 
indirectly promotes the transport activity of EAAC1, at least in mouse neurons (Akiduki 
and Ikemoto, 2008; Aoyama and Nakaki, 2012). 
In contrast, little is known about the potential regulation of EAAC1 by GTRAP3-
18/ARL6IP1 in peripheral tissues. In beef cows, hepatic GTRAP3-18 protein content is 
greater in aged vs. young cows, whereas EAAC1 and GLT1 contents did not differ (Miles 
et al., 2015). In the present study with growing vs. finished beef steers, EAAC1 content 
was less in finished vs. growing steers, concomitant with increased content of GTRAP3-
18 and ARL6IP1. Taken together, the decreased system X-AG -mediated Glu uptake and 
the reduced EAAC1 protein expression in cLPM in finished vs. growing steers indicate 
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that system X-AG -mediated glutamate transport activity was inversely proportional to 
GTRAP3-18 content in finished beef steers. Because GS activity in liver homogenates 
also was decreased in finished vs. growing steers, we conclude that a negative functional 
relationship exists between GTRAP3-18 content and EAAC1-mediated system X-AG and 
GS activities in bovine liver, as originally identified in rodent neuronal cells (Lin et al., 
2001). However, in contrast to ARL6IP1 paralleling EAAC1 content as reported for rat 
neurons (Akiduki and Ikemoto, 2008), ARL6IP1 content was up-regulated 25% in the 
liver of finished steers, suggesting that either (a) ARL6IP1 content was being stimulated 
by elevated GTRAP3-18 content, (b) novel regulators might exist in the EAAC1 
regulatory network for cattle liver vs. rat brain, or (c) that ARL6IP1 transcription and 
translation are controlled by discordant regulatory pathways in cattle liver. Overall, 
additional research is needed using cattle to further investigate pre-translational 
regulators, including the potential role of microRNAs to regulate expression of EAAC1, 
GTRAP3-18, and ARL6IP1, as is thought to occur for rodents (Kinoshita et al., 2014). 
The present study found that system X-AG activity in cLPM was abolished in 
finished vs. growing steers in concomitance with reduced GS activity. In contrast, system 
X-AG activity did not differ in bLPM of finished vs. growing steers. In addition to Glu and 
Aspartate uptake, system X-AG also transports cysteine, the rate-limiting substrate for 
GSH synthesis (Kilberg, 1982; Takada and Bannai, 1984; Sato et al., 1999; Matthews, 
2005). Therefore, although speculative, the metabolic significance of this finding may be 
that system X-AG transporters in canalicular liver plasma membrane function to deliver 
glutamate substrates for Gln synthesis, whereas the role of system X-AG in the basolateral 
liver plasma membrane is to transport amino acid (Glu, Aspartate, Cysteine) precursors 
 
62 
for other metabolites (e.g., glutathione synthesis). 
In summary, to our knowledge, this is the first report to describe (a) a shift in 
glutamate transport capacity in the liver as cattle develop from lean to finished 
phenotypes and, more globally, the relationship of (b) system X-AG activity and 
transporter content to GTRAP3-18 and ARP6IP1 content outside of brain tissue/cultured 
cells, and (c) decreased content of EAAC1 and system X-AG activity in hepatic apical 
membranes concomitant with decreased hepatic GS activity.  
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Table 4. 1 Growth and carcass characteristics of growing vs. finished Angus steers1 
 Treatment   
Item Growing Finished    SEM2 P-value 
Growth     
Initial BW, kg                              215        202 23.5 0.42 
Final BW, kg 301        576 28.7 <0.01 
ADG, kg 1.51            1.45               0.16 0.55 
Frame Score 4.73   4.61   0.25 0.76 
Carcass     
HCW, kg          164        339 14.0 <0.01 
Ribeye area, cm2               53.2         76.8  0.80 <0.01 
12th rib adipose, cm2 0.54            1.73 0.06 <0.01 
Marbling score  296        668 67.8 <0.01 
KPH, % 1.79            2.10 0.10 0.06 
Yield grade 2.13            3.65 0.22 <0.01 
Liver, g   4031      5786          243 <0.01 
Liver, g/100kg of BW 1341      1005             0.29 <0.01 
1Values are means (n = 8) and SEM from growing and finished Angus steers 
2Most conservative error of the mean 
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Table 4. 2 Enzymatic characterization of bovine canalicular (cLPM) and basolateral 
(bLPM) liver plasma membrane vesicles1 
Enzyme 
activity2 
Homogenate cLPM bLPM SEM3 P-value 
Na+K+-ATPase4 0.070a 1.039b 1.655c 0.049 <0.01 
GGT4 0.002a 0.054b 0.028c 0.054 <0.01 
1Values are means (n = 3) and SEM of marker enzyme activities in canalicular- and 
basolateral-enriched liver plasma membrane isolated from growing (BW = 301 kg) 
Angus steers 
2Values are specific activities expressed as μmol product ∙min-1 ∙ μg-1 protein 
3Most conservative error of the mean 
4Means within a row that lack a common letter differ (P < 0.01). 
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Table 4. 3 Glutamate uptake in canalicular liver plasma membrane vesicles of growing 
vs. finished Angus steers1 
Uptake activity2 Growing Finished SEM3 P-Value 
Total uptake4 8.78 2.23 1.82 0.02 
Na+- dependent5 6.99 0.67 1.89 0.03 
Na+ -dependent, %6 73.2 25.6 11.8 0.01 
Na+ -independent7 1.79 1.56 0.65 0.80 
Na+ -independent, %8 26.8 74.4 11.8 0.01 
Non-X-AG9 4.21 1.29 1.19 0.10 
Non-X-AG, %10 50.0 100 8.92 <0.01 
X-AG11 2.78 0 1.05 0.07 
X-AG, %12 50.1 0 8.92 <0.01 
1Values are means (n = 4 to 6) and SEM from growing (BW = 301 kg) and finished (BW = 
576 kg) Angus steers 
2Specific uptake activities are expressed as pmols Glu ∙ 10 min-1 uptake ∙ μg-1 protein in 
uptake buffer that contained 25 µM L-Glu 
3Most conservative error of the mean 
4Glu uptake measured in presence of 100 mM NaCl-containing uptake buffer 
5Na+-dependent Glu uptake is calculated as the difference between total and Na+-
independent uptake 
6Percentage of Na+-dependent Glu uptake is calculated as the amount of Na+-dependent Glu 
uptake divided by the amount of total Glu uptake 
7Glu uptake measured in presence of 100 mM choline chloride-containing uptake buffer 
8Percentage of Na+-independent Glu uptake is calculated as one minus percentage of Na+-
dependent Glu uptake 
9Glu uptake measured in the presence of 500 µM D-Asp and Na+-containing uptake buffer 
10Percentage of Non-X-AG activity is calculated as one minus percentage of X-AG activity 
11X-AG uptake is calculated as the amount of Na+-dependent uptake that was inhibited by 
500 µM D-Asp 
12The percentage of X-AG activity is calculated as the amount of X-AG uptake divided by the 
amount of Na+-dependent Glu uptake 
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Table 4. 4 Glutamate uptake in basolateral liver plasma membrane vesicles of growing 
vs. finished Angus steers1 
Uptake activity2 Growing Finished SEM3 P-Value 
Total uptake4 5.91 2.39 1.21 0.05 
Na+- dependent5 5.06 2.02 1.22 0.08 
Na+ -dependent, %6 79.8 86.6 6.41 0.47 
Na+ -independent7 0.85 0.37 0.17 0.08 
Na+ -independent, %8 20.2 13.5 6.47 0.47 
Non-X-AG9 3.21 0.87 0.93 0.08 
Non-X-AG, %10 79.0 37.0 13.0 <0.01 
X-AG11 1.85 1.15 0.90 0.55 
X-AG, %12 21.0 63.0 13.0 <0.01 
1Values are means (n = 4 to 6) and SEM from growing (BW = 301 kg) and finished (BW = 
576 kg) Angus steers 
2Specific uptake activities are expressed as pmols Glu ∙ 10 min-1 uptake ∙ μg-1 protein in 
uptake buffer that contained 25 µM L-Glu 
3Most conservative error of the mean 
4Glu uptake measured in presence of 100 mM NaCl-containing uptake buffer 
5Na+-dependent Glu uptake is calculated as the difference between total and Na+-
independent uptake 
6Percentage of Na+-dependent Glu uptake is calculated as the amount of Na+-dependent Glu 
uptake divided by the amount of total Glu uptake 
7Glu uptake measured in presence of 100 mM choline chloride-containing uptake buffer 
8Percentage of Na+-independent Glu uptake is calculated as one minus percentage of Na+-
dependent Glu uptake 
9Glu uptake measured in the presence of 500 µM D-Asp and Na+-containing uptake buffer 
10Percentage of Non-X-AG activity is calculated as one minus percentage of X-AG activity 
11X-AG uptake is calculated as the amount of Na+-dependent uptake that was inhibited by 
500 µM D-Asp 
12The percentage of X-AG activity is calculated as the amount of X-AG uptake divided by the 
amount of Na+-dependent Glu uptake 
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Table 4. 5 EAAC1 and GLT-1 content in canalicular (cLPM) and basolateral liver plasma 
membrane (bLPM) of growing vs. finished Angus steers1 
 Growing Finished SEM2 P-Value 
cLPM     
EAAC1 7453 3950 1742 0.09 
GLT-1 1732 1397   438 0.58 
bLPM     
EAAC1 6920 5162   610 0.05 
GLT-1 2228 3144 1201 0.50 
1Values (arbitrary densitometric units) are means (n = 4) and SEM of relative EAAC1 
and GLT-1 content in canalicular and basolateral liver plasma membranes prepared from 
growing (BW = 301 kg), and finished (BW = 576 kg) Angus steers. Densitometric 
quantification was of immunoreactive species identified by Western blot analysis (Fig. 2) 
2Most conservative error of the mean 
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Table 4. 6 Densitometric analysis of EAAC1, GLT-1, GTRAP3-18 and ARL6IP1 content 
of liver homogenates from growing vs. finished Angus steers1 
 Growing Finished SEM2 P-Value 
EAAC1 10607 8065 789 0.02 
GLT-1 1975 1771 345 0.66 
GTRAP3-18 1086 1775 228 0.03 
ARL6IP1 3416 4217 275 0.05 
1Values (arbitrary densitometric units) are means (n = 8) and SEM from liver 
homogenates of growing (BW = 301 kg) and finished (BW = 576 kg) Angus steers 
2Most conservative error of the mean 
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Table 4. 7 Glutamine synthetase (GS) activity and protein content in liver homogenates 
of growing vs. finished Angus steers 
 Growing Finished SEM3 P-Value 
GS activity1   0.99 0.67  0.09 0.01 
GS protein2 8787 8385  1035 0.72 
1Values are nmol ∙ min-1 ∙ mg-1 wet tissue (n = 8) 
2Values (arbitrary densitometric units) are means (n = 8) and SEM from liver 
homogenates of growing (BW = 301 kg) and finished (BW = 576 kg) Angus steers 
3Most conservative error of the mean 
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Figure 4. 1 Western blot analysis of β-catenin protein in enriched canalicular- (cLPM) 
and basolateral- (bLPM) liver plasma membrane vesicles (15µg per lane) of growing (G) 
and finished (F) steers. The apparent migration weight was ~ 94 kDa. Data are 
representative of 4 growing and 4 finished steers 
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Figure 4. 2 Western blot analysis of EAAC1 and GLT-1 in enriched canalicular- (cLPM) 
and basolateral- (bLPM) liver plasma membrane vesicles (15µg per lane) of growing (G, 
n = 4) and finished (F, n = 4) steers. The apparent migration weights (kDa) of the lower 
and upper immunoreactants for EAAC1 were 70 and 89, and 75 and 92 for GLT-1, 
respectively 
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Figure 4. 3 Western blot analysis of EAAC1, GLT-1, GTRAP3-18, ARLI6P1, and 
glutamine synthetase (GS) in homogenates (15µg per lane) of growing (G) and finished 
(F) steers. The apparent migration weights (kDa) for proteins were 70 kDa for the lower, 
and 89 kDa for the higher, predominant immunoreactants for EAAC1; 75 kDa for GLT-
1; 42 for GTRAP3-18; 21 for ARL6IP1; and 43 for GS; respectively. Data are 
representative of 8 growing and 8 finished steers 
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Chapter 5. The content of glutathione, glutamine synthetase, and EAAC1 glutamate 
transporter and controllers, differs in tissues of finished vs. growing beef steers 
 
ABSTRACT 
Skeletal muscle and adipose tissues play important roles in maintaining whole-
body Glu and N homeostasis via Glu transporters and Glu-utilizing enzymes. The goal of 
this study was to determine if the content of high affinity Glu transporter EAAC1, 
GTRAP3-18 (an inhibitor of EAAC1), ARL6IP1 (an inhibitor of GTRAP3-18), 
glutamine synthase (GS), glutathione (GSH), and mRNA expression of GSH-
synthesizing and metabolizing enzymes, changes in longissimus dorsi (LM) and 
subcutaneous adipose tissue (SF), as it does in the liver, when steers develop from 
predominately lean to lipid growth phases. Weaned Angus steers (BW = 209 ± 29.4 kg) 
were randomly assigned (n = 8) to develop through lean (GROW, final BW = 301 ± 7.06 
kg) vs. lipid (FINISH, final BW = 576 ± 36.9 kg) growth phases and individually fed 
enough of a cotton seed hull-based diet to achieve a constant ADG (1.5 kg/d) throughout 
the trial. The effect of development on experimental parameters was assessed by 1-way 
ANOVA using the GLM procedure of SAS. Marbling score (668, 296) and yield grade 
(3.65, 2.13) were greater (P < 0.01) for FINISH vs. GROW steers. Western blot analysis 
of LM homogenates showed less EAAC1 (30%, P = 0.02) and GS (28%, P = 0.02) 
content, whereas GTRAP3-18 (P = 0.80) and ARL6IP1 (P = 0.57) did not differ in 
FINISH vs. GROW steers. GSH content (mg/g wet tissue) in LM was increased (42%, P 
< 0.01) in FINISH vs. GROW steers in concomitance with increased mRNA expression 
of GSH-synthesizing enzymes (GCLC, GCLM). For SF, Western blot analysis found 
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greater GTRAP3-18 (123%, P = 0.03) and ARL6IP1 (43%, P = 0.01) content in FINISH 
vs. GROW steers, whereas EAAC1 (P = 0.11) and GS content (P = 0.37) did not differ. 
Concomitantly, the content of GSH in SF was decreased (38%, P = 0.04) in FINISH 
steers in parallel with decreased mRNA expression of GSH-metabolizing enzymes 
(GPX4, GGT1). We conclude that the negative regulatory relationship between 
GTRAP3-18 and ARL6IP1 with EAAC1 and GS expression, which exists in liver, does 
not exist in LM and SF of fattened cattle. Thus, novel regulators may contribute to the 
differential expression of EAAC1, GS and GSH content in LM and SF; and antioxidant 
capacity in LM and SF changes and differs as steer compositional gain shifts from lean to 
lipid phenotype. Our results provide mechanistic knowledge of how the antioxidant 
capacity is achieved in tissues of economic and metabolic importance to fattened cattle. 
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INTRODUCTION 
 
Glutathione (γ-L-glutamyl-L-cysteinylglycine, GSH) modulates diverse cellular 
processes. For example, GSH is involved in detoxification of xenobiotics and regulates 
cell proliferation, apoptosis and immunity, and redox signaling (Meister and Anderson, 
1983; Suthanthiran et al., 1990; Ballatori et al., 2009; Lu, 2009; Pallardó et al., 2009; Liu 
and Pravia, 2010). Aberrant redox signaling is induced by excessive production of 
reactive oxygen species (ROS) that can lead to sub-optimal growth by disrupting tissue 
metabolism. Glutathione functions as the major antioxidant (through oxidation of GSH to 
GSH disulfide (GSSG)) to protect against oxidative damage and to maintain the cellular 
redox potential (Aoyama et al., 2008; Forman et al., 2009; Schmidt and Dringen, 2012).  
Of the total cellular GSH pool, 80-85% is found in the cytosol versus 10-15% in the 
mitochondria and a small amount in the endoplasmic reticulum (Meredith and Reed, 
1982; Hwang et al., 1992; Yuan and Kaplowitz, 2009; Lu, 2013). 
Biosynthesis and whole-body utilization of GSH occurs in a tightly regulated 
manner in the animal body. Cellular GSH synthesis strongly depends on the availability 
of Glu and Cys (Sato et al., 1999; Flaring et al., 2003; Matthews, 2005), which are 
substrates of two high-affinity (µM), concentrative, Glu transporters (GLT-1 and 
EAAC1) that demonstrate system X-AG activity (Na+-dependent L-Glu, L-cysteine and L-
Asp uptake that is inhibited by D-Asp). EAAC1 and GLT-1 are expressed by the 
intestinal epithelia, liver, kidney, and skeletal muscle tissues of ruminants, whereas only 
EAAC1 protein is consistently detectable in ruminant adipose tissue (Howell et al. 2001; 
Howell et al. 2003; Xue et al. 2010; Miles et al. 2015; Matthews et al., 2016). In mouse 
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neuronal cells, the function of EAAC1 (solute carrier 1A1/SLC1A1) and GLT-1 
(SLC1A2) is inhibited by endoplasmic reticulum-localized GTRAP3-18 (glutamate 
transporter-associated protein 3-18; a.k.a. addicsin, ADP-ribosylation factor-like 6 
interacting protein 5/ARL6IP5, PRAF3) (Ruggiero et al. 2008; Watabe et al. 2008) and 
that the effect of GTRAP3-18 on EAAC1 activity is proportional to GTRAP3-18 content 
(Lin et al. 2001). Accordingly, inhibition of GTRAP3-18 leads to an increase in GSH 
production in mice neurons (Watabe et al., 2007, 2008; Aoyama et al., 2012). However, 
ADP-ribosylation factor-like 6 interacting protein 1 (ARL6IP1) binds and inhibits 
GTRAP3-18, and indirectly promotes EAAC1 activity and cellular GSH levels (Aoyama 
and Nakaki 2012; Akiduki and Ikemoto 2008; Aoyama and Nakaki 2013). The 
ARL6IP1/GTRAP3-18/EAAC1 triad is highly expressed in rat liver (Akiduki and 
Ikemoto, 2008), whereas cow liver expresses at least EAAC1 and GTRAP3-18 (Miles et 
al. 2015).  
To assess whether hepatic expression and activity of system X-AG transporters and 
regulatory proteins, and glutamine synthetase activity, is altered concomitantly with the 
shifts in whole-body compositional gain as cattle fatten, we conducted a study to compare 
these parameters as beef steers developed from predominantly-lean to predominantly-
lipid phenotypes (Chapter 4). However, knowledge about the expression of these proteins 
in skeletal muscle and adipose tissues is limited, despite evidence of the metabolic 
importance of their joint function to antioxidant capacity and whole-body N metabolism 
(Kowalski and Watford, 1994; Patterson et al., 2002; Vesali et al., 2002; Matthews et al., 
2016). The goal of the current research was to determine whether the content of system 
X-AG transporters, their regulatory proteins, glutamine synthetase (GS), GSH, and mRNA 
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expression of GSH-synthesizing and metabolizing enzymes, changed in longissimus dorsi 
(LM) and subcutaneous adipose (SA) tissues of the same steers developing from 
predominantly-lean into predominantly lipid growth phases. 
 
MATERIALS AND METHODS 
Animal Model 
All procedures involving animals were approved by the University of Kentucky 
Institutional Animal Care and Use Committee. The steers were raised, and trial 
conducted, at the University of Kentucky Research and Education Center in Princeton, 
KY.  
Sixteen weaned, predominately Angus, steers of similar shrunk (denied feed and 
water for 14 h) body weight (BW = 209 ± 29.4 kg) were randomly assigned (n = 8) to 
either growing (final BW = 301 ± 7.06 kg) or finished (final BW = 576 ± 36.9 kg) 
treatment groups. Steers then were randomly assigned to one of 4 feedlot pens that 
contained Calan gates in a dry-lot barn. Four steers were assigned per pen. Steers were 
individually fed enough of a diet that contained (% as-fed) cracked corn (60), cottonseed 
hulls (20), soybean meal (7), soybean hulls (5), dried distiller’s grain (2), alfalfa meal (2), 
glycerin (2), limestone (1.5), and urea (0.5) to support 1.51 kg gain/d (NRC 1996) 
throughout the trial. Steers had ad libitum access to fresh water and a vitamin-mineral 
mix (UK IRM Beef Cattle Vitamin-mineral Mix, Burkmann Mill, Inc., Danville, KY). 
Full BW were determined every 14 d and amount of diet adjusted to achieve target rate of 
gain. Steer average daily gain (ADG) was calculated as the difference between shrunk 
BW at trial initiation and 1 d before slaughter.  
 
78 
 
Slaughter, Tissue Collection, and Carcass Evaluation 
One steer per day was slaughtered. Steers were stunned by captive bolt pistol and 
then exsanguinated to allow recovery of carcasses for consumption. After the HCW was 
recorded, liver, Longissimus dorsi (between 12th and 13th rib) muscle and its adjacent 
subcutaneous adipose tissue were collected as described (Brown et al., 2009). For GSH 
content, fresh tissues were homogenized in 5% ice-cold metaphosphoric acid solution 
followed by centrifugation at 3000 x g, 4°C for 10 min. The supernatant was collected 
and stored at -80°C overnight for next day assay (see below). For all other analyses, 
tissue samples were placed in foil packs, snap-frozen in liquid nitrogen, and stored at -
80°C until assayed for RNA and protein expression. 
After 24 h postmortem, carcass evaluations were conducted on the right side of 
the carcass according to USDA standards (USDA, 1997).  
 
Western Blot Analysis 
In general, liver tissues were processed for immunoblot analysis of relative 
protein content as previously described by this research group (Howell et al., 2001; Miles 
et al., 2015). For liver homogenates, 1 g of liver tissue was homogenized on ice for 30 s 
(setting 11, POLYTRON, Model PT10/35; Kinematic, Inc., Neuchâtel) in 7.5 mL of 4°C 
sample extraction buffer solution (0.25 mM sucrose, 10 mM HEPES-KOH pH 7.5, 1 mM 
EDTA, and 50 µL of protease inhibitor (Sigma, St. Louis, MO). Protein was quantified 
by a modified Lowry assay, using bovine serum albumin as a standard (Kilberg, 1989). 
For liver homogenates and cLPM and blpm (protein quantified during preparation), 
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proteins were separated by 12% SDS-PAGE, followed by electrotransfer to a 0.45 µm 
nitrocellulose membrane (Bio-Rad, Hercules, CA). Blots were stained with Fast-Green 
(Fisher, Pittsburgh, PA) and the relative amount of stained protein per lane/sample 
determined by densitometric analyses and recorded as arbitrary units (Howell et al., 2001; 
Miles et al., 2015). 
The relative protein content of EAAC1, GLT-1, GTRAP3-18, GS, and beta-
catenin in liver homogenates was evaluated by immunoblot analyses as described (Brown 
et al., 2009; Miles et al., 2015), whereas for ARL6IP1, an antibody raised against the 
human ortholog (see below) was validated for detection of cattle ARL6IP1 using a 
standard pre-hybridization regimen (Xue et al., 2011; data not shown). Briefly, blots were 
hybridized with 1 μg of IgG antihuman EAAC1 polyclonal anti-body (Santa Cruz 
Biotechnology, Inc., Santa Cruz, CA), 1 μg of IgG anti-rabbit GLT-1 polyclonal antibody 
(Abcam Inc., Cambridge, MA), 4 μg of IgG antihuman GTRAP3-18 (Abcam Inc., 
Cambridge, MA), and 5 μg of IgG antihuman ARL6IP1 (Abgent Inc., San Diego, CA), 
respectively, per mL of blocking solution (1% nonfat dry milk (w, v) in 30 mM Tris-Cl, 
200 mM NaCl, 0.1% Tween 20 (v, v), pH 7.5) for 1.5 h at room temperature with gentle 
rocking. For β-catenin detection, blots were hybridized with 14.5 μg of IgG anti-chicken 
beta-catenin (Abcam Inc., Cambridge, MA) per mL of blocking solution (1.5% nonfat 
dry milk [wt/vol] in 30 mM Tris-Cl [pH 7.5], 200 mM NaCl, 0.1% Tween-20) for 1.5 h at 
room temperature with gentle rocking, whereas GS was detected using 1.25 μg of IgG 
anti-sheep polyclonal antibody (BD Biosciences, San Jose, CA) per mL of blocking 
solution (5% nonfat dry milk [wt/vol], 10 mM Tris-Cl [pH 7.5], 100 mM NaCl, 0.1% 
Tween 20 [vol/vol]) for 1 h at 37°C with gentle rocking.  
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All protein-primary antibody binding reactions were visualized with a 
chemiluminescence kit (Pierce, Rockford, IL) after hybridization of primary antibodies 
with horseradish peroxidase-conjugated donkey antirabbit IgG (Amersham, Arlington 
Heights, IL; GLT-1, EAAC1 and ARL6IP1, 1:5,000); horseradish peroxidase-conjugated 
goat antimouse IgG (BD Biosciences, San Jose, CA; GS, 1:5,000, and beta-catenin, 
1:10,000); and horseradish peroxidase-conjugated donkey antigoat IgG (Santa Cruz 
Biotechnology; GTRAP3–18, 1:5,000).  
Densitometric analysis of immunoreactive products was performed as described 
previously (Howell et al., 2003; Fan et al., 2004; Xue et al., 2011). Briefly, after exposure 
to autoradiographic film (Amersham, Arlington Heights, IL), a digital image of the 
radiographic bands was recorded and quantified as described (Swanson et al., 2000). 
Apparent migration weights (Mr) were calculated by regression of the distance migrated 
against the Mr of a 16 to 185 kDa standard (Gibco BRL, Grand Island, NY) using the 
Versadoc imaging system (BioRad) and Quantity One software (BioRad). Band 
intensities of all observed immunoreactive species (one for GTRAP3-18, ARL6IP1, GS, 
and β-catenin; two for EAAC1 and GLT-1) within a sample were quantified by 
densitometry (as described above for Fast-Green stained proteins) and reported as 
arbitrary units. Densitometric data then were corrected for unequal (≤ 12%) loading, 
transfer, or both, and amount of detected protein normalized to relative amounts of Fast-
Green-stained proteins common to all immunoblot lanes/samples (Miles et al., 2015). 
Digital images were prepared using PowerPoint software (Microsoft, PowerPoint 2003, 
Bellvue, MA). 
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GSH Content in Liver, longissimus dorsi (LM) and subcutaneous fat (SF) tissues   
Upon collection, liver, longissimus dorsi (LM) and subcutaneous fat (SF) tissues 
(0.30 g to 0.35 g) were rinsed in 0.9% (w,v) NaCl solution and homogenized in 2.5 mL 
5% (w,v) ice-cold metaphosphoric acid solution. The homogenates were then centrifuged 
at 3000 x g, 4°C for 10 min. After centrifugation, 100 μL to 200 μL of supernatant was 
collected and stored at -80°C overnight for use the next day.  
The reduced glutathione (GSH) concentrations in liver, LM and SF were 
determined using the GSH-400 kit (Oxis International Inc., Beverly Hills, CA), following 
the manufacturer’s instructions. For liver and LM, a standard curve was prepared using 0, 
20, 40, 60, and 80 μmol/L GSH. For SF, the standard curve was prepared with 0, 4, 8, 12, 
16, 20 µmol/L GSH.The final absorbance at 400 nm was measured using a Genesys 20 
spectrometer (Thermo Electron Corp., Waltham, MA). Samples were assayed in triplicate 
and values are reported as mg GSH/g wet tissue.  
 
RNA Extraction and Analysis 
For each animal, total RNA was extracted from frozen LM and SF tissue using 
TRIzol Reagent (Invitrogen Corporation, Carlsbad, CA) following the manufacturer’s 
instructions. The purity and concentration of total RNA samples was analyzed by a 
NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies, Wilmington, DE), 
which revealed that all samples were of high purity with 260:280 nm absorbance ratios of 
2.0 to 2.1 and 260:230 nm absorbance ratios ranging from 1.5 to 1.9. The integrity of 
total RNA was examined by gel electrophoresis using an Agilent 2100 Bioanalyzer 
System (Agilent Technologies, Santa Clara, CA) at the University of Kentucky 
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Microarray Core Facility (Lexington, KY). Visualization of gel images and 
electropherograms showed that all RNA samples had high quality with RNA integrity 
numbers being greater than 8.5 and 28S: 18S rRNA absorbance ratios greater than 1.8.  
 
Real-Time Reverse-Transcribed (RT) PCR Analysis  
Real-time RT-PCR was performed using RNA samples from LM and SF tissue to 
determine the expression of mRNA for glutathione-synthesizing and metabolizing 
proteins using an Eppendorf Mastercycler ep realplex2 system (Eppendorf, Hamburg, 
Germany) with iQ SYBR Green Supermix (Bio-RAD, Hercules, CA). Briefly, cDNA 
was synthesized using the SuperScript III 1st Strand Synthesis System (Invitrogen), with 
0.5 μg of RNA used for each reverse transcription reaction. Real-time RT-PCR was 
performed with a total volume of 25 μL per reaction, with each reaction containing 5 μL 
of cDNA, 1 μL of a 10 μM stock of each primer (forward and reverse), 12.5 μL of 2× 
SYBR Green PCR Master Mix, and 5.5 μL of nuclease-free water. The resulting real-
time PCR products were purified using a PureLink Quick Gel Extraction Kit (Invitrogen) 
and sequenced at Eurofins Scientific (Eurofins, Louisville, KY). Sequences were 
compared with the corresponding RefSeq mRNA sequences used as templates for primer 
set design. The sequences of the primers and the resulting sequence-validated real time 
PCR reaction amplicons are presented in Figure 5.3. Beta-actin (ACTB), glyceraldehyde 
3-phosphate dehydrogenase (GAPDH) and ubiquitin C (UBC) were used as the 
housekeeping genes in the LM, and beta-actin (ACTB), glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) and peptidylprolyl isomerase A (PPIA) were used as the 
housekeeping genes in the SF. RT-PCR reactions were run in triplicate and gene 
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expression was analyzed by the 2ΔΔCT method (Livak and Schmittgen, 2001).  
 
Statistical Analysis 
Individual steers were the observational units. Data were analyzed as a completely 
randomized design by ANOVA using the GLM procedures of SAS (SAS Inst. Inc., Cary, 
NC). All data were analyzed in a 1-way ANOVA model to test for finishing vs. growing 
treatment effects. Treatment differences were considered significant at the α = 0.05 level. 
Unequal experimental treatment observations resulted from loss of sample integrity 
during collection or storage. 
 
RESULTS 
 
Expression of System X-AG Transporters, the Regulatory Proteins and GS in LM and 
SF in Developing Steers 
EAAC1 (Mr = 70 kDa for the lower, and 89 kDa for the higher, predominant 
immunoreactants), GTRAP3-18 (Mr = 42 kDa), ARL6IP1 (Mr = 21 kDa) and GS (Mr = 
43 kDa) proteins were detected by Western blot analysis in LM (Figure 5.1) and SF 
(Figure 5.2) of growing and finished steers (Table 5.2). In contrast, GLT-1 was not 
detected in LM and SF (data not shown).  
 
Decreased EAAC1 and GS Content in LM, concomitant with Increased GSH Content, 
of Fattening Beef Steers 
Densitometry analysis of western blot data of LM homogenates (Table 5.1) 
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showed less EAAC1 (30%, P = 0.02) and GS (28%, P = 0.02) content in FINISH vs. 
GROW steers, whereas GTRAP3-18 (P = 0.80) and ARL6IP1 (P = 0.57) did not differ. 
GSH content (mg/g wet tissue) in LM was greater (42%, P < 0.01) in FINISH vs. GROW 
steers (Table 5.1). 
 
Increased GTRAP3-18 and ARL6IP1 Content in SF, concomitant with Decreased GSH 
Content, of Fattening Beef Steers 
For SF, densitometric analysis of western blot data (Table 5.2) found increased 
GTRAP3-18 (123%, P = 0.03) and ARL6IP1 (43%, P = 0.01) content in FINISH vs. 
GROW steers, whereas EAAC1 (P = 0.11) and GS content (P = 0.37) did not differ. 
Concomitantly, the content of GSH in SF was decreased (38%, P = 0.04) in FINISH vs. 
GROW steers.  
 
GSH content does not differ but mRNA Expression of Glutathione Synthesizing, 
Metabolizing, and Exporter Proteins Differed in LV of Fattening Steers 
The liver content of GSH did not differ between FINISH (1.08) and GROW 
(1.07) steers. For glutathione-synthesizing proteins in LV (Table 5.3), real time RT-PCR 
analysis found less GCLC (39%, P = 0.024) and GSS (29%, P = 0.009) mRNA 
expression, whereas GCLM (P = 0.683) and GSR expression (P = 0.354) did not differ 
in FINISH vs. GROW steers. For glutathione-metabolizing protein in LV, real time RT-
PCR assays showed less GPX1 (30%, P = 0.001) but more GSTM1 (113%, P = 0.001) 
mRNA expression, whereas GGT1 expression tended to be greater (P = 0.077) and 
mGST3 expression did not differ (P = 0.254) in FINISH vs. GROW steers. For 
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glutathione exporters in LV, mRNA abundance was less for ABCC1 (39%, P = 0.001), 
SLCO2B1 (61%, P = 0.025), and SLCO1B3 (32%, P = 0.001) in FINISH vs. GROW 
steers. 
 
mRNA Content of Glutathione-Synthesizing and Metabolizing Proteins Differed in LM 
of Fattening Steers 
For glutathione-synthesizing proteins in LM, the relative abundance of mRNA 
was greater for GCLC (61%, P = 0.004) and GCLM (29%, P = 0.001) in FINISH vs. 
GROW steers, but did not differ for GSS (P = 0.146) and GSR (P = 0.837) (Table 5.4). 
For glutathione-metabolizing protein in LM, GPX1 (61%, P = 0.004), GPX3 (29%, P = 
0.001) and GGT1 (56%, P = 0.045) mRNA abundance was greater in FINISH vs. 
GROW steers, whereas GPX2 (46%, P < 0.001) expression was less and GPX4 
expression tended to be less (P = 0.093). 
 
mRNA Content of Glutathione-Synthesizing and Metabolizing Protein in SF of 
Fattening Steers 
For glutathione-synthesizing proteins in SF, the relative abundance of GCLC, 
GCLM, GSS and GSR mRNA did not differ (P ≥ 0.261) in FINISH vs. GROW steers 
(Table 5.5). For glutathione-metabolizing proteins in SF, the relative content was less for 
GPX4 (52%, P = 0.013) and GGT1 (71%, P = 0.001) mRNA, whereas GPX1 (P = 
0.319) and GPX3 mRNA abundance did not differ (P = 0.101) in FINISH vs. GROW 
steers. 
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DISCUSSION 
 
Understanding the relationship between expression of system X-AG transporters, 
their regulatory proteins, GS, and proteins responsible for GSH content, could yield 
important insight into the importance of Glu use and metabolism. Importantly, these 
relationships likely reflect changes in tissues that support (e.g. liver) or account for 
(skeletal muscle, adipose) changes in compositional change as production animals 
transition from predominantly low to high lipid accretion phases. To assess whether 
hepatic expression and activity of system X-AG transporters and regulatory proteins, and 
glutamine synthetase activity, is altered concomitantly with the shifts in whole-body 
compositional gain as cattle fatten, we conducted a study that compared these parameters 
as beef steers developed from predominantly-lean to predominantly-lipid phenotypes 
(Chapter 4). However, knowledge about the expression of these proteins in skeletal 
muscle and adipose tissues is limited, despite evidence of the metabolic importance of 
their joint function to antioxidant capacity and whole-body N metabolism (Kowalski and 
Watford, 1994; Patterson et al., 2002; Vesali et al., 2002; Matthews et al., 2016). The 
goal of the current research was to determine whether the content of system X-AG 
transporters, their regulatory proteins, GS, GSH, and mRNA expression of GSH-
synthesizing and metabolizing enzymes, changed in longissimus dorsi (LM) and 
subcutaneous adipose (SA) tissues of the same steers developing from predominantly-
lean into predominantly lipid growth phases. 
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Decreased EAAC1 and GS Content but Increased GSH Content in LM of Fattening 
Beef Steers 
Because of its integral physiological role and economic importance in carcass 
evaluation, and its presumed relationship with intramuscular adipose content, LM was 
studied as the model for skeletal muscle tissue. In addition to having important roles in 
other tissues of the body, Glu is central to many metabolic processes in skeletal muscle. 
For example, Glu is required for transamination of branch-chain amino acids, pivotal to 
the formation of ammonia, Asp, Ala, and Gln, and is the primary AA taken up by resting 
and active muscles (Mourtzakis and Graham, 2002). A reduction in the capacity for 
plasma Glu uptake by skeletal muscle is thought to cause intracellular deficiencies of 
Glu, Gln, GSH, and citric acid cycle intermediates (Hack et al., 1996; Ushmorov et al., 
1999). Reports on the identity of glutamate transporters in muscle tissue are limited. 
However, system XAG- activity has been reported in skeletal myocytes (Low et al., 1994), 
as has EAAC1 mRNA and protein expression by rat and human skeletal muscle (Kanai 
and Hediger, 1992; Hediger and Welbourne, 1999). Similarly, we found both EAAC1 
mRNA and protein in fattening steer LM. In contrast, we did not detect GLT-1, GLAST-
1 or EAAT4 protein in LM, using the same amount of homogenate as for EAAC1 
(Matthews et al., 2016). Thus, EAAC1 plays an important role in supporting carbon and 
N metabolism in this skeletal muscle. 
The present study found that the protein content of EAAC1 in LM decreased as 
steers developed from growing to finishing phases, in contrast to a previous report that 
EAAC1 content in LM did not differ between backgrounding and finishing production 
stages (Matthews et al., 2016). Because about half of the Gln released from muscle 
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originates from Glu taken up from the blood (Wagenmakers, 1998), this current finding 
may be indicative of a decreased requirement for blood-derived Glu as the steers 
developed from a predominately-lean to predominately-lipid tissue accretion phases, due 
to either (a) an increased supply of intra-cellular Glu from increased glutamate 
dehydrogenase or ornithine transaminase activity, or (b) a reduced need to capture 
sinusoidal Glu and ammonia.  
The uptake of plasma Glu, its intracellular conversion to Gln, and subsequent 
export of Gln to the plasma by skeletal muscle is critical to the proper functioning of 
intestinal epithelia and immune system (Newsholme et al., 1990; Hack et al., 1996). 
Although the activities of glutamate dehydrogenase or ornithine transaminase were not 
determined, we did measure GS content in LM homogenates and found that GS content 
was decreased 33% in finished vs. growing steers, paralleling the reduced EAAC1 
content in LM. This finding suggests that the ability of LM to use blood ammonia 
decreased from growing to finished steers or that the load of blood ammonia decreased. 
With regard to the possibility of decreased use of blood ammonia, detoxification of 
ammonia by GS may have been limited due to a shortage of intracellular glutamate (Boon 
et al., 1999). If so, the above findings suggest that the observed decreased EAAC1 and 
GS content, was paralleled by a decreased ability to produce intracellular Glu. With 
regard to the second possibility of decreased blood levels of ammonia, ammonia 
concentrations in the blood may have been decreased due to an elevated capacity to 
scavenge ammonia for urea synthesis in the liver of finished vs. growing steers. 
Oxidative stress results in changes in metabolic balance and nutrient use 
efficiency (Elsasser et al., 2008). Glu transporter proteins and enzymes supporting the 
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Na+ and Glu gradients (e.g., Na, K-ATPase, glutamine synthetase) can be oxidized in 
presence of higher concentrations of reactive oxygen radicals, leading to inhibition of 
metabolic functions (Volterra et al., 1994; Gegelashvili and Schousboe, 1997). To protect 
against oxidative damage, GSH serves as the major antioxidant to maintain the celluar 
thiol reduction potential (Aoyama et al., 2008; Forman et al., 2009; Schmidt and Dringen, 
2012).  In a human trauma model, GSH concentration decreases in skeletal muscle, 
indicating oxidative stress caused by tissue injury (Flaring et al., 2003). However, 
glutathione depletion in muscle can be attenuated by glutamine supplementation via a 
supply of glutamate for glutathione synthesis (Flaring et al., 2003). Thus, dietary amino 
acid supplementation seems to be a good therapeutic strategy to modulate GSH synthesis. 
On the contrary, a deficient sulfur amino acids diet decreases growth and glycolysis of 
longissimus muscle in piglets (Conde-Aguilera et al., 2015), suggesting the inadequate 
nutrition supply impairs GSH homeostasis. 
To characterize the role of LM metabolism of Glu to support GSH-mediated 
antioxidant capacity in LM of fattening cattle, GSH content was determined in LM 
homogenates. Opposite with decreased EAAC1 and GS content, GSH content in LM was 
increased in finished vs. growing steers. This finding suggests that GS and the enzymes 
responsible for GSH synthesis may compete for Glu as a substrate, when the 
compositional gain of steers shifts from lean to lipid phenotypes. Concomitantly, the 
increased GSH content in LM is indicative of a decreased oxidative stress in LM 
(Aoyama et al., 2006; Findeisen et al., 2011; Aoyama and Nakaki, 2012) and/or the 
increased intracellular capacity for GSH synthesis in LM of finished vs. growing steers, 
either by increase of γ-glutamylcysteine ligase catalytic and modifier units (GCLC, 
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GCLM) or glutathione synthase activity (Lu, 2013). Consistent with this possibility was 
the increased expression of both GCLC and GCLM in LM tissue of FINISH vs. GROW 
steers (Table 5.4). Another possible explanation for the increased GSH content is that 
finished steers may have an increased capacity to import plasma GSH released from the 
liver into the LM (Lew et al., 1985; Ji and Fu, 1992). 
Expression of EAAC1 and GS in SF, Concomitant with Decreased GSH Content of 
Fattening Beef Steers 
Adipose tissues play a significant role in whole body amino acid metabolism 
(Fryan et al., 1991; Kowalski et al., 1997; Patterson et al., 2002). Subcutaneous adipose 
has been proven to be a net user of Glu and net producer of Gln (Frayn et al., 1991) with 
the metabolic capacity to be an important site for Gln synthesis in the body (Ritchie et al., 
2001). The inguinal adipose pad/adipocyte tissue of fed rats also appears to be a net user 
of Glu and ammonia, and a producer of Gln (Kowalski and Watford, 1994). Accordingly, 
these studies gave rise to the concept that the adipose tissues of normally-nourished 
mammals absorb Glu to synthesize Gln and, therefore, contribute to whole-body nitrogen 
metabolism through the production of Gln and removal of ammonia from the blood. 
Thus, it seems reasonable to suggest that the relative contribution of adipose-synthesized 
Gln to whole-body N metabolism is strongly influenced by the relative activity of Glu 
transporters and GS (Ritchie et al., 2001).  
 In addition to supporting nitrogen metabolism, adipose tissues also contribute to 
the redox potential and energy homeostasis in the whole animal body. Increased 
oxidative stress in obesity has been shown in human, mice and pig model: increased 
reactive species production and oxidative damage were observed in subcutaneous adipose 
 
91 
tissue in obese and type 2 diabetes (Chattopadhyay et al., 2015); dysregulation of adipose 
glutathione peroxidase 3 results in systemic oxidative stress in obese mice (Lee et al., 
2008); moreover, selenoprotein gene profiles change in different tissues such as liver and 
subcutaneous fat in pigs fed on a high fat diet (Zhao et al., 2015), suggesting a potential 
change of redox potential. In addition to obesity, adipogenesis can be inhibited by 
oxidative stress accumulation in adipose tissue in aging mice (Findeisen et al., 2011).  
However, knowledge on the role of adipose tissue metabolism of Glu in whole-
body N scavenging and antioxidant capacity in fattening cattle is very limited. Therefore, 
in terms of adipose tissue utilization of blood Glu, an important finding from this study 
was that EAAC1 was the only system XAG- transporter detected by SF in fattening cattle. 
Thus, EAAC1 function likely is critical for Glu-based adipose metabolism, including the 
synthesis of Gln and GSH from plasma Glu. That GLT-1 protein was not detected in 
these tissues, but that GLT-1 mRNA was, indicates that either GLT-1 was expressed in 
levels too low for immunoblot detection or that GLT-1 transcription and translation are 
controlled by discordant regulatory pathways. Alternatively, the sensitivity of GLT-1 
Western blot reagents were insufficient to detect GLT-1.  
To determine whether the expression of EAAC1 was associated with Gln and 
GSH production in SF, the relative expression of EAAC1 and GS, and GSH content were 
characterized in SF. The content of EAAC1 and GS did not differ in SF of finished vs. 
growing steers. For GS, this result is incompatible with that of Matthews et al. (2016), in 
which GS content decreased when steers developed from backgrounding to finishing 
production stages, but is consistent with the finding that EAAC1 content did not differ in 
SF between backgrounding and finishing phases. However, we found a decreased GSH 
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content in SF of finished vs. growing steers, suggesting an increased oxidative stress in 
SF or that GSH was quickly oxidized in the presence of high concentrations of reactive 
species (Aoyama et al., 2006; Findeisen et al., 2011; Aoyama and Nakaki, 2012). 
Alternatively, the intracellular capacity for GSH synthesis in SF may have decreased in 
finished vs. growing steers.  
  
Regulation of GSH Levels through Alteration of EAAC1 Expression and Function in 
LV, LM, and SF of Growing and Finishing Steers 
The main site for the GSH production is liver with amino acid transporters and 
glutathione and bile acid synthesizing enzymes localized to pericentral hepatocytes 
(Häussinger and Gerok, 1983; Boon et al., 1999; Braeuning et al., 2006). After exported 
into blood and bile, GSH can be utilized by other organs such as kidney, brain, muscle 
and intestine (Deneke and Fanburg, 1989). Because the liver is a net exporter of GSH, 
depletion of liver GSH under oxidative stress or xenobiotics metabolism may also deplete 
GSH in other tissues (Fernandez Checa and Kaplowitz, 2005; Lushchak, 2012). 
Therefore, hepatic GSH production and use vs. secretion play a critical role in the whole 
animal glutathione homeostasis (Lauterburg et al., 1984; Deneke and Fanburg, 1989; 
Ookhtens and Kaplowitz, 1998). 
As noted earlier, EAAC1 delivers substrates (Glu, Cys) to support GSH synthesis 
(Aoyama et al., 2005). However, EAAC1 expression and function are tightly regulated at 
the post-transcriptional and post-translational levels (Aoyama et al., 2005). At the post-
transcription level, miR-96-5p has been identified to target EAAC1 in mouse 
dopaminergic neurons (Kinoshita et al., 2014). Intracerebroventricular administration of 
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miR-96-5p inhibitor increases the level of EAAC1 as well as that of GSH and exhibits a 
neuroprotective effect in the mouse brain. At the post-translational level, the activity of 
EAAC1 is regulated by two endoplasmic reticulum (ER)-localized proteins, GTRAP3-18 
(glutamate transporter-associated protein 3-18, a.k.a. addicsin and ADP-ribosylation 
factor-like 6 interacting protein 5/ARL6IP5, or PRAF3) and ARL6IP1 (ADP-ribosylation 
factor-like 6 interacting protein 1). The negative regulator of EAAC1, GTRAP3-18 
decreases EAAC1-mediated transport activities by interacting with EAAC1 and retaining 
EAAC1 in the ER and consequently delays EAAC1 trafficking to the trans-Golgi and 
plasma membrane (Lin et al., 2001; Ruggiero et al., 2008). Inhibition of GTRAP3-18 
leads to an increase in GSH production in mice neurons (Watabe et al., 2007, 2008; 
Aoyama et al., 2012). However, an ER-localized protein ARL6IP1 serves as a positive 
regulator of EAAC1 by interacting with GTRAP3-18 to decrease the GTRAP3-
18/EAAC1 interaction. Consequently, high ARL6IP1 expression promotes the transport 
activity of EAAC1 and glutathione synthesis in mouse neurons (Akiduki and Ikemoto, 
2008; Aoyama and Nakaki, 2012). 
Although GTRAP3-18 regulation of EAAC1 is well known in the brain, 
knowledge on regulation of EAAC1 in peripheral tissues is very limited. However, 
hepatic GTRAP3-18 protein content was shown to increase in aged vs. young cows, 
whereas GS decreased and EAAC1, GLT1 contents did not differ (Miles et al., 2015). 
Our previous research (Chapter 4) found that in the liver of finished vs. growing steers, 
hepatic Glu transport and Gln synthesis capacities were decreased, concomitant with 
increased GTRAP3-18 and ARL6IP1 content. We also measured GSH content in the 
liver, however, GSH content did not change (1.08 vs. 1.07) in liver of finishing vs. 
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growing steers. This result may suggest that increased hepatic GSH synthesis parallels 
the increased potential for GSH export from hepatocytes into blood and bile (Table 5.3), 
and vice versa, resulting in no change of GSH content in liver of finishing vs. growing 
steers. However, assuming the intracellular GSH synthesis capacity in finishing steers 
was the same as in growing steers, this finding indicates that hepatic GSH synthesis 
likely is not limited by EAAC1-mediated cysteine uptake, as evidenced by decreased 
EAAC1 protein content in liver homogenate, canalicular and basolateral plasma 
membrane and reduced system X-AG activity in canalicular liver plasma membrane in 
finishing vs. growing steers (Chapter 4). When combined with the higher hepatic 
GTRAP3-18 content in finishing vs. growing steers, this finding is inconsistent with 
previous finding that GTRAP3-18 negatively regulates cellular GSH content via 
interaction with EAAC1 in human embryonic kidney 293 cells (Watabe et al., 2007) and 
that suppression of GTRAP3-18 increases neuronal GSH content in GTRAP3-18–/– mice 
(Aoyama and Nakaki, 2012). However, our finding is consistent with the previous studies 
showing no difference in hepatic GSH level between wild-type and EAAC1–/– mice 
(Aoyama et al., 2006) and that Cys in liver is derived from methionine via the 
transsulfuration pathway (Lu, 1999, 2013). These results suggest that EAAC1 might play 
a minor role in delivering substrates for GSH synthesis in bovine liver, thus highlighting 
the relationship of decreased EAAC1 and GS activity in livers of finishing vs. growing 
steers.  
To test the hypothesis that expression of EAAC1, GS, and GSH content were 
inversely proportional to GTRAP3-18 and proportional to ARL6IP1 in LM, immunoblot 
analysis was performed to evaluate the expression of GTRAP3-18 and ARL6IP1 protein 
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in LM homogenate of finishing vs. growing steers. Concomitant with decreased EAAC1 
and GS expression but increased GSH content, GTRAP3-18 and ARL6IP1 content did 
not differ in LM of finished vs. growing steers (Table 5.1). These data demonstrate the 
negative regulatory relationship between GTRAP3-18 and ARL6IP1 with EAAC1 and 
GS expression, that exists in liver, does not exist in LM of fattened cattle, indicating 
novel regulators contribute to the differential expression of EAAC1, GS and GSH content 
in LM. Overall, additional research is needed for cattle to further investigate pre-
translational regulators, including putative microRNAs reported to regulate expression of 
EAAC1 and GS, and GSH content in rodents (Kinoshita et al., 2014). 
To test whether the expression of EAAC1 and GS, and GSH content were 
inversely proportional to GTRAP3-18 and proportional to ARL6IP1 in SF, immunoblot 
analysis was performed to evaluate the expression of GTRAP3-18 and ARL6IP1 protein 
in SF homogenate of finishing vs. growing steers. Concomitant with decreased GSH 
content, both GTRAP3-18 and ARL6IP1 content increased in SF of finished vs. growing 
steers (Table 5.2). This finding is consistent with previous studies that GTRAP3-18 
negatively regulate cellular GSH content via interaction with EAAC1 in human 
embryonic kidney 293 cells (Watabe et al., 2007) and that suppression of GTRAP3-18 
increases GSH content in GTRAP3-18–/– mice (Aoyama and Nakaki, 2012). Assuming 
increased GTRAP3-18 content leads to decreased EAAC1 transport activity, this finding 
suggests that in SF, EAAC1 activity is regulated by GTRAP3-18 and ARL6IP1 to 
support GSH synthesis rather than Gln production.  
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Mechanisms of How Antioxidant Capacity Is Achieved in LM and SF of Fattening 
Steers: Transcriptional Changes of GSH Synthesizing and Metabolizing Proteins in 
Tissues of Fattening vs. Growing steers 
GSH is the most abundant cellular thiol present in mammalian tissues. GSH 
synthesis involves two consecutive ATP-requiring enzymatic reactions: formation of γ-
glutamylcysteine from Glu and cysteine by γ-glutamylcysteine ligase (GCL) and 
formation of glutathione from γ-glutamylcysteine and glycine by glutathione synthase. 
The rate-limiting enzyme GCL is composed of a catalytic subunit (GCLC) and a modifier 
subunit (GCLM) (Yang et al., 2002; Franklin et al., 2009). GCLC catalyzes γ-
glutamylcysteine synthesis, whereas GCLM modulates GCLC by lowering the Km for 
Glu and increasing the Ki for the feedback inhibition of GCL by glutathione (Richman 
and Meister, 1975; Huang et al., 1993a; Huang et al., 1993b; Chen et al., 2005). 
Consequently, the holoenzyme GCL more efficiently catalyzes γ-glutamylcysteine 
synthesis and is subject to less GSH feedback inhibition compared to GCLC. The second 
step of GSH synthesis from γ-glutamylcysteine and glycine is catalyzed by glutathione 
synthase (GSS). Although glutathione synthase is usually not considered to be rate 
limiting, increased glutathione synthase expression can further promote GSH production 
in rat hepatocytes (Huang et al., 2000; Dalton et al., 2004). 
Several GSH related enzymes guard cells against oxidative injury by scavenging 
reactive oxygen species and nitrogen radicals. In the cytosol and mitochondria, 
superoxide dismutase (SOD) catalyzes the dismutation of superoxide radical (O2-) into 
H2O2, which is subsequently reduced into water and oxygen by catalase in peroxisome 
(Salvi et al., 2007). However, in mitochondria and cytosol, GSH is especially important 
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in defending against oxidative stress (Fernandez Checa et al., 1997; Garcia Ruiz and 
Fernandez Checa, 2006; Lu, 2013). The antioxidant function of GSH is catalyzed by 
GSH peroxidase (GPX), which reduces lipid peroxide and hydrogen peroxide into 
corresponding alcohols and water to prevent the organism from the oxidative damage. 
GSH can also conjugate with xenobiotics via glutathione-S-transferases (GST) for the 
purpose of detoxification (Schmidt and Dringen, 2012). At the same time, GSH (reduced 
form of glutathione) is oxidized to GSSG (disulfide-oxidized form) that can be 
subsequently reduced back into 2 GSH by GSSG reductase (GSR), forming a redox 
cycle.  In the cell, the ratio of GSH to GSSG mainly determines the intracellular redox 
potential (Forman et al., 2009). However, severe oxidative injury may compromise the 
ability of the cell to reduce GSSG into 2 GSH molecules, leading to GSSG accumulation 
(Lu, 2009). To maintain the redox equilibrium, GSSG is either exported out of the cell or 
reacts with a protein sulfhydryl group to form a mixed disulfide (Schmidt and Dringen, 
2012; Lu, 2013). 
GSH is transported out of the cell by GSH transporters such as the multidrug 
resistance protein Mrp family (Schmidt and Dringen, 2012; Bachhawat et al., 2013). The 
unique structure of GSH is that cysteine is linked with γ-carboxyl group of Glu instead of 
α-carboxyl group, which makes glutathione resistant to intracellular degradation (Lu, 
2013). The only enzyme to hydrolyze the γ-carboxyl-amine bond of glutathione is γ-
glutamyltranspeptidase (GGT), expressed on the surface of certain cell types (Meister and 
Anderson, 1983). GGT is highly expressed in epithelium of lung, kidney and intestine 
(Deneke and Fanburg, 1989). However, importantly, GGT is lowly expressed in 
hepatocytes, which is consistent with the role of liver as a net exporter of GSH (see 
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below) (Lauterburg et al., 1984). GGT transfers the γ-glutamyl motif to an acceptor 
amino acid, forming γ-glutamyl amino acid and cysteinylglycine. The γ-glutamyl amino 
acid can be transported back into the cell to release 5-oxoproline, which is finally 
converted to Glu as the substrate for GSH synthesis. On the other hand, cysteinylglycine 
is broken down by dipeptidase to yield cysteine and glycine, which are also transported 
back into the cell to be reincorporated into GSH. Once inside the cell, most of the 
cysteine is used for GSH synthesis while the rest is broken down into sulfate and taurine 
or is incorporated into new protein.  Therefore, the γ-glutamyl cycle is important to 
maintain GSH homeostasis by breaking down extracelluar glutathione through GGT and 
recycling back into the rate-limiting cysteine for intracellular GSH synthesis (Lu, 2013). 
The main site for the GSH production is the liver with amino acid transporters and 
glutathione and bile acid synthesizing enzymes localized to pericentral hepatocytes 
(Häussinger and Gerok, 1983; Boon et al., 1999; Braeuning et al., 2006). After GSH 
synthesized by the liver is exported into blood and bile, the kidney can either directly take 
up GSH from the plasma into cells or salvage plasma GSH through the GGT reaction.  
Plasma GSH can also be utilized by other organs such as lung and intestinal epithelium 
with high levels of GGT activity (Deneke and Fanburg, 1989). The portal vein brings 
blood from the intestine to the liver where xenobiotics are neutralized by hepatocytes if 
not detoxified in the intestine (Fernandez Checa and Kaplowitz, 2005; Lushchak, 2012). 
Because the liver has low GGT activity and is a net exporter of GSH, depletion of liver 
GSH under oxidative stress or xenobiotics metabolism may also deplete GSH in other 
tissues. Therefore, hepatic GSH production and secretion play a critical role in the whole 
animal glutathione homeostasis (Lauterburg et al., 1984; Deneke and Fanburg, 1989; 
 
99 
Ookhtens and Kaplowitz, 1998). 
Liver 
For glutathione-synthesizing protein in LV (Table 5.3), real time RT-PCR assays 
found less GCLC and GSS mRNA in FINISH vs. GROW steers, whereas GCLM and 
GSR expression did not differ. These results suggest a decreased capacity for GSH 
synthesis in FINISH vs. GROW steers. For glutathione-metabolizing protein, we found a 
decreased GPX1 expression, indicating a decreased capacity to reduce hydrogen peroxide 
in the liver as steers develop from growing to finished stages. However, GSTM1 
expression was increased in FINISH vs. GROW steers, suggesting that finishing steers 
may have a greater capacity for detoxification of xenobiotics, including environmental 
toxins and products of oxidative stress, by conjugation with GSH (Schmidt and Dringen, 
2012). In parallel with decreased expression of enzymes responsible for GSH synthesis 
(GCLC and GSS) in FINISH steers, we also found a decreased expression of genes that 
encode for GSH exporters (ABCC1, SLCO2B1 and SLCO1B3), suggesting a decreased 
GSH efflux in the liver of FINISH vs. GROW steers in concomitance with reduced GSH 
synthesis capacity. Cellular glutathione homeostasis is maintained through substrate 
uptake, de novo biosynthesis, and the amount of glutathione that has been utilized and 
exported out of the cell. Thus, if the relative abundance in mRNA documented in this 
manuscript corresponds to actual changes in metabolic capacities, these transcriptional 
changes of GSH-related enzymes and exporters may account the equal GSH content in 
the liver of FINISH vs. GROW steers.  
 
LM 
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In LM, our RT-PCR data showed increased GCLC and GCLM mRNA 
expression, whereas GSS expression did not differ in FINISH vs. GROW steers (Table 
5.4). These results indicate an increased capacity for GSH synthesis in LM of FINISH vs. 
GROW steers, and glutathione synthase appears not to be the rate-limiting enzyme for 
GSH synthesis in LM as steers develop from growing to finished stage. For GSH-
metabolizing protein, our RT-PCR data showed increased GPX1 and GPX3 mRNA 
expression, indicating a higher capacity to metabolize hydrogen peroxide and fatty acid 
hydroperoxides (Thomas et al., 1990; Esworthy et al., 1991) in LM of FINISH vs. 
GROW steers. On the other hand, GPX2 expression was decreased in FINISH vs. GROW 
steers, suggesting a reduced reactivity towards organic hydroperoxides (Chu et al., 1993) 
in LM of fattening steers. Consistent with increased GSH content in LM, we also found 
an increased mRNA expression of GGT1 in LM, suggesting more extra-cellular GSH can 
be cleaved by GGT and recycled back to support intracellular GSH synthesis. Thus, 
combined with transcriptional changes of GSH-synthesizing and metabolizing enzymes, 
and increased GSH content in LM of FINISH vs. GROW steers, these results suggest an 
increased antioxidant capacity in the muscle when beef steers compositional gain shifts 
from lean to lipid phenotype. 
 
SF 
In contrast to LV and LM, the mRNA expression of GCLC, GCLM and GSS 
expression did not differ in SF of FINISH vs. GROW steers (Table 5.5). However, we 
found decreased GPX4 mRNA expression in SF of FINISH vs. GROW steers, suggesting 
a decreased ability to catalyze the reduction of phospholipid hydroperoxide, cholesterol 
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hydroperoxide, and linoleic acid hydroperoxide (Maiorino et al., 1990) when steers 
develop from growing to finishing stage. Moreover, the mRNA expression of GGT1 in 
SF was decreased in concomitance with decreased GSH content, suggesting a decreased 
capacity of recycling extracellular GSH to support intracellular GSH synthesis in FINISH 
vs. GROW steers. Thus, combined with the above findings, these data indicate decreased 
antioxidant capacity in SF, when steers develop from lean to lipid phenotype. 
 
Summary 
In summary, our results provide mechanistic knowledge of how the GSH-
mediated antioxidant capacity may be achieved in liver, LM, and SF of fattened cattle. 
Moreover, we identified differential regulatory relationships between GTRAP3-18 and 
ARL6IP1 with EAAC1 and GS expression in liver, LM and SF, when beef steers 
compositional gain shifts from lean to lipid phenotype. 
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Table 5. 1 Densitometric analysis of EAAC1, GTRAP3-18, ARL6IP1, glutamine 
synthetase (GS) and glutathione (GSH) content in longissimus dorsi (LM) tissues of 
growing vs. finished Angus steers 
 Growing Finished SEM3 P-Value 
Protein1     
EAAC1        10689 7443 972 0.02 
GTRAP3-18 2969 3102 363 0.80 
ARL6IP1 6755 5821         1285 0.57 
GS 8298 5935  700 0.02 
Metabolites2     
GSH 0.24 0.34 0.02 <0.01 
1Values (arbitrary densitometric units) are means (n = 8) and SEM of relative EAAC1, 
GTRAP3-18, ARL6IP1 and GS content in LM homogenates (Figure 6.1) of growing 
(BW = 301 kg) and finished (BW = 576 kg) Angus steers. Densitometric quantification 
was of immunoreactive species identified by immunoblot analyses. 
2Values are mg glutathione/g wet tissue. 
3Most conservative error of the mean. 
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Table 5. 2 Densitometric analysis of EAAC1, GTRAP3-18, ARL6IP1, glutamine 
synthetase (GS) and glutathione (GSH) content in subcutaneous adipose (SF) tissues of 
growing vs. finished Angus steers 
 Growing Finished SEM3 P-Value 
Protein1     
EAAC1 8774 6117         1317 0.11 
GTRAP3-18 4069 9084         1667 0.03 
ARL6IP1        19264        27471         2348 0.01 
GS 7004 5826 953 0.37 
Metabolites2     
GSH 0.13 0.08 0.02 0.04 
1Values (arbitrary densitometric units) are means (n = 8) and SEM of relative EAAC1, 
GTRAP3-18, ARL6IP1 and GS content in SF homogenates (Figure 6.2) of growing (BW 
= 301 kg) and finished (BW = 576 kg) Angus steers. Densitometric quantification was of 
immunoreactive species identified by immunoblot analyses. 
2Values are mg glutathione/g wet tissue. 
3Most conservative error of the mean. 
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Table 5. 3 Real-time RT-PCR analysis of the relative content of glutathione-synthesizing 
and metabolizing protein mRNA by liver from growing vs. finished Angus steers1 
Protein2 Growing Finished SEM3 P-Value4 
Glutathione-
synthesizing protein 
    
GCLC 1.07 0.65 0.14 0.024 
GCLM 0.95 0.91 0.07 0.683 
GSS 1.03 0.73 0.09 0.009 
GSR 1.02 0.92 0.08 0.354 
Glutathione-
metabolizing protein 
    
GPX1 1.01 0.71 0.06 0.001 
GSTM1 0.93 1.99 0.20 0.001 
mGST3 1.02 1.12 0.07 0.254 
GGT1 1.04 1.27 0.10 0.077 
GSH/GSSG exporter 
protein 
    
ABCC1 1.02 0.62 0.07 0.001 
SLCO2B1 1.24 0.48 0.26 0.025 
SLCO1B3 0.95 0.65 0.05 0.001 
1The relative mRNA levels of glutathione-synthesizing and metabolizing protein 
expressed by liver of growing (n = 8, BW = 301 kg) and finished (n = 8, BW = 576 kg) 
steers are presented as normalized to the relative expression level of three reference 
genes: TATA-box binding protein (TBP), glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) and Tyrosine 3-Monooxygenase (YWHAZ). 
2Gene symbols: GCLC (γ-glutamate-cysteine ligase catalytic subunit); GCLM (γ-
glutamate-cysteine ligase modifier subunit); GSS (glutathione synthetase); GSR (GSSG 
reductase); GPX1 (glutathione peroxidase 1); GSTM1 (glutathione-S-transferase M1 
subunit); mGST3 (microsomal glutathione-S-transferase 3); GGT1 (γ-
glutamyltranspeptidase 1); ABCC1 (ATP-binding cassette, sub-family C (CFTR/MRP), 
member 1); SLCO2B1 (solute carrier organic anion transporter family, member 2B1); 
SLCO1B3 (solute carrier organic anion transporter family, member 1B3). 
3Most conservative error of the mean. 
4P-values were obtained from ANOVA F-test. 
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Table 5. 4 Real-time RT-PCR analysis of the relative content of glutathione-synthesizing 
and metabolizing protein mRNA by Longissimus dorsi (LM) from growing vs. finished 
Angus steers1 
Protein2 Growing Finished SEM3 P-Value4 
Glutathione-
synthesizing protein 
    
GCLC 0.94 1.51 0.12 0.004 
GCLM 0.96 1.24 0.05 0.001 
GSS 1.01 0.90 0.06 0.146 
GSR 1.05 1.09 0.18 0.837 
Glutathione-
metabolizing protein 
    
GPX1 1.04 1.48 0.12 0.017 
GPX2 1.01 0.55 0.06 <0.001 
GPX3 1.05 1.81 0.12 0.001 
GPX4 1.02 0.83 0.08 0.093 
GGT1 1.06 1.65 0.24 0.045 
1The relative mRNA levels of glutathione-synthesizing and metabolizing protein 
expressed by Longissimus dorsi (LM) of growing (n = 8, BW = 301 kg) and finished (n = 
8, BW = 576 kg) steers are presented as normalized to the relative expression level of 
three reference genes: beta-actin (ACTB), glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) and ubiquitin C (UBC). 
2Gene symbols: GCLC (γ-glutamate-cysteine ligase catalytic subunit); GCLM (γ-
glutamate-cysteine ligase modifier subunit); GSS (glutathione synthetase); GSR (GSSG 
reductase); GPX1 (glutathione peroxidase 1); GPX2 (glutathione peroxidase 2); GPX3 
(glutathione peroxidase 3); GPX4 (glutathione peroxidase 4); GGT1 (γ-
glutamyltranspeptidase 1). 
3Most conservative error of the mean. 
4P-values were obtained from ANOVA F-test. 
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Table 5. 5 Real-time RT-PCR analysis of the relative content of glutathione-synthesizing 
and metabolizing protein mRNA by subcutaneous adipose tissues (SF) from growing vs. 
finished Angus steers1 
Protein2 Growing Finished SEM3 P-Value4 
Glutathione-
synthesizing protein 
    
GCLC 1.10 0.90 0.27 0.599 
GCLM 1.01 1.01 0.12 0.991 
GSS 1.04 0.72 0.16 0.261 
GSR 1.02 1.21 0.14 0.324 
Glutathione-
metabolizing protein 
    
GPX1 1.00 1.17 0.16 0.319 
GPX3 1.04 1.92 0.42 0.101 
GPX4 1.02 0.49 0.11 0.013 
GGT1 1.02 0.30 0.11 0.001 
1The relative mRNA levels of glutathione-synthesizing and metabolizing protein 
expressed by subcutaneous adipose tissues (SF) of growing (n = 4, BW = 301 kg) and 
finished (n = 4, BW = 576 kg) steers are presented as normalized to the relative 
expression level of three reference genes: beta-actin (ACTB), glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) and peptidylprolyl isomerase A (PPIA). 
2Gene symbols: GCLC (γ-glutamate-cysteine ligase catalytic subunit); GCLM (γ-
glutamate-cysteine ligase modifier subunit); GSS (glutathione synthetase); GSR (GSSG 
reductase); GPX1 (glutathione peroxidase 1); GPX3 (glutathione peroxidase 3); GPX4 
(glutathione peroxidase 4); GGT1 (γ-glutamyltranspeptidase 1). 
3Most conservative error of the mean. 
4P-values were obtained from ANOVA F-test. 
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Figure 5. 1 Western blot analysis of EAAC1, GTRAP3-18, ARLI6P1, and glutamine 
synthetase (GS) in LM homogenates (15µg per lane) of growing (G) and finished (F) 
steers. The apparent migration weights (kDa) for proteins were 70 kDa for the lower, and 
89 kDa for the higher, predominant immunoreactants for EAAC1; 42 for GTRAP3-18; 
21 for ARL6IP1; and 43 for GS; respectively. Data are representative of 8 growing and 8 
finished steers. 
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Figure 5. 2 Western blot analysis of EAAC1, GTRAP3-18, ARLI6P1, and glutamine 
synthetase (GS) in SF homogenates (15µg per lane) of growing (G) and finished (F) 
steers. The apparent migration weights (kDa) for proteins were 70 kDa for the lower, and 
89 kDa for the higher, predominant immunoreactants for EAAC1; 42 for GTRAP3-18; 
21 for ARL6IP1; and 43 for GS; respectively. Data are representative of 8 growing and 8 
finished steers. 
 
 
 
 
 
109 
Figure 5. 3 The sequences of the real-time RT-PCR products (5’ to 3’ orientation). 
Within a sequence, two underlines indicate the forward and reverse primer positions, 
respectively.  
 
Gapdh:   
ATATCAAGGGGGGTGATGCAGGTGCTGRGTATGTGGTGGAGTCCACTGGGGT
CTTCACTACCATGGAGAAGGCTGGGGCTCACTTGAAGGGTGGCGCCAAGAGG
GTCATCATCTCTGCACCTTCTGCCGATGCCCCCATGTTTGTGATGGGCGTGAA
CCCACGAGAAGTATAACAACACCCTCAAGATTGTCAGCAATGCC 
 
Tbp:   
CCGCTGTTTCTGGTGTGCACAAAGATAACCCACAGAGCCGAGCAAGTCGCCA
AGAATAGTGTGCTGGGGATGCTCTAGGAAAAGACTGAATGCTGAGGCAATTT
CCAGTCCAGTAGGTTTTTGATTTGCCAAGAAGGTGAACGTCATGGATCAGAA
CAACAGCCTCCCACCCTATGCCCAGGGCCTGGCCTCCCCTCAGGGTGCCATG
ACTCCTGGAATCCCTATCTTTAGTCCAATGTGCCCTTACGGCA 
 
Ywhaz:   
TTGATCCCCAACGCTTCACAAGCAGAGAGCAAAGTCTTCTATTTGAAAATGA
AGGAGACTACTACCGCTACTTGGCTGAGGTTGCAGCTGGTGATGACAAGAAA
GGGATTGTGGACCAGTCACAGCAAGCATACCAAGAAGCTTTGAAATCAGCAA
AAAGGAAATGCAACCAACACATCCTATCAGACTGGGTCTGGCCCTTAACT 
 
GCLC:   
TTTGCAAAGGTGGCAACGCCGTGGTGGACGGCTGCGGCAAGGCCGCGGGCA
GGGCGGAGCCAGCGGCGGAGGAGTACGCGCTCATGACCATCGACACCATCA
TCAACGGCAAGGAAGGCGTGTTCCCCGGGCTGATCCCCGTCCTGAACTCCTA
CCTGGAGAGCATGGAGGTGGACGTGGACACCAGGTGCAGCATTCTGAACTAC
CTGAAGCTCATCAAGAAGAGGGCGTCCGGAGAATTAATGACAGTGCCAAATG
GATGAGGGAGTTTATCGCAAAGCATCCCGACTACAAGCAGGACAG 
 
GCLM:   
TCCCTGACATTCGAGCACACGAGTGGGTGCCTCTGTGGCTACTGCGGTACTCA
GTCATTGTTAAAAGTAGAGGAATTATCAAATCAAAAGGCTACATCTTACAAG
CTAAAAGAAAGGGTTCGTAACTGCAGCTTAGGATCATAACCTACTGACCTGT
ATTTTCCTTGAATATAAGATAACATGGAGCTGTGTAAAAAACTAATTACTGCC
TGTAAGTGTGTCATGGAGGCAGA 
 
GSS:   
GGAGGCCAGNGNNAGGAACGCGGCTGGACGACGGAAGAGTTGGGATGGCCA
CCGGCTGGGGGAGCCTCTTGCAGGATGAACAGCAGCTGGAGGAGCTAGCAA
GGCAGGCTGTGGACCGGGCTCTGGCTGAGGGTGTGTTGCTGAGGACCTCACA
GGCACCCAGCTCCTCTCATGTGGTGAGCTATGCTCCATTCACACTCTTNCCTT
CACCGGT 
 
GSR:   
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GTGGAACACTGCTGTCCACTCTGAATTCATGCATGACCACGTTGACTATGGCT
TTCAAAGTTGTGAAAGTAAATTCAATTGGCGGATTATAAAGGAAAAGCGGGA
CGCCTATGTGAGCCGCCTGAACACCATCTATCAAAATAATCTAACCAAGTCC
CACATAGACATCATCCATGGCCATGCAGCATTCACGTGCGATCCTCAGCCCA
CAGTGAGGTCAACGGGAAAAAATACACCGCTCCTCACATCCTGATC 
 
GPX1:    
AAACGCCAAGAACGAGGAGATCCTGAATTGCCTGAAGTACGTCCGACCAGG
CGGCGGGTTCGAGCCCAACTTTATGCTCTTCGAAAAGTGCGAGGTGAATGGC
GAGAAGGCGCATCCGCTCTTCGCCTCCTTCGGGAGGTTCTGCCCACGCCAAG
TGACGACGCCACTGCTCTCATGACCGAC 
 
GGT1:   
CAATGTGACTGAGGTGGTCCGCAACATGACCTCCGAGTTCTTTGCCGCCAGCT
CTGGGCCCGGATCTCCGACAGCACCACTCACCCAGCCTCCTACTACGAGCCT
GAGTTCTACACGCCAGACGGTGGGGGCACCGCCCACCTGTCGGTGGTCTCGG
AGGACGGCAGCGCTGTGTCGGCCACCAGCACCATCAACCTCTACTTCGGTTC
CAAGGTGCG 
 
GSTM1:   
GTAGGAGATGCTCCCGACTATGACAGAAGCCAGTGGCTGAATGAAAAATTCA
AGCTGGGCCTGGACTTCCCCAATCTGCCCTACTTAATCGATGGGACTCACAA
GCTCACCCAGAGCAACGCCATCCTTCGGTACATCGCTCGCAAGCACAACCTG
TGTGGGGAGACAGAGGAGGAGATGATTCGTGTGGACATTTTGGAGAACCAG
GTTATGGATGTCCGCTTGGC 
 
MGST3:   
TGGCCGTCCNCTCTAAGGAATATGGTTTCGTGATTCTAACTGGTGCTGCCAGC
TTCTTGATGGTAACTCATCTAGCCATCAATGTTTCTAAGGCCCGCAAGAAGTA
CAAAGTGGAGTATCCTACCATGTACAGCACTGACCCTGAAAACGGGCACATC
TTCAACTGCATTCAGCGAGCTCACCAGAACACGTTGGAAGTGTACCCTCCCTT
CTTATTTTTTCTAGCTGTCGGAGGTGNNATACCA 
 
ABCC1:   
GGACCCCGTTTTGTTTTCGGGTTCCCTCCGCATGAACCTGGACCCGTTCAGCC
AGTACTCGGATGAAGAGGTCTGGACGTCCCTGGAGCTCGCCCACCTGAAGGG
CTTCGTGTCGGCCCTTCCCGACAAACTGAACCACGAGTGTGCGGAAGGCGGG
GAGAACCTCAGCGTCGGGCAACGCCAGCTTGTGTGCCTGGCCCGGGCCCTGC
TGAGGAAGACGAAGATCCTCGTGTTGGACGAAGCCACGGCGGCCGTGGACCT
GGAAACGGACGACTCATTCAGTCC 
SLCO2B1:  
TGACTGTCCCGCACTTCATATCAGAGCCGTACCGCTACGACAGCGCCAGCCC
CGACATGCCACAAGACTTTGAGGCTTCCCTGTGCCTGCCCAGCACCAAGGCC
CTAGCTTCAGCCTCATCCAACAGCAGCTGCTCTAGCTACACAGAGGCTCGGC
ACCTGGCTGTGGTGGGGATCATGTTCACAGCCCASACCCTGCTTGGTGTGGGC
GGGGTGCCCATTCAGCCCTTTGGCATCTCCTACATCGATGACTTTTCCCACAA
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CAGCAACTCGCCCCTCTACCTCGGTATCCTGTTTGCAGTGACCATGATGGGGC
CGGGCATGGCCTATGGGCTGGGCAGCCTCATGTTGCACCTTTACG 
 
SLCO1B3:  
CGTAGAGCAGCAGTATGGCAATTCAGCATCTGAGACGAGCATTTTGCTTGGA
TTCATATCCATACCATCTTTGGCAGCTGGAATGTTTACAGGAGGATTTATTGT
TAAAAAGTTCAAGTTTACCTTGGTTGGAATTGCCAAATTTTCACTTTGTGCCC
ATATGACATCCTTCCTATTTCATCNTAATAAATTTTGCACTAATCTGTGAAAA
CAAATCAGTCGCCGGACTAAACAA 
 
SLC1A1:     
GACAGGGANNCCCCCTGAAGTTAGCACAGTGGATGCCATGTTAGACCTGATC
AGGAATATGTTCCCTGAGAACCTTGTCCAAGCCTGTTTTCAGCAGTACAAAAC
CACACGTGAAGAAGTGGAGCTTTCTGAGGAGCCAGGGACAAACAGCACGGA
AGCGACTGTCACAGCCATCATGACAACTGCAATTTCCAAGAACAAAACAAAG
GAATACAAAGTCGTAGGCATGTATTCAGATGGCATAAATGTCCTGGGCTTGA
TCGTCTTTTGCC 
 
SLC1A2:   
TTGCCTGCCTAATCTGTGGGAAGATCATTGCAATCAAGGACTTAGAAGTGGTT
GCTAGGCAACTGGGGATGTACATGATTACGGTGATTGTCGGCCTCATCATCC
ATGGGGGGATCTTTCTCCCCTTGATTTACTTTCTAGTGACCAGGAAAAACCCT
TTCTCCTTTTTTGCTGGCATTTTCCAAGCTTGGATCACTGCCCTGGGTACCGCT
TCCAGTGCTGGAACTTTGCCTGTCACCTTCCGCTGCTTGGAAGAAAATCTGGG
GATTGATAAGCGTGTGACTAGATTTGTCCTGCCAGTCGGA 
 
ARL6IP1:  
GCAAGGATGGGGAGAAGTGATGCTGATGGCAGATAAAGTCCTCCGATGGGA
AAGAGCCTGGTTTCCACCTGCCATCATGGGTGTGGTTTCTTTGGTGTTTCTGA
CTATCTACTATCTAGATCCATCTGTTCTATCTGGTGTTTCCTGTTTTGTTATGTT
TTTGTGCTTGGCTGACTACCTTGTTCCCATTCTAGCACCTAGAATTTTTGGCTC
CAATAAATGGACCACCGAGCAACAGCAAAGATTCC 
 
ARL6IP5:  
GCCGGACTTCAGGGACATTTCCAAATGGAACAACCGTGTGGTGAGCACCTGC
TCTATTACCAGACCAACTACCTAGTGGTGGCTGCCATGATGATTTCCGTTGTG
GGGTTCCTGAGCCCCTTCAACATGATCCTTGGAGGCATTGTGGTGGTGCTGGT
GTTCACAGGCTTCGTGTGGGCAGCCCACAATAAAGACTCCTCCGTCGGATGA
AGAAGCAGTACCCCACAGCGTTTGTCATGGTGG 
 
GLUL:  
GAAGAGTTGCCCGAGTGGAATTTTGATGGCTCTAGTACTTTTCAGTCTGAAGG
CTCCAACAGTGACATGTATCTTGTCCCCGCTGCCATGTTTCGGGACCCTTTCC
GCAAGGACCCCAACAAGCTGGTGTTCTGTGAAGTCTTCAAGTACAACCGAAA
GCCTGCAGAGACCAATTTAAGGCACACCTGTAAACGGATAATGGACATGGTG
AGCAACCAGCGCCCCTGGTTTGGAATGGAGCAGGAATATACCCTCATGGGCA
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CTGATGGGCACCCCTTTGGTTGGCCTTCCAATGGCTTTCCTGGGCCCCAAGGT
CCCTACTACTGTGGTGTGGGAGCGGACAAGGCCTACGGCAGGGATATTGTGG
AGG 
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Chapter 6. Shifts in hepatic transcriptome profiles of growing vs. finished beef 
steers 
 
Abstract 
Transcriptome analysis was conducted to gain a greater understanding of hepatic 
metabolic shifts associated with the change in whole-body compositional gain of growing 
vs. finished beef steers. Weaned Angus steers (BW = 209 ± 29.4 kg) were randomly 
assigned (n = 8) to develop through lean (GROW, final BW = 301 kg) or lipid (FINISH, 
final BW = 576 kg) growth phases and individually fed enough of a cotton seed hull-
based diet to achieve a constant ADG (1.5 kg/d). Marbling score (668, 296) and yield 
grade (3.65, 2.13) were greater (P < 0.01), but liver weight (1005, 1341 g/100 kg BW) 
less (P < 0.01), for FINISH vs. GROW steers, respectively. Total hepatic RNA was 
isolated, subjected to microarray (Bovine Affymetrix Gene 1.0 ST GeneChip) analysis, 
and differences in gene expression (false discovery rate < 10%; P < 0.01) between 
treatment groups determined by 1-way ANOVA (Partek Genomics Suite). Expression of 
405 mRNA was increased (5 to 567%) and 695 (6 to 638%) decreased in FINISH vs. 
GROW steers. Bioinformatic (Ingenuity Pathway Analysis) analysis found that the top 
functional gene category was cell death and survival (47 genes; P ≤ 0.025) and the top 
canonical cell signaling pathway was calcium-induced T lymphocyte apoptosis (13 
genes; P ≤ 0.0005). Functional analysis of canonical metabolic pathways found that 
FINISH steers had increased (P ≤ 0.009; 17 to 414%) capacities for ammonia (GLS2, 
GLUD1, GPT2), Arg (OAT, GOT1, ASS1, ASL), and urea production (ARG2), and 
shunting of amino acid carbons into pyruvate (ALT2, SDS, LDHB). For carbohydrate 
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metabolism, capacity for glycolysis (PGK1, PKM2) was inhibited (P ≤ 0.003; 19 and 
42%), whereas glycogen synthesis (GYG2, GYS2) was greater (P ≤ 0.002; 30 and 31%), 
in FINISH steers. For lipid metabolism, FINISH steers showed decreased (P ≤ 0.008; 28 
to 163%) capacity for fatty acid activation (ACSL5, ACSF2) and desaturation (SCD, 
FADS1, FADS2), but increased (P ≤ 0.009; 26 to 61%) capacity for fatty acid β-oxidation 
(ACADL, ACAA1) and lipid storage (LIPA, PLIN3). In addition, redox capacity (GPX1, 
GSS, GGT1) and inflammatory responses (NOS2, SOCS2, CCL2, IL6R, TLR3) were 
decreased (P ≤ 0.008; 18 to 191%) in FINISH steers. These findings elaborate the shift in 
hepatic metabolic capacities as compositional gain shifted from the lean to lipid 
phenotype in beef steers. 
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Introduction 
 
How to improve efficiency of nutrient use in maturing cattle remains a major 
question in beef production. Growing and finishing phases are two important animal 
production stages, which differ fundamentally in compositional growth. The growing 
stage reflects the acceleration growth phase of greatest lean (protein) to fat deposition. In 
contrast, the finishing phase reflects a time of greatest fat to lean deposition ratio with 
maximized meat yield and fat cover (U.S market weight). However, the molecular and 
cellular mechanisms that contribute to these physiological changes are poorly understood. 
Thus, an understanding of potentially altered metabolic pathways and regulatory 
mechanisms in tissues of metabolic importance, such as the liver, when beef steers 
develop from growing to finished stage, is critical. 
The liver is a highly metabolically active tissue and it is the principle site of 
amino acid, carbohydrate, and lipid metabolism. For amino acid metabolism, liver plays 
important roles in maintaining whole-body Glu and N homeostasis via Glu transporters 
and enzymes to produce the Gln-Glu “cycle” (Heitmann and Bergman, 1981a; Wu, 1998; 
Burrin and Stoll, 2009). Blood Gln from the peripheral tissues is efficiently absorbed by 
periportal hepatocytes and deaminated by glutaminase (liver-type) to release ammonia 
and Glu. The released ammonia can be incorporated into carbamoyl phosphate for 
ureagenesis, whereas the remaining Glu is available for conversion to α-ketoglutarate (as 
an anapleurotic reaction to replenish the citric acid cycle), used for gluconeogenesis, used 
for protein synthesis, or transported into the sinusoids (Meijer et al., 1990; Brosnan, 
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2000; Watford, 2000). Sinusoidal blood Glu absorbed by pericentral hepatocytes and the 
“scavenged” sinusoidal ammonia that escapes incorporation into urea by periportal 
hepatocytes are incorporated into Gln by pericentral hepatocyte-specific GS activity, thus 
completing the hepatic Gln-Glu cycle (Moorman et al., 1989; Moorman et al., 1990; 
Wagenaar et al., 1994). 
For carbohydrate metabolism, because little glucose is absorbed into the hepatic 
portal system in ruminants (Baird et al., 1980; Huntington et al., 1981), approximately 
85-90% of the glucose is generated by gluconeogenesis for energy production (Nafikov 
and Beitz, 2007). In ruminant digestion, the microorganisms in the rumen break down the 
feedstuff to produce the volatile fatty acids, acetic acid, propionic acid, and butyric acid, 
which are absorbed through the rumen. Liver metabolizes 50–90% of the butyrate and 
propionate absorbed by the rumen (Huntington, 1990) and converts them into glucose 
through gluconeogenesis pathway (Bergman, 1990). In addition to gluconeogenesis, the 
liver is the major site for glycolysis, glycogen synthesis and lysis, which also helps to 
regulate blood glucose levels in cattle. For lipid metabolism, fatty acid from the blood 
taken up by the liver can either be broken down to provide energy via beta-oxidation, or 
be used as a substrate for triglyceride synthesis and lipid storage.  
Another important function of the liver is to maintain the whole-body/systemic 
redox potential. The liver is the major producer of glutathione (GSH), the most abundant 
antioxidant that modulates diverse cellular processes in the body. GSH is involved in 
detoxification of xenobiotics and regulates cell proliferation, apoptosis and immunity, 
and redox signaling (Meister and Anderson, 1983; Suthanthiran et al., 1990; Ballatori et 
al., 2009; Lu, 2009; Pallardó et al., 2009; Liu and Pravia, 2010). GSH synthesized by the 
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liver is exported into blood and bile, and subsequently, plasma GSH can be taken up and 
utilized by other organs such as kidney, lung and intestine. Depletion of liver GSH under 
oxidative stress or xenobiotics metabolism may also deplete GSH in other tissues. Thus, 
hepatic GSH production and secretion play a critical role in the whole animal glutathione 
homeostasis (Lauterburg et al., 1984; Deneke and Fanburg, 1989; Ookhtens and 
Kaplowitz, 1998). 
Our previous study has identified hepatic metabolic shift in the efficiency of 
nitrogen use associated with the change in whole-body compositional gain of growing vs. 
finished beef steers (Chapter 4), using biochemical and targeted-gene and protein 
analyses. Because of the pivotal role of the liver in metabolism, the goal of the current 
research was to conduct a transcriptome analysis of the same hepatic tissue samples to 
gain a greater perspective into other potentially altered hepatic metabolic pathways and 
perhaps identify candidate regulatory mechanisms. For convenience, the L-isomer form 
of AA is implied unless indicated otherwise. GSH is used to indicate reduced glutathione 
and GSSG to indicate oxidized GSH. 
 
 
MATERIALS AND METHODS 
Animal Model 
All procedures involving animals were approved by the University of Kentucky 
Institutional Animal Care and Use Committee. The steers were raised, and trial 
conducted, at the University of Kentucky Research and Education Center in Princeton, 
KY.  
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Sixteen weaned, predominately Angus, steers of similar shrunk (denied feed and 
water for 14 h) body weight (BW = 209 ± 29.4 kg) were randomly assigned (n = 8) to 
either growing (GROW, final BW = 301 ± 7.06 kg) or finished (FINISH, final BW = 576 
± 36.9 kg) treatment groups. Steers then were randomly assigned to one of 4 feedlot pens 
that contained Calan gates in a dry-lot barn. Four steers were assigned per pen. Steers 
were individually fed enough of a diet that contained (% as-fed) cracked corn (60), 
cottonseed hulls (20), soybean meal (7), soybean hulls (5), dried distiller’s grain (2), 
alfalfa meal (2), glycerin (2), limestone (1.5), and urea (0.5) to support 1.51 kg gain/d 
(NRC 1996) throughout the trial. Steers had ad libitum access to fresh water and a 
vitamin-mineral mix (UK IRM Beef Cattle Vitamin-mineral Mix, Burkmann Mill, Inc., 
Danville, KY). Full BW were determined every 14 d and amount of diet adjusted to 
achieve target rate of gain. Steer average daily gain (ADG) was calculated as the 
difference between shrunk BW at trial initiation and 1 d before slaughter.  
 
Sample Collection and RNA Extraction 
The liver sample from each animal was collected from the mid-lower part of the 
right lobe, placed in foil packs, snap-frozen in liquid nitrogen, and stored at –80°C. The 
time from killing an animal to freezing of the sample in liquid nitrogen ranged from 35 to 
45 min. For each animal, total RNA was extracted from 400 mg of frozen liver tissue 
using TRIzol Reagent (Invitrogen Corporation, Carlsbad, CA) following the 
manufacturer’s instructions. The purity and concentration of total RNA samples was 
analyzed by a NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies, 
Wilmington, DE), which revealed that all samples were of high purity with 260:280 nm 
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absorbance ratios of 2.0 to 2.1 and 260:230 nm absorbance ratios ranging from 1.5 to 1.9. 
The integrity of total RNA was examined by gel electrophoresis using an Agilent 2100 
Bioanalyzer System (Agilent Technologies, Santa Clara, CA) at the University of 
Kentucky Microarray Core Facility (Lexington, KY). Visualization of gel images and 
electropherograms showed that all RNA samples had high quality with RNA integrity 
numbers being greater than 8.5 and 28S: 18S rRNA absorbance ratios greater than 1.8.  
Microarray Analysis 
The GeneChip Bovine 1.0 ST Array (Affymetrix, Inc., Santa Clara, CA), which 
contains 24,341 bovine gene transcripts, was used to investigate the effect of growing vs. 
finished growth stage on potential changes of bovine liver gene expression profiles. 
Microarray analysis was conducted according to the manufacturer’s standard protocol at 
the University of Kentucky Microarray Core Facility. Briefly, 3 μg RNA for each sample 
first is reverse transcribed (RT) to cDNA and then from cDNA (double stranded) to 
complementary RNA (cRNA; single stranded), which was then labeled with biotin. The 
biotinylated cRNA were further fragmented and used as probes to hybridize the gene 
chips in the GeneChip Hybridization Oven 640 (Affymetrix), using 1 chip per RNA 
sample. After hybridization, the chips were washed and stained on a GeneChip Fluidics 
Station 450 (Affymetrix). The reaction image and signals were read with a GeneChip 
Scanner (GCS 3000, 7G; Affymetrix) and data were collected using the GeneChip 
Operating Software (GCOS; version 1.2; Affymetrix). The raw expression intensity 
values from the GCOS (i.e., 19 *.cel les from the raw methylation measurements) were 
imported into Partek Genomics Suite (PGS) software (version 6.4; Partek Inc., St. Louis, 
MO). For GeneChip background correction, the algorithm of Robust Multichip 
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Averaging adjusted with probe length and GC oligo contents was implemented (Irizarry 
et al., 2003; Wu et al., 2004). The background-corrected data were further converted into 
expression values using quantile normalization across all the chips and median polish 
summarization of multiple probes for each probe set (Partek, Inc., 2009).  
All the GeneChip transcripts are annotated using NetAffx annotation database for 
Exon array on the Bovine GeneChip Array, provided online by the manufacturer 
(http://www.affymetrix.com/ analysis/index.affx). Quality control of the microarray 
hybridization and data presentation was performed by MA plot on all the gene expression 
values and box plot on the control probe sets on the Affymetrix chips (data not shown). 
Principal component analysis (PCA) was performed to elucidate the quality of the 
microarray hybridization and visualize the general data variation among the chips 
(Partek, Inc., 2009). To test the growing vs. finished treatment effects on the relative 
expression of the liver gene transcripts, qualified microarray data were subjected to the 1-
way ANOVA analysis using the same PGS software (Partek, Inc., 2009). To achieve a 
higher degree of confidence (i.e., a conservative approach), the transcripts showing 
treatment effects at the significance level of P < 0.01 and the controlled false discovery 
rate of 10% were defined as being differentially affected. These differentially expressed 
genes/gene transcripts (DEG) were subjected to hierarchical clustering and functional, 
canonical, and network pathway analyses using the Core Analysis program of Ingenuity 
Pathways Analysis online software (8.7-3203; http://www.ingenuity.com [accessed Dec 
5, 2016]; Ingenuity Systems, Inc., Redwood City, CA).  
All the microarray *.cel files collected by GCOS plus the GC Robust Multichip 
Averaging-corrected data processed by PGS software of this manuscript will be deposited 
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in the National Center for Biotechnology Information’s Gene Expression Omnibus 
(GEO; http:// www.ncbi.nlm.nih.gov/geo/), as minimum information about a microarray 
experiment (MIAME) compliant (Brazma et al., 2001). 
 
Real-Time Reverse-Transcribed PCR Analysis  
Real-time RT-PCR was performed using RNA samples from liver tissue to 
determine the expression of mRNA for EAAC1 regulatory proteins using an Eppendorf 
Mastercycler ep realplex2 system (Eppendorf, Hamburg, Germany) with SYBR Green 
Supermix (Bio-RAD, Hercules, CA). Briefly, cDNA was synthesized using the 
SuperScript III 1st Strand Synthesis System (Invitrogen), with 0.5 μg of RNA used for 
each reverse transcription reaction. Real-time RT-PCR was performed with a total 
volume of 25 μL per reaction, with each reaction containing 5 μL of cDNA, 1 μL of a 10 
μM stock of each primer (forward and reverse), 12.5 μL of 2× SYBR Green PCR Master 
Mix, and 5.5 μL of nuclease-free water. The resulting real-time PCR products were 
purified using a PureLink Quick Gel Extraction Kit (Invitrogen) and sequenced at 
Eurofins Scientific (Eurofins, Louisville, KY). TATA-box binding protein (TBP), 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and tyrosine 3-monooxygenase 
(YWHAZ) were used as the housekeeping genes. RT-PCR reactions were run in triplicate 
and gene expression was analyzed by the 2ΔΔCT method (Livak and Schmittgen, 2001).  
 
Statistical Analysis 
To test for GROW vs. FINISH treatment effects on the relative expression of the 
liver gene transcripts, microarray hybridization data were subjected to 1-way ANOVA 
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analysis using the PGS software as described in the “Microarray Analysis” section above. 
The effects of treatment on the relative expression of all other data were subjected to 1-
way ANOVA analysis using the GLM procedure of SAS (version 9.1; SAS Inst., Inc., 
Cary, NC). For these latter data, significance was declared when P ≤ 0.05 and tendency to 
differ was declared when 0.10 ≤ P > 0.05.  
 
RESULTS 
 
Differentially Expressed Genes 
Principal component analysis of all microarray data was performed to examine 
the correlation and variation among the gene chips, revealing a total variance of 30.5% 
(Figure 6.1). The first principal component (PC number 1; x-axis) included genes with a 
high degree of variance (13.3%), whereas PC number 2 (y-axis) and PC number 3 (z-axis) 
encompassed genes that had median (9.55%) and low (7.71%) ranges of variance. 
Overall, PCA demonstrated that the chips within each treatment group were closely 
clustered together.  
Individual ANOVA was conducted to identify altered expression of RNA 
transcripts in the livers of GROW vs. FINISH steers. At the P < 0.05 level, 4,693 gene 
transcripts were identified. To refine this analysis, genes with a false discovery rate of 
less than 10% and P < 0.01 were considered to be DEG. Of the 1100 DEG, 405 genes 
(37%) were upregulated by 5 to 567% and 695 genes (63%) were downregulated by 6 to 
638%.  
Importantly, hierarchical cluster analysis of the 1100 annotated DEG revealed 2 
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treatment clusters associated with each of the growing and finished treatment groups 
(Figure 6.2). Relative to growing steers, approximately 40% of the genes in the finished 
steers were upregulated and 60% were downregulated.  
 
Canonical Pathway Analysis 
To determine the physiological significance of treatment-induced DEG, 
bioinformatic analysis of canonical pathways was performed. Canonical cell signaling 
pathway analysis of the DEG revealed that the most affected pathways belong to the 
cellular immune response category (Table 6.1). The top 7 pathways were calcium-
induced T lymphocyte apoptosis (13 genes), protein kinase A signaling (43 genes), netrin 
signaling (8 genes), leukocyte extravasation signaling (32 genes), hepatic fibrosis / 
hepatic stellate cell activation (28 genes), macropinocytosis signaling (16 genes) and cell 
cycle control of chromosomal replication (8 genes). 
Canonical metabolic pathway analysis of the 1100 DEG found that the most 
affected pathways were related to AA metabolism (Table 6.2). Of the top 7 pathways 
identified, arginine biosynthesis (4 genes) and superpathway of citrulline metabolism (6 
genes) contained the most DEG. 
In addition to Ingenuity Pathway analysis, the microarray data showed that genes 
involved in amino acid, carbohydrate, lipid metabolism, antioxidant capacity and 
inflammatory responses were differentially expressed (Table 6.3). 
 
Semi-Quantitative Real-time RT-PCR Analysis of Selected mRNA 
 
To corroborate the altered expression of genes known to be responsible for 
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EAAC1 regulatory pathways (Table 6.4) identified by our current microarray analyses, 
hepatic expression of these genes by finished vs. growing steers was compared by real-
time RT-PCR analysis (Table 6.4). Although the fold changes measured by the two 
analytical techniques were similar for EAAC1 regulatory pathway genes, the statistical 
significance (ANOVA P values) differed between microarray and real-time PCR 
analyses. The incongruences between microarray and real-time RT-PCR analyses may be 
due to the different regions of DNA sequences used for primer design for RT-PCR.  
 
 
DISCUSSION 
 
The growing and finishing phases are two important animal production stages that 
fundamentally differ in compositional gain. The growing stage reflects the acceleration 
growth phase of greatest lean (protein) to fat deposition. In contrast, the finishing phase 
reflects a time of greatest fat to lean deposition with maximal meat yield and fat cover 
(U.S market weight). Our previous study has identified hepatic metabolic shift in the 
efficiency of nitrogen use associated with the change in whole-body compositional gain 
of growing vs. finished beef steers (Chapter 4), using biochemical and targeted-gene and 
protein analyses. We have demonstrated that the Glu transport and Gln synthesis capacity 
was decreased in finished vs. growing steers, concomitant with increased GTRAP3-18 
(an inhibitor of Glu transporters) content. Moreover, the mRNA expression of GSH-
synthesizing and metabolizing enzymes differed in the liver of finished vs. growing steers 
(Chapter 5). Because of the pivotal role of the liver in metabolism, the goal of the current 
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research was to conduct a transcriptome analysis of the same hepatic tissues samples to 
gain a greater perspective into other potentially altered hepatic metabolic pathways and 
perhaps identify candidate regulatory mechanisms. 
 
The Role of Arginine Metabolism in Urea Synthesis and Glu-Gln Cycle 
Among the top 7 canonical metabolic pathways (Table 6.2), the arginine 
biosynthesis pathway ranked as the most significant pathway by IPA of DEG in our 
microarray dataset. Thus, we focused on the arginine biosynthesis pathway to determine 
if the capacity for arginine biosynthesis and metabolism changes when beef steers 
compositional gain shifts from lean to lipid phenotype.  
Arginine synthesis and metabolism are essential to support several metabolic and 
physiological functions in the body (Wu and Morris, 1998; Wheatley and Campbell, 
2002; Yeh, 2004; Wu et al., 2009). Arg biosynthesis pathway is part of urea cycle 
(Morris Jr, 2004). In the urea cycle, the three key enzymes involved in Arg biosynthesis 
and metabolisms are arginosuccinate synthetase (ASS), arginosuccinate lyase (ASL) and 
arginase (ARG) (Morris, 2002). In the cytoplasm, ASS catalyzes the conversion of 
citrulline and aspartate into arginiosuccinate. Subsequently, arginosuccinate is cleaved by 
ASL to produce arginine and fumarate. Arginine is then further cleaved by arginase to 
produce urea and ornithine. Two isoforms of arginase (ARG1 and ARG2) encoded by 
different genes have been identified in mammals (Colleluori et al., 2001; Cederbaum et 
al., 2004). ARG1 and ARG2 isoforms have 58% similarity in the amino acid sequences, 
with distinct tissue, cellular and subcellular distributions (Choi et al., 2012). ARG1 is 
located in the cytosol of periportal hepatocytes (Burke et al., 2009) and is an important 
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enzyme in the urea cycle. In contrast, ARG2 is located in the mitochondria of various cell 
types (Cederbaum et al., 2004). It is constitutively expressed (Morris, 2002) and plays a 
pivotal role in the regulation of hepatic ureagenesis by supplying ornithine for net 
synthesis of N-acetylglutamate, citrulline, and aspartate (Nissim et al., 2005). Our 
Microarray data showed that the expression of ASS, ASL and ARG2 was increased, 
suggesting an increased capacity for Arg synthesis and metabolism, and urea production 
in the liver of finished vs. growing steers. 
 Recognizing that finished steers had a higher capacity for urea production than 
growing steers prompted us to ask whether the capacity for ammonia production would 
differ between growing and finished steers. A primary function of the mammalian liver is 
to coordinate whole-body energy and N metabolism. Hepatic transport and intermediary 
metabolism of glutamate are critical to these processes as glutamate is a central substrate 
for hepatic ureagenesis, gluconeogenesis, glutathione production, de novo protein 
synthesis, and nitrogen shuttling via glutamine (Meijer et al., 1990; Watford, 2000). An 
important aspect of glutamate metabolism in the liver is the heterogeneity of Gln/Glu 
metabolism. Specifically, Gln, arriving from the peripheral tissues, is efficiently absorbed 
by periportal hepatocytes and deaminated by glutaminase (liver-type) to release ammonia 
and Glu. Alanine transaminase (glutamic-pyruvic transaminase, GPT), also primarily 
expressed by periportal vs. pericentral hepatocytes, supports ammonia production by 
transaminating Ala to pyruvate (Welsh, 1972), producing Glu from α-KG. Glutamate, in 
turn, can be deaminated by glutamate dehydrogenase to produce ammonia and α-KG. 
Ammonia from peripheral Gln and Ala now can be incorporated into carbamoyl 
phosphate for ureagenesis. Moreover, aspartate transaminase (GOT) expressed in the 
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periportal hepatocytes (Boon et al., 1999; Braeuning et al., 2006) converts oxaloacetate 
and Glu into aspartate and oxoglutarate, that also feed into urea cycle. In the urea cycle, 
Arginase (ARG1 and ARG2) cleaves arginine to produce urea. Our microarray data 
showed an increased mRNA expression of GPT2, GOT1, and ARG2, suggesting an 
increased capacity for ammonia and urea production in finished vs. growing steers.  
In contrast to the periportal zone, when released into the sinusoidal blood, Glu is 
available for absorption by “down-acinus” pericentral hepatocytes, which express the 
high-affinity system X-AG activity (Häussinger and Gerok, 1983; Braeuning et al., 2006; 
Brosnan and Brosnan, 2009). If absorbed by pericentral hepatocytes, Glu and the 
“scavenged” sinusoidal ammonia that escapes incorporation into urea by periportal 
hepatocytes are incorporated into Gln by pericentral hepatocyte-specific GS activity, thus 
completing the hepatic Gln-Glu cycle (Moorman et al., 1989; Moorman et al., 1990; 
Wagenaar et al., 1994). Besides supporting Gln synthesis by GS, pericentral hepatocyte-
localized system X-AG  uptake of Glu complements pericentral hepatocyte-specific 
synthesis of glutathione synthesis by glutamylcysteine ligase and glutathione synthetase 
(Braeuning et al., 2006), as well as supplying Glu as source of gluconeogenic carbons 
and for de novo protein synthesis (Watford, 2000).  
Two high-affinity (µM), concentrative, Glu transporters (GLT-1 and EAAC1) that 
demonstrate system X-AG activity (Na+-dependent L-Glu and L-Aspartate uptake that is 
inhibited by D-Aspartate) are expressed by the intestinal epithelia, liver, and kidney of 
sheep (Howell et al., 2001; Howell et al., 2003; Xue et al., 2010) and cattle (Howell et al., 
2001; Miles et al., 2015). In mouse neuronal cells, the function of EAAC1 (solute carrier 
1A1/SLC1A1) and GLT-1 (SLC1A2) is inhibited by endoplasmic reticulum-localized 
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GTRAP3-18 (glutamate transporter-associated protein 3-18; a.k.a. addicsin, ADP-
ribosylation factor-like 6 interacting protein 5/ARL6IP5, PRAF3) (Ruggiero et al., 2008; 
Watabe et al., 2008) and that the effect of GTRAP3-18 on EAAC1 activity is 
proportional to GTRAP3-18 content (Lin et al., 2001). However, ADP-ribosylation 
factor-like 6 interacting protein 1 (ARL6IP1) binds and inhibits GTRAP3-18, and 
indirectly promotes EAAC1 activity (Akiduki and Ikemoto, 2008; Aoyama and Nakaki, 
2012, 2013). The ARL6IP1/GTRAP3-18/EAAC1 triad is highly expressed in rat liver 
(Akiduki and Ikemoto, 2008), whereas cow liver expresses at least EAAC1 and 
GTRAP3-18 (Miles et al., 2015).  
Our previous studies demonstrated decreased Glu transport capacity and EAAC1 
content in concomitance with increased GTRAP3-18 and ARL6IP1 content in the liver of 
finished vs. growing steers. To further investigate the regulation of EAAC1, we focused 
on the mRNA expression profiles of upstream regulators of EAAC1 in our microarray 
dataset, and these upstream regulators were also selected for targeted gene expression 
analysis. In mouse neuronal cells, platelet-derived growth factor (PDGF) stimulates 
EAAC1 expression and transport activities through the phosphatidylinositol 3-kinase 
(PI3K) pathway (Sims et al., 2000). PI3K activates serum- and glucocorticoid- inducible 
kinase 1 (SGK1) and protein kinase B (Akt/PKB) through phosphoinositide-dependent 
kinase 1(PDK1) activation (Aoyama and Nakaki, 2013). The constitutively active SGK1 
and Akt/PKB stimulate glutamate uptake by EAAC1 (Schniepp et al., 2004). Another 
upstream regulator of EAAC1 is protein kinase C (PKC). PKCa activation increases the 
transport activity and the cell surface expression of EAAC1, whereas PKCe activation 
stimulates glutamate transport activity of EAAC1 without changing the protein 
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abundance on the plasma membrane (González et al., 2002; Huang et al., 2006). EAAC1 
is also up-regulated by the serine/threonine kinase mammalian target of rapamycin 
(mTOR) (Almilaji et al., 2012), which plays a critical role in protein synthesis, cell 
growth and proliferation (Hay and Sonenberg, 2004). Conversely, EAAC1 activity and 
expression were decreased by expression of the constitutively active AMP-activated 
protein kinase (AMPK) in Xenopus oocytes (Sopjani et al., 2010).  
In contrast to the findings in mouse neuronal models, in cattle liver, our 
microarray data showed a reduced mRNA expression of PDGF, PI3K, SGK, Akt and 
PKCe in finished vs. growing steers (Table 6.4). Consistent with decreased Glu transport 
activity and reduced EAAC1 content when beef steers compositional gain shifts from 
lean to lipid phenotype (Chapter 4), our microarray data showed a decreased mRNA 
expression of upstream stimulators of EAAC1 in the liver of finished vs. growing beef 
steers. However, the mRNA expression of AMPK, the upstream inhibitor of EAAC1, was 
also decreased in finished vs. growing steers, suggesting a feedback inhibitory 
mechanism of decreased EAAC1 activity and expression in cattle liver hepatocytes. 
Paralleling decreased EAAC1 expression and activity, the microarray data 
showed an increased expression of ornithine transaminase (OAT) that converts ornithine 
into Glu. Because OAT is mainly expressed in the pericentral hepatocytes, these findings 
indicate an increased capacity for intracellular Glu production although the ability of 
taking up Glu from blood and bile was decreased in the pericentral hepatocytes of 
finished steers. Concomitantly, our previous studies showed a decreased GS activity in 
finished vs. growing steers. This prompted us to determine the molecular and cellular 
mechanisms that contribute to decreased GS activity when beef steers compositional gain 
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shifts from lean to lipid phenotype. Our microarray data showed an increased capacity of 
incorporating ammonia into urea in the periportal hepatocytes in finished steers, which 
may decrease ammonia concentration in the blood, and consequently, less ammonia will 
be available for incorporation into Gln in the pericentral hepatocytes, and GS activity is 
decreased correspondingly, when beef steers develop from growing to finished stage.  
 
The Role of Arginine Metabolism in Cellular Redox Potential and Immune Response 
Arginine can be cleaved by arginase to produce urea, however, it is also the 
substrate for nitric oxide synthetase (NOS) that converts arginine into nitric oxide (NO) 
and citrulline (Morris, 2004; Mori, 2007). Three distinct isoforms of NOS have been 
found as the products of different genes. These isoforms share 50% sequence similarity, 
but differ in intracellular localization and enzymatic properties: NOS1 is prevalent in 
neuronal tissue; NOS2 is the inducible isoform, which is present in various cells of the 
immune system; and NOS3 is mainly found in endothelial cells (Alderton et al., 2001; 
Bogdan, 2001). Our microarray data showed upregulation of ARG2 paralleling 
downregulation of NOS2, suggesting NOS2 competes with ARG2 for arginine use as a 
substrate in the liver, when beef steers develop from growing to finished production 
stages. This finding is consistent with previous reports that ARG activation limits the 
availability of arginine as a substrate for NOS and consequently, negatively regulates the 
enzymatic activity of NOS (Gotoh and Mori, 1999; Munder et al., 1999; Bronte and 
Zanovello, 2005). Moreover, some studies showed that upregulation of ARG impeded the 
translation of NOS2 mRNA and the stability of NOS2 protein in myeloid cells (El-Gayar 
et al., 2003).  
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In addition to NOS and ARG, arginine can be cleaved by arginine decarboxylase 
(ADC) to produce agmatine that inhibits NOS (Morris Jr, 2004; Satriano, 2004; Halaris 
and Plietz, 2007). Consistent with decreased expression of NOS2, we found an increased 
mRNA expression of ADC in finished vs. growing steers. Combined, these data suggest a 
decreased capacity for NO production when beef steers compositional gain shifts from 
lean to lipid phenotype. In addition to ADC, anabolic growth promoters, such as growth 
hormone (GH), modulate arginase and NOS activities (Elsasser et al., 2008). Daily 
injection of GH decreases arginase activity (Elsasser et al., 1996) and increases the 
enzymatic activity of NOS (Elsasser et al., 2007). Although the mRNA expression of GH 
did not differ between growing and finished steers, the microarray data showed a 
decreased expression of growth hormone receptor (GHR). Thus, combined with increased 
mRNA expression of ARG2 and decreased expression of NOS2, these results suggest 
that finished steers have a greater capacity of channeling of arginine toward urea 
synthesis instead of generation of NO, a pro-inflammatory mediator. 
Upregulation of ARG can lead to low arginine concentration in the local cellular 
environment.  When arginine concentrations are suboptimal, ARG shifts the function of 
NOS2 from the production of mostly NO to mostly superoxide (O2-) (Xia and Zweier, 
1997; Xia et al., 1998). That is, instead of producing NO, NOS2 transfers electrons to the 
co-substrate oxygen (O2) and produces O2–, which reacts with other molecules to 
generate reactive nitrogen species and reactive oxygen species (Bronte and Zanovello, 
2005). Consequently, these reactive species cause damage to lipids, protein and DNA and 
drive cellular dysfunction. Thus, it is critical to maintain an optimal intracellular arginine 
concentration to support the normal physiological functions in animal body. 
 
132 
Induction of ARG expression in the cells is closely linked to upregulation of the 
CAT family membrane transporters that augment L-arginine transport (Schwartz et al., 
2002). The cationic amino-acid transporters CATs are integral membrane proteins that 
transfer L-arginine, L-lysine and L-ornithine from extracellular to intracellular 
compartment (Cunningham and Albritton, 1991). Our microarray data showed the mRNA 
expression of CAT-2 (SLC7A2), the main arginine transporter (Elsasser et al., 2008), was 
increased in finished vs. growing steers, suggesting a greater capacity of delivering 
arginine into the cells to compensate for arginine degradation by intracellular ARG (or 
NOS) when beef steers develop from growing to finished stages. As we mentioned 
earlier, finished steers have increased capacities for arginine biosynthesis. Combined, 
these results suggest finished steers have developed a capacity to compensate for arginine 
degradation by increasing the mRNA expression of enzymes (ASS and ASL) responsible 
for arginine synthesis and inducing the expression of arginine membrane transporters 
(CAT2), to prevent excessive production of reactive species and maintain normal 
physiological functions. 
Excessive production of reactive species can cause oxidative stress that lead to 
suboptimal animal growth. To protect against oxidative damage, glutathione functions as 
the most abundant antioxidant to maintain cellular redox potential (Aoyama et al., 2008; 
Forman et al., 2009; Schmidt and Dringen, 2012). Glutathione synthesis involves two 
consecutive ATP-requiring enzymatic reactions: formation of γ-glutamylcysteine from 
glutamate and cysteine by γ-glutamylcysteine ligase (GCLC and GCLM) and formation 
of glutathione from γ-glutamylcysteine and glycine by glutathione synthase (GSS). The 
rate-limiting enzyme GCL is composed of a catalytic subunit (GCLC) and a modifier 
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subunit (GCLM) (Yang et al., 2002; Franklin et al., 2009). GCLC catalyzes γ-
glutamylcysteine synthesis, whereas GCLM modulates GCLC by lowering the Km for 
glutamate and increasing the Ki for the feedback inhibition of GCL by glutathione 
(Richman and Meister, 1975; Huang et al., 1993a; Huang et al., 1993b; Chen et al., 
2005). Consequently, the holoenzyme GCL more efficiently catalyzes γ-glutamylcysteine 
synthesis and is subject to less GSH feedback inhibition compared to GCLC. The second 
step of GSH synthesis from γ-glutamylcysteine and glycine is catalyzed by glutathione 
synthase (GSS). Although glutathione synthase is usually not considered to be rate- 
limiting, increased glutathione synthase expression can further promote GSH production 
in rat hepatocytes (Huang et al., 2000; Dalton et al., 2004). Our previous RT-PCR data 
(Chapter 5) showed a decreased mRNA expression of GCLC and GSS in finished vs. 
growing steers, whereas GCLM did not differ. In contrast, the microarray data showed a 
decreased mRNA expression of GSS between finished vs. growing steers, although 
GSLC and GCLM did not differ. The incongruences between microarray and real-time 
RT-PCR analyses may be due to the different regions of DNA sequences used for primer 
design for RT-PCR. Combined, this data suggest a decreased capacity for GSH synthesis 
when beef steers compositional gain shifts from lean to lipid phenotype.  
GSH modulates diverse cellular processes. For example, GSH is involved in 
redox signaling, detoxification of xenobiotics and regulates cell proliferation, apoptosis 
and immunity (Meister and Anderson, 1983; Suthanthiran et al., 1990; Ballatori et al., 
2009; Lu, 2009; Pallardó et al., 2009; Liu and Pravia, 2010). Glutathione conjugate with 
xenobiotics via glutathione-S-transferases (GST) for the purpose of detoxification 
(Schmidt and Dringen, 2012). Our microarray data showed an increased mRNA 
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expression of GST1, GST2 and MGST3 (microsome GST3) in fininshed vs. growing 
steers, indicating a greater capacity of detoxification of blood and waste removal. 
Several GSH related enzymes guard cells against oxidative injury by scavenging 
reactive oxygen species and nitrogen radicals. In the cytosol and mitochondria, 
superoxide dismutase (SOD) catalyzes the dismutation of highly reactive superoxide 
radical (O2-) into less reactive hydrogen peroxide (H2O2) (Salvi et al., 2007). H2O2 and 
glutathione then can be converted to water and oxidized glutathione (GSSG) catalyzed by 
glutathione peroxidases (GPXs) (Fernandez Checa et al., 1997; Garcia Ruiz and 
Fernandez Checa, 2006; Lu, 2013). Among the GPXs enzymes, GPX1 is the most 
abundant isoform expressed in liver, accounting for more than 90% of total GPX activity 
(de Haan et al., 1998; Lei, 2001). Consistent with previous RT-PCR data of decreased 
GPX1 in finished vs. growing steers (Chapter 5), our microarray data showed an 
increased mRNA expression of SOD3 but decreased expression of GPX1, suggesting 
elevated H2O2 production and a decreased capacity of clearance of reactive species in 
finished vs. growing steers. 
Nitric oxide and superoxide anion are pro-inflammatory mediators. Recognizing 
that finished steers have less capacity for NO production but greater potential of 
converting highly reactive O2- into less reactive H2O2 prompted us to determine whether 
the inflammatory responses change when beef steers compositional gain shifts from lean 
to lipid phenotype. Among the top 7 canonical signaling pathways, several 
immunological signaling pathways (calcium-induced T lymphocyte apoptosis, leukocyte 
extravasation signaling and macropinocytosis signaling, etc.) were inhibited in finished 
vs. growing steers. Consistently, the microarray data showed a decreased mRNA 
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expression of genes (NOS2, SOCS2, CCL2, IL6R, TLR3) involved in inflammatory 
responses and an increased expression of inflammation resolution genes (CRP and SAA3, 
SERPINA14) (Suffredini et al., 1999; Foley et al., 2012), indicating a decreased 
inflammatory response in finished vs. growing steers. These findings are inconsistent 
with the previous reports that increased inflammation was found when non-ruminants 
such as mice and human develop from lean to obese phenotype (Zeyda and Stulnig, 
2009). However, our findings that finished steers have a reduced expression of hepatic 
GPX1 in concomitance with decreased inflammatory response are consistent with recent 
studies that hepatic GPX1 knockout mice were protected from inflammation and fibrosis 
(Loh et al., 2009; Haas and Staels, 2016; Merry et al., 2016). Because GPX1 acts 
primarily to attenuate insulin signaling, loss of hepatic GPX1 is beneficial in the context 
of inflammation and insulin resistance (Haas and Staels, 2016). 
 
Carbohydrate Metabolism 
Liver is a major organ for glycolysis and glycogen synthesis, which help to 
regulate blood glucose level in animal body. For glycolysis, the two critical regulatory 
steps are catalyzed by phosphoglycerate kinase (PGK) and pyruvate kinase (PK) 
(Newsholme and Gevers, 1967). PGK catalyzes the enzymatic transfer of a phosphate 
group from 1,3-bisphosphoglycerate to ADP, forming ATP and 3-phosphoglycerate. The 
final step of glycolysis pathway is catalyzed by PK, which converts phosphoenolpyruvate 
into a molecule of pyruvate and a molecule of ATP. Our microarray data showed a 
decreased mRNA expression of PGK1 and PKM2 in finished vs. growing steers, 
suggesting the capacity for glycolysis was inhibited when beef steers compositional gain 
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shifts from lean to lipid phenotype. 
In the liver, the two key enzymes involved in glycogen synthesis are glycogenin 
(GYG) and glycogen synthase (GYS) (Berg, 2012). Glycogen is initially synthesized 
from UDP-glucose by glycogenin (GYG) to produce glucosyl-glycogenin. Subsequently, 
the enzyme glycogen synthase (GYS) uses UDP-glucose to lengthen the glycogen chain. 
Our microarray data showed an increased mRNA expression of GYG2 and GYS2 in 
finished vs. growing steers, suggesting the capacity for glycogen synthesis was 
stimulated when beef steers compositional gain shifts from lean to lipid phenotype. 
 
Lipid Metabolism 
In addition to adipose tissue, the liver is the principle site for lipid metabolism. 
Fatty acid from the blood taken up by the liver can either be broken down to provide 
energy via beta-oxidation, or be used as a substrate for triglyceride synthesis and lipid 
storage. The first step of beta-oxidation of the fatty acid is mediated by acyl-CoA 
dehydrogenase (ACAD). After hydration and oxidation by NAD+, the intermediate 
product beta-ketoacyl CoA is subsequently cleaved by acetyl-CoA acyltransferase 
(ACAA) to produce acetyl-CoA and acyl-CoA (Schulz, 1991). Our microarray data 
showed an increased mRNA expression of ACADL (acyl-CoA dehydrogenase, long 
chain) and ACAA1, suggesting an increased capacity for beta-oxidation in finished vs. 
growing steers.  
Growth hormone plays essential roles in mediating hepatic lipid metabolism 
(Davidson, 1987; Møller and Jørgensen, 2009; Vijayakumar et al., 2010). Deletion of the 
hepatic growth hormone receptor (GHR) gene in mice resulted in enhanced intrahepatic 
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triglyceride synthesis and decreased efflux from the liver (Fan et al., 2009). To maintain 
the normal lipid metabolism in the liver, lysosomal acid lipase (LIPA) functions to 
hydrolyze triglyceride and cholesteryl esters. Deficiency of LIPA leads to massive 
storage of triglyceride and cholesteryl esters in the liver of a mouse model (Du et al., 
2001). Our microarray data showed a decreased mRNA expression of GHR and LIPA in 
finished vs. growing steers, suggesting increased lipid storage in the liver when beef 
steers compositional gain shifts from lean to lipid phenotype. 
 
In summary, the results of this transcriptomic study extended the previous 
findings that shifts in hepatic nitrogen metabolism are associated with the change in 
whole-body compositional gain of growing vs. finished beef steers (Chapter 4 and 5). 
The changes in relative mRNA abundance putatively represent parallel shifts in 
functional capacities for (1) arginine synthesis and metabolism, (2) downregulation of 
upstream regulators of high-affinity Glu transporters, (3) decreased antioxidant capacity, 
(4) altered inflammatory responses, and (5) altered carbohydrate and lipid metabolism. 
Although not further evaluated in this manuscript, transcriptomic analysis identified that 
calcium induced-T lymphocytes apoptosis pathway was the top canonical signaling 
pathway affected when beef steers compositional gain shifts from lean to lipid phenotype. 
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Figure 6. 1 Principle component (PC) analysis of microarray transcriptome analysis of 16 
liver samples from growing (lean, n = 8, red dots) and finished (lipid, n = 8, blue dots) 
Angus steers. The red and blue dots represent linear combinations of the relative 
expression data, including expression values and variances, of the 26,773 gene transcripts 
in each Bovine GeneChip. The center dot (centroid) for each treatment groups represents 
the overall treatment expression pattern. The relative relationship of genes with either a 
high (13.3%, PC #1, x-axis), median (9.55%, PC#2, y-axis), and low (7.71%, PC#3, z-
axis) range of variance are mapped.  
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Figure 6. 2 Hierarchical cluster analysis of the 1100 genes selected as being differentially 
expressed (ANOVA P values of < 0.01 and false discovery rates of < 10%) by the liver of 
finished (lipid, n = 8) vs. growing (lean, n = 8) steers. The expression level for each gene 
transcript was standardized to mean of 0 and scale to SD of 1, which is the default setting 
of the Partek Genomics Suite software. As indicated by the legend color box, gray color 
in the middle represents the mean value, 0, red color represents gene expression levels 
above the mean expression whereas blue color denotes expression below the mean. The 
intensity of the color reflects the relative intensity of the fold change.  
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Figure 6. 3 The sequences of the real-time RT-PCR products (5’ to 3’ orientation). 
Within a sequence, two underlines indicate the forward and reverse primer positions, 
respectively. 
Akt3: NM_001191309.1  
TGGGTTCAGAAGAGGGGAGAATATATAAAAAACTGGAGGCCAAGATATTTCCTTTTG
AAGACAGATGGCTCATTCATAGGATATAAAGAGAAACCCCAAGATGTGGATTTACCT
TATCCCCTCAACAACTTTTCAGTAGCAAAATGCCAGTTAATGAAAACAGAACGACCA
AAGCCAAACANA 
 
Jak2: XM_015464498.1  
TGCCGGTATGACCCTCTACAAGACAATACTGGGGAGGTGGTGGCTGTGAAAAAGCTCCAGCA
CAGTACTGAAGAGCACCTCAGAGACTTCGAAAGAGAAATTGAAATCCTTAAATCCTTGCAGC
ATGACAACATTGTAAAATACAAAGGAGTCTGCTACAGTGCTGGCCGGCATAATCTAAGATTA
ATTATGGAGTATTTACCATATGGAAGTTTACGAGACTATCTCCAAAAACATAAAGAACGGATA
GATCATAAAAAACTTCTGCAATACACATCTCAGATATGCAAGGGGATGGAATATCTTGGTACA
AAAAGATATATCCACAGGGATCTGGNAANAACAAGG 
 
Mtor: XM_015466778.1  
CGGCAACTTGACCATCCTCTGCCAACGGTTCACCCCCAGGTGACCTACGCCTACATG
AAAAATATGTGGAAGAGCGCCCGCAAGATTGATGCCTTCCAGCACATGCAGCACTTT
GTTCAGACCATGCAGCAGCAAGCCCAGCATGCCATCGCCACCGAGGACCAGCAGCA
CAAGCAGGAGCTGCACAAGCTCATGGCCCGATGTTTCCTGAAACTCGGGGAGTGGCA
GCTGAACCTACAGGGCATCAACGAGAGCACGATCCC 
 
Pdgfra: NM_001192345.2   
GTGGAACACTGCTGTCCACTCTGAATTCATGCATGACCACGTTGACTATGGCTTTCAA
AGTTGTGAAAGTAAATTCAATTGGCGGATTATAAAGGAAAAGCGGGACGCCTATGT
GAGCCGCCTGAACACCATCTATCAAAATAATCTAACCAAGTCCCACATAGACATCAT
CCATGGCCATGCAGCATTCACGTGCGATCCTCAGCCCACAGTGAGGTCAACGGGAAA
AAATACACCGCTCCTCACATCCTGATC 
 
Pdgfrb: NM_001075896.2  
AGGCATCAGCAGCAAGGATACCATGTGGCTTCCGAGCGCCATGCAAGCTGTTGTCCT
CAAAGGCCGGGTGCTATTGCTGCCCCTGCTGTTTCTGCTGGGACCACAGGCCTCCTG
GGGCCTGGCCATCATACCCCCGGGGCCAGAACTTGTCCTCAACCTCTCCAGCACCTTT
GTCCTGACCTGCTCGGGCCCAGCTCCAGTGGTGTGGGAACGGATGTCCCAGAAACCC
CCCCAGGAAATGACCGAGACCCAGG 
 
Pdpk1: XM_015469224.1  
CAATGTGACTGAGGTGGTCCGCAACATGACCTCCGAGTTCTTTGCCGCCAGCTCTGG
GCCCGGATCTCCGACAGCACCACTCACCCAGCCTCCTACTACGAGCCTGAGTTCTAC
ACGCCAGACGGTGGGGGCACCGCCCACCTGTCGGTGGTCTCGGAGGACGGCAGCGC
TGTGTCGGCCACCAGCACCATCAACCTCTACTTCGGTTCCAAGGTGCG 
 
Pik3cg: NM_001102125.2  
CTGCGCCTAGACATGCTTATTCTACAGATTCTACGAATTATGGAGTCCATTTGGGAGA
CTGAATCTTTGGATCTGTGCCTCCTGCCATATGGTTGCATTTCAACTGGTGACAAAAT
AGGAAACCACCAGCACGAACCTGGAAAATAACCTTCTGGTTGAGAAAGCTCTCTACC
CTCCACTGAACAAAGACACAGCCATTCCTCCTCTGGGTCCGGTGCTTGGTTCCAGTTC
ACA 
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Pik3r1: NM_174575.1   
AGAGGACATTGACTTGCACCTGGGGGACATATTGACTGTGAACAAAGGGTCCTTAGT
CGCTCTTGGATTCAGTGAGGACAGGAAGCCAAGCCTGAAGAAATTGGCTGGTTAAAT
GGTATAACGAGACGACAGGGGAGAG 
 
Prkaa1: NM_001109802.2  
TTTGCGTGTTCGGAGGAAGAATCCTGTGACAAGTACATACTCCAAAATGAGTCTGCA
GTTATACCAAGTGGATAGTAGAACGTATTTACTGGATTTCCGAAGTATTGATGATGA
AATTACTGAAGCCAAATCAGGGACTGCTACGCCACAGAGATCGGGCTCAGTTAGCA
ACTATCGAGCTTGCCA 
 
Prkag1: NM_174586.2    
GATGAGAAAGGGCGTGTGGTGGACATCTACTCCAAGTTTGATGTTATCAACCTGGCA
GCAGAAAAGACCTACAACAACCTAGATGTGTCAGTGACCAAAGCCCTGCAACATCG
ATCACATTACTTTGAGGGTGTTCTCAAGTGCTACCTGCATGAGACTCTGGAAACCATC
ATCAATAGGCTGGTAGAAGCAGAGGTTCACCGACTT 
 
Prkar2b: NM_174649.2   
GATGAGAAAGGGCGTGTGGTGGACATCTACTCCAAGTTTGATGTTATCAACCTGGCA
GCAGAAAAGACCTACAACAACCTAGATGTGTCAGTGACCAAAGCCCTGCAACATCG
ATCACATTACTTTGAGGGTGTTCTCAAGTGCTACCTGCATGAGACTCTGGAAACCATC
ATCAATAGGCTGGTAGAAGCAGAGGTTCACCGACTT 
 
Prkca: NM_174435.1    
CGGATGAANAGCTGCACGTCACAGTACGAGACGCGAAAAACCTAATCCCTATGGAT
CCAAATGGGCTTTCAGATCCTTACGTGAAGCTGAAGCTTATTCCTGACCCCAAGAAC
GAGAGCAAACAGAAAACCAAGACCATCCGCTCGACGCTGAACCCCCGGTGGGACGA
GTCCTTCACGTTCAAATTAAAACCTTCTGATAAAGACCGGCGACTGTCCGTGGAAAT
CTGGGACTGGGATCGAACCACACGGAACGACTTCATGGGGTCCCTTTCCTTTGGGGT
CTCGGAGCTGATGAAGATGCC 
 
Prkce: NM_001111120.2   
CAGACTTTCCCTTCGACCCCTACATCGCCCTCAACGTGGACGACTCGCGCATCGGCC
AAACGGCCACCAAGCAGAAGACCAACAGCCCGGCCTGGCACGACGAGTTCGTCACT
GATGTGTGCAACGGGCGCAAGATCGAGTTGGCTGTCTTCCACGATGCCCCCATCGGC
TACGATGACTTCGTGGCCAACTGCACCATCCAGTTTGAGGAGCTGCTGCAGAACGGG
AGCCGTCACTTCGAGGACTGGATTGATCTGGAGCCAGAAGGAAGAGTGTATGTGATC
ATTGATCTCTCGGGGTCGTCAGGTAAAGCCCCTAA 
 
Sgk1: NM_001102033.1   
CTCCAGAATGAGAGGCATGGTAGCAATTCTCATCGCTTTTATGAAACAGAGAAGGAT
GGGCCTGAATGACTTTATTCAGAAGATTGCCAATAACTCCTATGCATGCAAACACCC
TGAAGTTCAGTCCATTTGAAATCTCCCCACCTCAGGAACCTGAGCTTATGAATGCCA
ACCCTTCTCCTCCACCAAG 
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CHAPTER 7. Summary and Conclusions  
 
Improvement of feeding regimens for production animals has been hindered by a 
lack of fundamental knowledge about how the capacity to regulate nutrient absorption 
across cell membranes affects the function of nutrient metabolizing enzymes. The overall 
objective of this dissertation was to determine how Glu transport capacity is regulated to 
support peripheral tissue metabolism, and to identify the metabolic shift when beef steers 
compositional gain shifts from lean to lipid phenotype.  
In chapter 4, this study aimed to determine if hepatic activities and protein content 
of system X-AG transporter (EAAC1, GLT-1) and system X-AG regulatory proteins 
(GTRAP3-18, ARL6IP1), and glutamine synthetase (GS) activity and content, differed as 
beef steers transitioned from predominantly-lean (growing) to –lipid (finished) tissue 
accretion phases. There are three salient observations from this study. To our knowledge, 
this is the first report to describe a decrease in glutamate transport capacity in the liver as 
cattle develop from lean to finished phenotypes. Second, the decreased content of 
EAAC1 and system X-AG activity in hepatic apical membranes was concomitant with 
decreased hepatic GS activity. Both of these findings appear incongruent with accepted 
understandings for nonruminants. That is, for nonruminants, it has been argued that Na+-
dependent Glu uptake does not limit pericentral hepatocyte GS activity and that GS 
activity is relatively insensitive to change in various metabolic states (as reviewed by 
Watford, 2000). Thus, our findings may represent another difference in hepatic Gln 
metabolism between ruminants and nonruminats. Third, a negative functional 
relationship of system X-AG activity and transporter content to GTRAP3-18 and ARP6IP1 
content outside of brain tissue/cultured cells, was first identified in finished vs. growing 
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steers. In summary, these results indicate the metabolic shift in nitrogen metabolism 
when beef steers compositional gain shifts from lean to lipid phenotype. Moreover, future 
research is warranted to measure the ammonia concentration in the blood of growing and 
finished steers, and to investigate the mechanisms of how GTRAP3-18 regulates blood 
ammonia concentrations when steers develop from growing to finished production stage. 
In addition to liver, skeletal muscle and adipose tissues play important roles in 
maintaining whole-body Glu and N homeostasis via Glu transporters and Glu-utilizing 
enzymes. The goal of Chapter 5 was to determine if the content of high affinity Glu 
transporter EAAC1, GTRAP3-18 (an inhibitor of EAAC1), ARL6IP1 (an inhibitor of 
GTRAP3-18), glutamine synthase (GS) and glutathione (GSH) changes in longissimus 
dorsi (LM) and subcutaneous adipose tissue (SF), as it does in the liver, when steers 
develop from predominately lean to lipid growth phases. There are two major findings in 
Chapter 4. First, the negative regulatory relationship between GTRAP3-18 and ARL6IP1 
with EAAC1 and GS expression, which exists in liver, does not exist in LM and SF of 
fattened cattle. Thus, novel regulators may contribute to the differential expression of 
EAAC1, GS and GSH content in LM and SF. Second, the antioxidant capacity in LM and 
SF changes and differs as steer compositional gain shifts from lean to lipid phenotype. 
These findings provide mechanistic knowledge of how the antioxidant capacity is 
achieved in tissues of economic and metabolic importance to fattened cattle. Given the 
potentially large economic benefits associated with optimized tissue accretion, future 
research is needed to determine if activities of glutamate transport, GS and antioxidant 
enzymes change in LM and SF when beef steers develop from growing to finished 
production stage. 
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To further explore the upstream regulatory machinery of EAAC1, transcriptome 
analysis (Chapter 6) was conducted to gain a greater understanding of hepatic metabolic 
shifts associated with the change in whole-body compositional gain of growing vs. 
finished beef steers. The expression of upstream regulators of EAAC1 was decreased in a 
manner consistent with the decreased EAAC1 activity in Experiment 1. Thus, the results 
of this transcriptomic study extended the previous findings that shifts in hepatic nitrogen 
metabolism are associated with the change in whole-body compositional gain of growing 
vs. finished beef steers. In addition to nitrogen metabolism, the changes in relative 
mRNA abundance putatively represent parallel shifts in functional capacities for (1) 
arginine synthesis and metabolism, (2) decreased antioxidant capacity, (3) altered 
inflammatory responses, and (4) altered carbohydrate and lipid metabolism. Although not 
further evaluated in Chapter 6, transcriptomic analysis identified that calcium induced-T 
lymphocytes apoptosis pathway was the top canonical signaling pathway affected when 
beef steers compositional gain shifts from lean to lipid phenotype. 
In conclusion, these studies describe novel regulatory relationships of system X-
AG in liver and peripheral tissues, and the metabolic mechanisms that control nutrient use 
efficiency, as beef steers develop from lean to lipid phenotypes. By understanding the 
molecular and cellular mechanisms associated with different phases of growth, this 
dissertation provides mechanistic knowledge that can be applied to optimize tissue 
protein accretion, resulting in improved carcass quality and diminished animal waste. 
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Appendix 1. Examples of SAS Analysis and Outputs 
 
Analysis of mRNA expression of GPX1 in the liver of finished vs. growing steers 
(Chapter 4) 
 
1. Representative of SAS editor programming language using Proc glm (mRNA 
expression of GPX1 in the liver of finished vs. growing steers) (Chapter 4)   
/* Import data */ 
PROC IMPORT OUT= WORK.liver 
            DATAFILE= "C:\Users\as_gen\Desktop\SAS\liver.csv"  
            DBMS=csv REPLACE; 
     GETNAMES=YES; 
     DATAROW=2;  
RUN; 
 
PROC PRINT DATA=liver; 
RUN; 
proc means n mean stddev stderr min max print; 
by trt; 
run; 
proc glm DATA=liver plots=diagnostics; 
class trt; 
model GPX1=trt; 
LSMEANS trt/STDERR PDIFF; 
run;quit; 
 
2. SAS output 
The SAS System 
 
The GLM Procedure 
Class Level Information 
Class Levels Values 
trt 2 LEAN LIPID 
 
Number of Observations Read 16 
Number of Observations Used 16 
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The SAS System 
 
The GLM Procedure 
  
Dependent Variable: GPX1  
Source DF Sum of Squares Mean Square F Value Pr > F 
Model 1 0.35479819 0.35479819 16.51 0.0012 
Error 14 0.30090523 0.02149323     
Corrected Total 15 0.65570342       
 
R-Square Coeff Var Root MSE GPX1 Mean 
0.541096 16.97259 0.146606 0.863779 
 
Source DF Type I SS Mean Square F Value Pr > F 
trt 1 0.35479819 0.35479819 16.51 0.0012 
 
Source DF Type III SS Mean Square F Value Pr > F 
trt 1 0.35479819 0.35479819 16.51 0.0012 
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The SAS System 
 
The GLM Procedure 
Least Squares Means 
trt GPX1 
LSMEAN 
Standard 
Error 
H0:LSMEAN=0 H0:LSMean1=LSMean2 
Pr > |t| Pr > |t| 
LEAN 1.01269133 0.05183294 <.0001 0.0012 
LIPID 0.71486664 0.05183294 <.0001   
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